
<html lang="en"     class="pb-page"  data-request-id="33ccc43c-d5ce-4765-bbbf-95a7eadf8ae5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm4010237;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-21;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Tumor Diagnosis with New 111In-Radioligands Based on Truncated Human Gastrin Releasing Peptide Sequences: Synthesis and Preclinical Comparison" /></meta><meta name="dc.Creator" content="Panteleimon J.  Marsouvanidis" /></meta><meta name="dc.Creator" content="Theodosia  Maina" /></meta><meta name="dc.Creator" content="Werner  Sallegger" /></meta><meta name="dc.Creator" content="Eric P.  Krenning" /></meta><meta name="dc.Creator" content="Marion   de Jong" /></meta><meta name="dc.Creator" content="Berthold A.  Nock" /></meta><meta name="dc.Description" content="Radiolabeled analogs of the frog tetradecapeptide bombesin (BBN) have been proposed for diagnosis and therapy of gastrin releasing peptide receptor (GRPR)-expressing tumors. Following a different a..." /></meta><meta name="Description" content="Radiolabeled analogs of the frog tetradecapeptide bombesin (BBN) have been proposed for diagnosis and therapy of gastrin releasing peptide receptor (GRPR)-expressing tumors. Following a different a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 23, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4010237" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4010237" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4010237" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4010237" /></link>
        
    
    

<title>Tumor Diagnosis with New 111In-Radioligands Based on Truncated Human Gastrin Releasing Peptide Sequences: Synthesis and Preclinical Comparison | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4010237" /></meta><meta property="og:title" content="Tumor Diagnosis with New 111In-Radioligands Based on Truncated Human Gastrin Releasing Peptide Sequences: Synthesis and Preclinical Comparison" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0005.jpeg" /></meta><meta property="og:description" content="Radiolabeled analogs of the frog tetradecapeptide bombesin (BBN) have been proposed for diagnosis and therapy of gastrin releasing peptide receptor (GRPR)-expressing tumors. Following a different and yet unexplored approach, we have developed four novel 111In-labeled truncated analogs of the human 27-mer GRP after conjugation of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) at the N-terminus of GRP(13/14/17/18–27) fragments. Analog affinities for the human GRPR determined against [125I-Tyr4]BBN were at the nanomolar level and dependent on truncation site. The respective 111In radioligands specifically internalized in GRPR-expressing PC-3 cells. The shorter chain [111In-DOTA]GRP(17/18–27) analogs showed higher metabolic stability in mice. Radioligands specifically localized in human PC-3 xenografts in SCID mice, with [111In-DOTA]GRP(17–27) exhibiting the most favorable pharmacokinetic profile. This study has demonstrated the efficacy of human GRP-based radiopeptides to target GRPR-positive lesions in vivo and has revealed the impact of GRP chain length on key biological parameters of resulting radiotracers." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4010237"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4010237">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4010237&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4010237&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4010237&amp;href=/doi/10.1021/jm4010237" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 8579-8587</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401276h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401040b" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Tumor Diagnosis with New <sup>111</sup>In-Radioligands Based on Truncated Human Gastrin Releasing Peptide Sequences: Synthesis and Preclinical Comparison</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Panteleimon+J.++Marsouvanidis">Panteleimon J. Marsouvanidis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Theodosia++Maina">Theodosia Maina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Werner++Sallegger">Werner Sallegger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+P.++Krenning">Eric P. Krenning</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marion+++de+Jong">Marion de Jong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Berthold+A.++Nock">Berthold A. Nock</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Molecular Radiopharmacy, INRASTES, National Center for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>‡</sup>Department of Nuclear Medicine and Radiology and <sup>§</sup>Department of Radiology, Erasmus MC, 3015 CE Rotterdam, The Netherlands</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">∥</span> <span class="aff-text">piCHEM, A-8045 Graz, Austria</span></div><div class="corresp-info"><strong>*</strong>Phone: +30-210-6503908. E-mail: <a href="/cdn-cgi/l/email-protection#533d3c30380c313621273b3c3f377d32133b3c273e323a3f7d303c3e"><span class="__cf_email__" data-cfemail="d6b8b9b5bd89b4b3a4a2beb9bab2f8b796beb9a2bbb7bfbaf8b5b9bb">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4010237&amp;href=/doi/10.1021%2Fjm4010237" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 8579–8587</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 4, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 July 2013</li><li><span class="item_label"><b>Published</b> online</span>23 October 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 November 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4010237" title="DOI URL">https://doi.org/10.1021/jm4010237</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8579%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPanteleimon%2BJ.%2BMarsouvanidis%252C%2BTheodosia%2BMaina%252C%2BWerner%2BSallegger%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D21%26contentID%3Djm4010237%26title%3DTumor%2BDiagnosis%2Bwith%2BNew%2B111In-Radioligands%2BBased%2Bon%2BTruncated%2BHuman%2BGastrin%2BReleasing%2BPeptide%2BSequences%253A%2BSynthesis%2Band%2BPreclinical%2BComparison%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8587%26publicationDate%3DNovember%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4010237"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">506</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4010237" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Tumor Diagnosis with New 111In-Radioligands Based on Truncated Human Gastrin Releasing Peptide Sequences: Synthesis and Preclinical Comparison&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Panteleimon&quot;,&quot;last_name&quot;:&quot;J. Marsouvanidis&quot;},{&quot;first_name&quot;:&quot;Theodosia&quot;,&quot;last_name&quot;:&quot;Maina&quot;},{&quot;first_name&quot;:&quot;Werner&quot;,&quot;last_name&quot;:&quot;Sallegger&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;P. Krenning&quot;},{&quot;first_name&quot;:&quot;Marion&quot;,&quot;last_name&quot;:&quot; de Jong&quot;},{&quot;first_name&quot;:&quot;Berthold&quot;,&quot;last_name&quot;:&quot;A. Nock&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;8579-8587&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4010237&quot;},&quot;abstract&quot;:&quot;Radiolabeled analogs of the frog tetradecapeptide bombesin (BBN) have been proposed for diagnosis and therapy of gastrin releasing peptide receptor (GRPR)-expressing tumors. Following a different and yet unexplored approach, we have developed four novel 111In-labeled truncated analogs of the human 27-mer GRP after conjugation of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) at the N-terminus of GRP(13/14/17/18–27) fragments. Analog affinities for the human GRPR determined against [125I-Tyr4]BBN were at the nanomolar level and dependent on truncation site. The respective 111In radioligands specifically internalized in GRPR-expressing PC-3 cells. The shorter chain [111In-DOTA]GRP(17/18–27) analogs showed higher metabolic stability in mice. Radioligands specifically localized in human PC-3 xenografts in SCID mice, with [111In-DOTA]GRP(17–27) exhibiting the most favorable pharmacokinetic profile. This study has demonstrated the efficacy of human GRP-based radiopeptides to target GRPR-positive le&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4010237&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4010237" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4010237&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4010237" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4010237&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4010237" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4010237&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4010237&amp;href=/doi/10.1021/jm4010237" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4010237" /></input><a href="/doi/pdf/10.1021/jm4010237" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4010237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4010237%26sid%3Dliteratum%253Aachs%26pmid%3D24094035%26genre%3Darticle%26aulast%3DMarsouvanidis%26date%3D2013%26atitle%3DTumor%2BDiagnosis%2Bwith%2BNew%2B111In-Radioligands%2BBased%2Bon%2BTruncated%2BHuman%2BGastrin%2BReleasing%2BPeptide%2BSequences%253A%2BSynthesis%2Band%2BPreclinical%2BComparison%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D21%26spage%3D8579%26epage%3D8587%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jmcmar.2013.56.issue-21/production/jmcmar.2013.56.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/medium/jm-2013-010237_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4010237&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Radiolabeled analogs of the frog tetradecapeptide bombesin (BBN) have been proposed for diagnosis and therapy of gastrin releasing peptide receptor (GRPR)-expressing tumors. Following a different and yet unexplored approach, we have developed four novel <sup>111</sup>In-labeled truncated analogs of the human 27-mer GRP after conjugation of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) at the N-terminus of GRP(13/14/17/18–27) fragments. Analog affinities for the human GRPR determined against [<sup>125</sup>I-Tyr<sup>4</sup>]BBN were at the nanomolar level and dependent on truncation site. The respective <sup>111</sup>In radioligands specifically internalized in GRPR-expressing PC-3 cells. The shorter chain [<sup>111</sup>In-DOTA]GRP(17/18–27) analogs showed higher metabolic stability in mice. Radioligands specifically localized in human PC-3 xenografts in SCID mice, with [<sup>111</sup>In-DOTA]GRP(17–27) exhibiting the most favorable pharmacokinetic profile. This study has demonstrated the efficacy of human GRP-based radiopeptides to target GRPR-positive lesions in vivo and has revealed the impact of GRP chain length on key biological parameters of resulting radiotracers.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The overexpression of gastrin releasing peptide receptors (GRPRs) in various frequently occurring human tumors, including prostate, breast, and lung cancer,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> has provided the opportunity for GRPR-directed tumor diagnosis and therapy with the aid of radiolabeled peptide probes. As a result, a considerable amount of data has accumulated over the past two decades referring to the preclinical and the clinical evaluation of radiolabeled analogs of the amphibian tetradecapeptide bombesin (BBN) and its derivatives for visualization and treatment of GRPR-positive cancer.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> These analogs have been modified by conjugation of suitable chelators at the N-terminus to accommodate a wide range of medically appealing radiometals.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> After administration of such radiolabeled BBN-like peptide carriers, γ and positron emitters specifically accumulate in GRPR-positive primary and metastatic tumor sites, allowing diagnostic imaging with SPECT or PET. On the other hand, lesion-localized particle emitters uploading cytotoxic radiation selectively on cancer cells can induce apoptosis and death.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15">(10-15)</a></div><div class="NLM_p">Native BBN isolated from the skin of the European frog <i>Bombina bombina</i><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> binds with comparable affinity to the mammalian bombesin receptor subtypes neuromedin B (NMBR, BB<sub>1</sub>R) and GRPR (BB<sub>2</sub>R).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> These two subtypes are physiologically expressed in the human brain and gut, especially in stomach, pancreas, and gastrointestinal tract and are pharmacologically distinguished by their selectivity for different endogenous human homologues of frog BBN.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Thus, the decapeptide neuromedin B (NMB) displays high affinity for the NMBR, whereas the 27-mer GRP, the 14-mer GRP(14–27), and the C-terminal decapeptide fragment, known also as neuromedin C [NMC, GRP(18–27)], strongly bind the GRPR.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> All these peptides and their receptors are implicated in cancer.<a onclick="showRef(event, 'ref6 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref6 ref20 ref21 ref22 ref23">(6, 20-23)</a></div><div class="NLM_p">In contrast to frog BBN-like peptides, the respective human homologues have surprisingly remained unexploited as radionuclide-carriers for targeting GRPR-positive cancer. Prompted by the lack of relevant studies we decided to expand our current search toward human GRP-sequences and explore their applicability in GRPR-targeted diagnosis and therapy of human tumors. As a first step, we have recently introduced the human NMC-based radiotracer, [<sup>99m</sup>Tc]Demomedin C {[<sup>99m</sup>Tc-N<sub>4</sub>]GRP(18–27)} and its analogs.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> Compared to previously reported <sup>99m</sup>Tc-radiopeptides, which were based on the full-length BBN or its truncated BBN(7–14) octapeptide fragment,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> [<sup>99m</sup>Tc]Demomedin C showed superior in vivo characteristics in tumor-bearing mice, such as faster renal clearance and improved tumor to background ratios.</div><div class="NLM_p">This positive experience motivated us to broaden the spectrum of radionuclides considered for labeling beyond the diagnostic γ-emitter <sup>99m</sup>Tc to include a variety of trivalent radiometals attractive for clinical diagnosis and therapy, such as <sup>111</sup>In, <sup>67/68</sup>Ga, <sup>177</sup>Lu, <sup>90</sup>Y, and others. For this purpose, we have now coupled the universal chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> at the N-terminal Gly of NMC [GRP(18–27)]. This position is occupied by basic Arg<sup>17</sup> in the native GRP sequence while in [<sup>99m</sup>Tc]Demomedin C it is taken by the positively charged N<sub>4</sub><sup>+<i>x</i></sup>/[<sup>99m</sup>Tc(O)<sub>2</sub>(N<sub>4</sub>)]<sup>+1</sup> moiety.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Another analog was produced by elongation of the peptide chain of NMC to positions 17 of human GRP and DOTA conjugation to the corresponding Arg<sup>17</sup>. Further elongation on the natural GRP sequence to Met<sup>14</sup> and coupling of DOTA provides the conjugate corresponding to the endogenously occurring GRP(14–27) fragment. Finally, DOTA was coupled to the basic amino acid Lys<sup>13</sup> of native GRP. In short, four truncated GRP analogs have been obtained and labeled with <sup>111</sup>In, corresponding to the naturally occurring GRP(14/18–27) sequences and their GRP(13/17–27) counterparts containing the basic amino acids Lys<sup>13</sup> and Arg<sup>17</sup>, respectively.</div><div class="NLM_p">The four peptide conjugates, [DOTA]GRP(13–27) (<b>1</b>), [DOTA]GRP(14–27) (<b>2</b>), [DOTA]GRP(17–27) (<b>3</b>), and [DOTA]GRP(18–27) (<b>4</b>), were labeled with <sup>111</sup>In. The suitability of the resulting [<sup>111</sup>In]<b>1</b>–[<sup>111</sup>In]<b>4</b> radioligands (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) for diagnostic imaging of GRPR-expressing tumors was directly compared in GRPR-positive in vitro models and in SCID mice bearing human prostate cancer PC-3 xenografts. Accordingly, important information on the impact of GRP-chain length as well as of the positively charged Lys<sup>13</sup> and Arg<sup>17</sup> residues on several biological parameters of respective (radio)peptides could be acquired. These results are instrumental for early screening of the respective <sup>177</sup>Lu/<sup>90</sup>Y/<sup>213</sup>Bi-radioligands potentially considered for GRPR-aimed tumor therapy.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/medium/jm-2013-010237_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structure of [<sup>111</sup>In]<b>1</b>; sequences corresponding to [<sup>111</sup>In]<b>2</b>, [<sup>111</sup>In]<b>3</b>, and [<sup>111</sup>In]<b>4</b> are listed below along with the native BBN sequence for comparison purposes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4010237&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21567" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21567" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of [DOTA]GRPs and <sup>111</sup>In Labeling</h3><div class="NLM_p">The four peptide sequences (i) H-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub> (for <b>1</b>), (ii) H-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub> (for <b>2</b>), (iii) H-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub> (for <b>3</b>), and (iv) H-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub> (for <b>4</b>) were assembled on the solid support following typical Fmoc-protection methodology, and 1-(acetic acid)-4,7,10-tris(<i>tert</i>-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (DOTA-tris(<sup><i>t</i></sup>Bu ester)) was attached to their N-terminus in the last cycle. After release from the resin and removal of lateral protecting groups with TFA treatment, the four new DOTA–GRP conjugates (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) were isolated by chromatographic methods in ≥95% purity, as shown by analytical HPLC; MALDI-TOF spectra of the purified products <b>1</b>–<b>4</b> were consistent with the expected formulas (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Analytical Data for <b>1–4</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">MW<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">HPLC <i>t</i><sub>R</sub> (min), UV trace</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center">sequence</th><th class="colsep0 rowsep0" align="center">% purity<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">calcd</th><th class="colsep0 rowsep0" align="center" char=".">found(<i>m</i>/<i>z</i>, [M + H]<sup>+</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">system 1<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">system 2<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>1</b></td><td class="colsep0 rowsep0" align="left">[DOTA]GRP(13–27)</td><td class="colsep0 rowsep0" align="left">≥99</td><td class="colsep0 rowsep0" align="char" char=".">2182.6</td><td class="colsep0 rowsep0" align="char" char=".">2184.0</td><td class="colsep0 rowsep0" align="char" char=".">9.4</td><td class="colsep0 rowsep0" align="char" char=".">20.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>2</b></td><td class="colsep0 rowsep0" align="left">[DOTA]GRP(14–27)</td><td class="colsep0 rowsep0" align="left">≥97</td><td class="colsep0 rowsep0" align="char" char=".">2054.4</td><td class="colsep0 rowsep0" align="char" char=".">2055.6</td><td class="colsep0 rowsep0" align="char" char=".">9.9</td><td class="colsep0 rowsep0" align="char" char=".">22.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>3</b></td><td class="colsep0 rowsep0" align="left">[DOTA]GRP(17–27)</td><td class="colsep0 rowsep0" align="left">≥98</td><td class="colsep0 rowsep0" align="char" char=".">1662.9</td><td class="colsep0 rowsep0" align="char" char=".">1663.6</td><td class="colsep0 rowsep0" align="char" char=".">9.1</td><td class="colsep0 rowsep0" align="char" char=".">17.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>4</b></td><td class="colsep0 rowsep0" align="left">[DOTA]GRP(18–27)</td><td class="colsep0 rowsep0" align="left">≥98</td><td class="colsep0 rowsep0" align="char" char=".">1506.7</td><td class="colsep0 rowsep0" align="char" char=".">1507.5</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td><td class="colsep0 rowsep0" align="char" char=".">19.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Purity was determined by HPLC system 2.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Average mass.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">System 1: A Nucleosil-100 C18 column (5 μm, 150 mm × 4 mm) was eluted at a flow rate of 1 mL/min with a linear gradient of 0.1% TFA in MeCN (from 10% to 90% in 30 min) and 0.1% aqueous TFA as complementary phase; runs were monitored by UV detection at 215 nm.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">System 2: RP-HPLC with UV detection at 220 nm; An Xterra RP18 column (5 μm, 4.6 mm × 150 mm) was eluted at a flow rate of 1 mL/min with a linear gradient: 15% B to 30% B in 30 min, with A = 0.1% TFA in H<sub>2</sub>O (v/v) and B = MeCN.</p></div></div></div><div class="NLM_p">The corresponding four [<sup>111</sup>In-DOTA]GRP radiopeptides (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) were easily prepared by ≤20 min heating of respective [DOTA]GRP conjugates with <sup>111</sup>InCl<sub>3</sub> in acidic medium. Complete incorporation of <sup>111</sup>In by DOTA was verified by RP-HPLC, corresponding to >98% radiolabeling yield (less than 2% EDTA-bound <sup>111</sup>In<sup>3+</sup>).<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> The respective [<sup>111</sup>In-DOTA]GRP radioligands formed in >96% radiochemical purity (percentage of single [<sup>111</sup>In-DOTA]GRP species versus total peptide-associated radioactivity). Typical specific activities of 3.7–7.4 MBq/nmol peptide were easily achieved, and consequently, [<sup>111</sup>In]<b>1</b>–[<sup>111</sup>In]<b>4</b> were used as such without subsequent purification in all further experiments. The presence of 20 mM Met in the radiolabeling reaction mixtures as well as keeping incubation times at elevated temperatures as briefly as possible (≤20 min at 90 °C) successfully prevented sulfoxide formation (<5%). Without these precautions, up to 30% sulfoxide species (40 min at 90 °C and no Met addition) were detected by radio-HPLC, in agreement with previous reports.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p last">Furthermore, all solutions of [<sup>111</sup>In-DOTA]GRP radioligands (used in in vitro and in in vivo studies) contained methionine at a concentration of at least 1 mM. Tracer stock solutions used in biological testing (kept at room temperature and never used for longer than 2 h after their preparation) were always reanalyzed by HPLC, which did not reveal any significant increase in sulfoxide or any other radiochemical impurity.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> In Vitro Studies</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Affinity of [DOTA]GRPs for the Human GRPR</h4><div class="NLM_p">The binding affinities of the four new [DOTA]GRP conjugates for the human GRPR were determined against [<sup>125</sup>I-Tyr<sup>4</sup>]BBN in PC-3 cell membranes using human GRP(14–27) as reference peptide (IC<sub>50</sub> = 0.5 ± 0.1 nM). All analogs were able to effectively displace the radioligand from GRPR sites in a monophasic and dose-dependent manner, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. According to the IC<sub>50</sub> values determined, the following rank of affinity could be established: <b>1</b> (IC<sub>50</sub> = 2.3 ± 0.2 nM) > <b>2</b> (IC<sub>50</sub> = 6.6 ± 0.9 nM) > <b>3</b> (IC<sub>50</sub> = 19.2 ± 2.9 nM) ≫ <b>4</b> (IC<sub>50</sub> = 112 ± 16 nM). These results demonstrate the impact of peptide chain length and of positively charged Lys<sup>13</sup> and Arg<sup>17</sup> residues on receptor affinity of the respective DOTA–GRP conjugates.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/medium/jm-2013-010237_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Curves of [<sup>125</sup>I-Tyr<sup>4</sup>]BBN displacement from human GRPR sites in PC-3 cell membranes during 1 h incubation at 22 °C by increasing concentrations of test peptide: gray asterisks, GRP(14–27) (reference); red squares, <b>1</b>; open squares, <b>2</b>; red diamonds, <b>3</b>; and open diamonds, <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4010237&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Internalization of [<sup>111</sup>In-DOTA]GRPs in PC-3 Cells</h4><div class="NLM_p">It is interesting to note that the internalization efficacy of [<sup>111</sup>In-DOTA]GRP radioligands in PC-3 cells was in line with the receptor affinity of the respective unlabeled analogs. As summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, [<sup>111</sup>In]<b>1</b> showed the highest internalization efficiency (29.0 ± 0.3% specifically internalized of total added radioactivity), whereas the poorest internalization capacity was exhibited by [<sup>111</sup>In]<b>4</b> (4.1 ± 0.2% specifically internalized of total added radioactivity). Internalization of [<sup>111</sup>In]<b>2</b> and [<sup>111</sup>In]<b>3</b> also paralleled receptor affinity results with the respective values amounting to 21.3 ± 0.1% and 17.5 ± 0.5%. In all cases, internalization dropped below 0.5% in the presence of 1 μM [Tyr<sup>4</sup>]BBN, indicating a GRPR-mediated process.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/medium/jm-2013-010237_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Internalization of [<sup>111</sup>In-DOTA]GRP radioligands, expressed as percentage internalized of total added radioactivity in confluent monolayers of PC-3 cells after 1 h incubation at 37 °C: solid red bar, [<sup>111</sup>In]<b>1</b>; solid black bar, [<sup>111</sup>In]<b>2</b>; cross-hatched red bar, [<sup>111</sup>In]<b>3</b>; cross-hatched black bar, [<sup>111</sup>In]<b>4</b>. In the presence of 1 μM [Tyr<sup>4</sup>]BBN (nonspecific internalization) values dropped to <0.5% (left group of bars).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4010237&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Metabolic Stability of [<sup>111</sup>In-DOTA]GRPs in Mice</h3><div class="NLM_p">The percentage of [<sup>111</sup>In-DOTA]GRP radiopeptides found intact 5 min after entry into the bloodstream of mice was measured by RP-HPLC analysis of mouse blood samples. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, a different extent of degradation and distinct radiometabolite patterns were observed for individual [<sup>111</sup>In-DOTA]GRPs. Experimental results ranked the analogs according to stability as follows: [<sup>111</sup>In]<b>3</b> (26.6%; 25.3% intact) ≈ [<sup>111</sup>In]<b>4</b> (22.5%; 24.5% intact) > [<sup>111</sup>In]<b>1</b> (22 ± 6% intact, <i>n</i> = 3) ≫ [<sup>111</sup>In]<b>2</b> (4.5%; 4% intact).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/medium/jm-2013-010237_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative radiochromatograms of blood samples collected 5 min postinjection in mice for (A) [<sup>111</sup>In]<b>1</b> (<i>t</i><sub>R</sub> = 38.0 min), (B) [<sup>111</sup>In]<b>2</b> (<i>t</i><sub>R</sub> = 39.8 min), (C) [<sup>111</sup>In]<b>3</b> (<i>t</i><sub>R</sub> = 29.3 min), and (D) [<sup>111</sup>In]<b>4</b> (<i>t</i><sub>R</sub> = 32.7 min); co-injection with labeling reaction samples indicated the position of parent radiopeptides (green arrow); chromatographic system 3 was applied in analyses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4010237&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Biodistribution of [<sup>111</sup>In-DOTA]GRPs in SCID Mice Bearing Human PC-3 Xenografts</h3><div class="NLM_p">Data of [<sup>111</sup>In-DOTA]GRPs biodistribution in SCID mice bearing human PC-3 xenografts are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> (for [<sup>111</sup>In]<b>1</b> and [<sup>111</sup>In]<b>2</b>) and Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> (for [<sup>111</sup>In]<b>3</b> and [<sup>111</sup>In]<b>4</b>). Results are expressed as average % ID/g values with standard deviation for 4 and 24 h postinjection. All radiopeptides showed a fast blood clearance. In all cases, radioactivity washed out from the body of mice via the kidneys rapidly into urine with excretion via the hepatobiliary pathway playing a minor role. It is interesting to note that the Lys<sup>13</sup>-containing [<sup>111</sup>In]<b>1</b> showed a much elevated renal uptake (46.0 ± 3.7% ID/g at 4 h postinjection), which exceeded the kidney uptake of all other members by 8–16-fold.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biodistribution Data of [<sup>111</sup>In]<b>1</b> and [<sup>111</sup>In]<b>2</b> in PC-3 Xenograft-Bearing SCID Mice</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char="±">% ID/g tissue ± SD, <i>n</i> = 4</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">[<sup>111</sup>In]<b>1</b></th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">[<sup>111</sup>In]<b>2</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organs</th><th class="colsep0 rowsep0" align="center" char="±">4 h block<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th><th class="colsep0 rowsep0" align="center" char="±">4 h block<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.02 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">1.13 ± 0.48</td><td class="colsep0 rowsep0" align="char" char="±">0.74 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">0.63 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.98 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">0.40 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.34 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>kidneys</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>13.14 ± 2.82</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>46.02 ± 3.73</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>29.00 ± 4.86</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>8.09 ± 1.50</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>5.70 ± 1.54</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>3.02 ± 0.19</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stomach</td><td class="colsep0 rowsep0" align="char" char="±">0.23 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">0.84 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">0.59 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.58 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">0.45 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">0.47 ± 0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intestines</td><td class="colsep0 rowsep0" align="char" char="±">2.02 ± 1.34</td><td class="colsep0 rowsep0" align="char" char="±">9.22 ± 1.52</td><td class="colsep0 rowsep0" align="char" char="±">2.76 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">3.22 ± 0.58</td><td class="colsep0 rowsep0" align="char" char="±">5.84 ± 1.13</td><td class="colsep0 rowsep0" align="char" char="±">2.46 ± 1.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="char" char="±">0.80 ± 0.67</td><td class="colsep0 rowsep0" align="char" char="±">1.55 ± 0.53</td><td class="colsep0 rowsep0" align="char" char="±">1.33 ± 0.43</td><td class="colsep0 rowsep0" align="char" char="±">0.64 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">0.53 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">0.20 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.15</td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.00 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">femur</td><td class="colsep0 rowsep0" align="char" char="±">0.08 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">0.21 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.01 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>pancreas</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>0.35 ± 0.16</b>*</td><td class="colsep0 rowsep0" align="char" char="±"><b>39.74 ± 6.79</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>37.62 ± 2.84</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>0.21 ± 0.04</b>*</td><td class="colsep0 rowsep0" align="char" char="±"><b>26.94 ± 5.64</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>16.51 ± 1.90</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>tumor</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>0.52 ± 0.16</b>*</td><td class="colsep0 rowsep0" align="char" char="±"><b>7.74 ± 1.93</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>5.25 ± 0.87</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>0.53 ± 0.10</b>*</td><td class="colsep0 rowsep0" align="char" char="±"><b>4.13 ± 0.40</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>2.51 ± 0.03</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Co-injection of 40 nmol [Tyr<sup>4</sup>]BBN for in vivo GRPR blockade; * indictates a highly significant (<i>P</i> < 0.005) difference between blocked and unblocked animals (unpaired two-tailed Student’s <i>t</i> test).</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biodistribution Data of [<sup>111</sup>In]<b>3</b> and [<sup>111</sup>In]<b>4</b> in PC-3 Xenograft-Bearing SCID Mice</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char="±">% ID/g tissue ± SD, <i>n</i> = 4</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">[<sup>111</sup>In]<b>3</b></th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">[<sup>111</sup>In]<b>4</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organs</th><th class="colsep0 rowsep0" align="center" char="±">4 h block<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th><th class="colsep0 rowsep0" align="center" char="±">4 h block<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="char" char="±">0.14 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">0.68 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">0.39 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.34 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">0.46 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">0.31 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">0.20 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="char" char="±">0.20 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.10 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.10 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.10 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.08 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.09 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>kidneys</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>3.39 ± 0.28</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>4.23 ± 1.09</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>3.23 ± 0.32</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>2.94 ± 0.80</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>2.92 ± 0.64</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>3.97 ± 0.99</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stomach</td><td class="colsep0 rowsep0" align="char" char="±">0.29 ± 0.22</td><td class="colsep0 rowsep0" align="char" char="±">0.55 ± 0.23</td><td class="colsep0 rowsep0" align="char" char="±">0.88 ± 0.53</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.37 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">0.79 ± 0.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intestines</td><td class="colsep0 rowsep0" align="char" char="±">1.17 ± 0.31</td><td class="colsep0 rowsep0" align="char" char="±">5.19 ± 1.12</td><td class="colsep0 rowsep0" align="char" char="±">1.70 ± 0.58</td><td class="colsep0 rowsep0" align="char" char="±">1.03 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">4.31 ± 0.81</td><td class="colsep0 rowsep0" align="char" char="±">1.51 ± 1.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="char" char="±">1.20 ± 0.24</td><td class="colsep0 rowsep0" align="char" char="±">0.77 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">0.60 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">0.81 ± 0.27</td><td class="colsep0 rowsep0" align="char" char="±">0.62 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">0.33 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.04 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.04 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">0.34 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.14 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">0.21 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">0.07 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">femur</td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.14 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>pancreas</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>0.37 ± 0.03</b>*</td><td class="colsep0 rowsep0" align="char" char="±"><b>22.06 ± 2.44</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>21.38 ± 3.62</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>0.37 ± 0.08</b>*</td><td class="colsep0 rowsep0" align="char" char="±"><b>19.06 ± 2.13</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>17.06 ± 0.43</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>tumor</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>0.44 ± 0.04</b>*</td><td class="colsep0 rowsep0" align="char" char="±"><b>4.63 ± 0.59</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>2.49 ± 0.31</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>0.47 ± 0.03</b>*</td><td class="colsep0 rowsep0" align="char" char="±"><b>3.54 ± 1.09</b></td><td class="colsep0 rowsep0" align="char" char="±"><b>1.76 ± 0.31</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Co-injection of 40 nmol [Tyr<sup>4</sup>]BBN for in vivo GRPR blockade; * indicates a highly significant (<i>P</i> < 0.005) difference between blocked and unblocked animals (unpaired two-tailed Student’s <i>t</i> test).</p></div></div></div><div class="NLM_p last">Uptake of [<sup>111</sup>In-DOTA]GRPs in the experimental tumors substantially differed across compounds. Thus, the highest PC-3 tumor uptake was exhibited by [<sup>111</sup>In]<b>1</b> (7.74 ± 1.93% ID/g at 4 h postinjection; Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), whereas the lowest was displayed by [<sup>111</sup>In]<b>4</b> (3.54 ± 1.09% ID/g at 4 h postinjection; Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>); the remaining two radiopeptides, [<sup>111</sup>In]<b>2</b> and [<sup>111</sup>In]<b>3</b>, showed very comparable tumor uptake (4–4.6% ID/g at 4 h postinjection). In all cases, the observed tumor values were significantly reduced (≈0.5% ID/g at 4 h postinjection, <i>P</i> < 0.005) in the animals treated with excess [Tyr<sup>4</sup>]BBN (in vivo GRPR blockade), demonstrating specific targeting of the human GRPR-positive xenografts by all four [<sup>111</sup>In-DOTA]GRP analogs. This trend was also preserved in the respective uptake of [<sup>111</sup>In-DOTA]GRPs in the mouse pancreas, which likewise reached the highest level in the case of [<sup>111</sup>In]<b>1</b> (≈40% ID/g at 4 h postinjection; Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76661" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76661" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over the past two decades significant effort has been invested in the development of radiolabeled BBN analogs with the aim to diagnose and combat GRPR-positive cancer in man.<a onclick="showRef(event, 'ref5 ref6 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref10">(5, 6, 10)</a> This pursuit has been based on the rationale that GRPRs, which are abundantly expressed in frequently occurring human cancers, can serve as easily accessible and highly selective molecular targets for BBN-like radionuclide carriers. In view of the lower GRPR expression in healthy background tissues, high contrast imaging and/or good therapeutic efficacy can be achieved.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Frog BBN binds with high affinity to human GRPR, inducing internalization, which in turn is expected to promote the localization of radiolabeled BBN-like agonists in GRPR-positive target cells and further improve diagnostic/therapeutic outcome.<a onclick="showRef(event, 'ref8 ref14'); return false;" href="javascript:void(0);" class="ref ref8 ref14">(8, 14)</a> Accordingly, a great number of BBN and BBN(7–14) octapeptide analogs designed to carry a wide range of diagnostic and therapeutic radiometals to GRPR-positive cancer have been tested both in animal models and in patients.<a onclick="showRef(event, 'ref9 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref9 ref11 ref12 ref13 ref14 ref15">(9, 11-15)</a></div><div class="NLM_p">Surprisingly, however, reports on GRPR-directed radiopeptides based on the more selective native human homologues of amphibian BBN have been altogether missing. The 27-mer GRP, GRP(14–27), and the C-terminal GRP(18–27) decapeptide fragment, referred to also as NMC, are the three well-known endogenous human homologues of BBN showing high interaction capacity with the GRPR (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref6 ref19'); return false;" href="javascript:void(0);" class="ref ref6 ref19">(6, 19)</a> We have recently been engaged in the study of human GRP(18–27)-based radioligands as an alternative route to target GRPR-expressing tumors in man. In our first attempt we coupled an acyclic tetraamine to the N-terminal Gly of NMC and its derivatives for stable binding of the SPECT radionuclide <sup>99m</sup>Tc.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> The resulting radiotracer [<sup>99m</sup>Tc]Demomedin C showed a very promising preclinical profile related to its faster background clearance when compared to previously reported and less GRPR-selective [<sup>99m</sup>Tc]Demobesin 3–6, which were based on BBN.</div><div class="NLM_p">In the present study, we first of all aimed toward multipurpose GRP analogs suitable for labeling with a wider spectrum of clinically relevant radiometals, including γ (<sup>111</sup>In, <sup>67</sup>Ga: SPECT), positron (<sup>68</sup>Ga: PET), and particle emitters (<sup>90</sup>Y, <sup>177</sup>Lu, <sup>213</sup>Bi: radionuclide therapy).<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> For this purpose we have used the universal chelator DOTA, instead of a tetraamine unit, for conjugation to the peptide moiety and <sup>111</sup>In labeling for a first screening of new compounds.</div><div class="NLM_p">In the design of our analogs we used human GRP-based sequences truncated in four different positions and based on the endogenous GRP(14–27) and GRP(18–27) structures. More specifically, we have coupled DOTA at the N-terminus of the following four different chain-length fragments: GRP(13/14/17/18–27) (<b>1</b>–<b>4</b>), whereby the shortest corresponds to the decapeptide NMC. Truncation sites were selected around the two basic amino acid Arg<sup>17</sup> and Lys<sup>13</sup> residues with the purpose to assess the significance of the positive charge present in these sites on key-biological characteristics of end (radio)ligands, such as GRPR-affinity, metabolic stability, and renal clearance. It should be noted, that in Demomedin C/[<sup>99m</sup>Tc]Demomedin C a positively charged moiety (N<sub>4</sub><sup>+<i>x</i></sup>/[<sup>99m</sup>Tc(O)<sub>2</sub>(N<sub>4</sub>)]<sup>+1</sup>) is replacing Arg<sup>17</sup>.<a onclick="showRef(event, 'ref24 ref28'); return false;" href="javascript:void(0);" class="ref ref24 ref28">(24, 28)</a> In the case of <b>4</b>, DOTA is instead introduced in this position, which after binding of <sup>111</sup>In forms a highly polar metal chelate. In <b>3,</b> the DOTA chelator is shifted next to Arg<sup>17</sup>, whereas a parallel pattern is reproduced around Lys<sup>13</sup> in the longer chain <b>1</b> and <b>2</b> members.</div><div class="NLM_p">The effect of above structural variations on GRPR affinity was first assessed during competition binding assays against [<sup>125</sup>I-Tyr<sup>4</sup>]BBN in PC-3 cell membranes. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, both peptide chain length and DOTA position greatly affect receptor affinity. In particular, GRP affinity increases in the longer chain members and especially when basic Lys is preserved in position 13 (IC<sub>50</sub> = 2.3 ± 0.2 nM, for <b>1</b>). The poorest affinity is exhibited by the shortest-chain analog <b>4</b> (IC<sub>50</sub> = 112 ± 16 nM), whereby DOTA is replacing Arg<sup>17</sup>. By comparing this affinity with the affinity of Demomedin C (IC<sub>50</sub> = 0.36 ± 0.01 nM)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> it becomes apparent that the presence of the negatively charged DOTA chelator at position 17 is not well tolerated by the GRPR. The internalization of the respective [<sup>111</sup>In-DOTA]GRP radiopeptides in PC-3 cells after 1 h incubation at 37 °C follows similar but less pronounced differences compared to the relative affinities of nonmetalated conjugates for the GRPR. Again, both peptide chain length and charge at positions 17 and 13 affect internalization capacities, as summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div><div class="NLM_p">After entry into circulation, all four [<sup>111</sup>In-DOTA]GRP radioligands suffered rapid enzymatic degradation in mice. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, radiometabolite patterns differed across analogs as well as the extent of breakdown within 5 min. In general, the shorter-chain [<sup>111</sup>In]<b>3</b> and [<sup>111</sup>In]<b>4</b> survived better (>20% intact at 5 min postinjection) as compared to the longer-chain [<sup>111</sup>In]<b>1</b> and [<sup>111</sup>In]<b>2</b> members. The poorest stability was displayed by [<sup>111</sup>In]<b>2</b> with only <5% detected intact in blood after the brief 5 min exposure in mouse circulation. Interestingly, the shorter-chain members presenting less putative cleavage sites to assailing enzymes survived longer in circulation, showing in vivo stability similar to that of  [<sup>99m</sup>Tc]Demomedin C.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Comparative biodistribution in mice bearing human GRPR-positive PC-3 xenografts reveals how the combination of receptor affinity, internalization capacity, and metabolic stability synergistically translates into the final in vivo profile, with focus primarily on tumor uptake and background clearance. It is interesting to note that the most GRPR-affine and best internalizing [<sup>111</sup>In]<b>1</b> exhibits the highest tumor uptake (7.74 ± 1.93% ID/g at 4 h postinjection) in this series of analogs, while the least receptor-affine and poorly internalizing [<sup>111</sup>In]<b>4</b> shows the lowest uptake in the experimental tumor (3.54 ± 1.09% ID/g at 4 h postinjection). These two analogs do not differ much in terms of metabolic stability. The high tumor uptake of [<sup>111</sup>In]<b>1</b> is however greatly compromised by unfavorably high and persistent accumulation of radioactivity in the kidneys (46.02 ± 3.73% ID/g at 4 h postinjection; 29.00 ± 4.86% ID/g at 24 h postinjection) which exceeds by far the respective values of the other [<sup>111</sup>In-DOTA]GRP analogs (Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and  <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Renal uptake seems to be related to the Lys<sup>13</sup>-residue, as previously reported for other Lys-containing radiopeptides.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a><sup></sup> Co-injection of Lys and/or gelofusine or other kidney-protection regimens are currently considered as potential means to reduce the observed high renal uptake.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Alternatively, replacement of Lys<sup>13</sup> by another positively charged residue, e.g., by Arg, amino acid <span class="smallcaps smallerCapital">d</span>-enantiomers, or other unnatural basic residues, may prove to be effective for this purpose.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Despite its higher affinity and internalization efficiency, the tumor uptake of [<sup>111</sup>In]<b>2</b> is markedly lower (4.13 ± 0.40% ID/g at 4 h postinjection), presumably as a consequence of rapid enzymatic degradation upon entry into the bloodstream of mice. Slightly higher tumor uptake is shown by the more stable albeit less GRPR-affine [<sup>111</sup>In]<b>3</b> (4.63 ± 0.59% ID/g at 4 h postinjection). This analog shows faster renal clearance and lower accumulation in GRPR-rich pancreas. In view of the above considerations, [<sup>111</sup>In]<b>3</b> displays the most preferable overall pharmacokinetic profile. It is interesting to compare this profile with previously reported [<sup>99m</sup>Tc]Demomedin C in the same animal model. The <sup>99m</sup>Tc-radioligand displays higher uptake in the PC-3 xenografts (6.36 ± 0.85% ID/g at 4 h postinjection) but also higher uptake in both pancreas and kidneys.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p last">Extrapolation of stability and biodistribution data of [<sup>111</sup>In]<b>3</b> to [<sup>177</sup>Lu/<sup>90</sup>Y/<sup>213</sup>Bi]<b>3</b>, intended for radionuclide therapy, should be made with caution and should be supported by experimental data. Potential changes in biological responses may ensue by using a different radiometal, owing to coordination chemistry differences across metals causing changes in the physicochemical properties of end radioligands.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Interestingly, the metabolic stability of bombesin-like radiopeptides has been elegantly investigated thus far in vivo only for [<sup>177</sup>Lu]AMBA and is in the same range with [<sup>111</sup>In]<b>3</b>.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This stability appears to be inferior compared to the highly in vivo stable analogs of octreotide (e.g., Lutathera, [<sup>90</sup>Y]DOTATOC) used in radionuclide therapy<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and may eventually prove to be a hurdle for application in human. On the other hand, the blood clearance of systemically administered radiopeptides is in general also a very fast process, and highly enzyme-resistant analogs may inadvertently show unfavorably prolonged retention in excretory organs (e.g., in the kidneys), reducing their therapeutic index. Ongoing studies will eventually address these issues and systematically explore the applicability of human GRP-related radioligands in radionuclide therapy of GRPR-expressing cancer.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As a part of our ongoing quest for human GRP-based radioligands to visualize and treat GRPR-expressing human tumors, we present four new DOTA-coupled GRP analogs truncated at positions 13, 14, 17, and 18 in the natural GRP 27-mer sequence and their respective <sup>111</sup>In-radioligands. Receptor affinity, internalization efficiency, and tumor uptake of new analogs in mice were favored both by longer peptide chain and by the presence of basic amino acids in positions 17 and 13 in the parent peptide. However, Lys<sup>13</sup> provokes unfavorably high renal accumulation of [<sup>111</sup>In]<b>1</b>, which could be probably reduced by the application of kidney protection regimens or after Lys<sup>13</sup> substitution by Arg or another positively charged residue. Due to its better metabolic stability in combination with a faster clearance from background, [<sup>111</sup>In]<b>3</b> seems to represent the best choice for further studies in animal models and eventually in man, labeled not only with <sup>111</sup>In but also with other radiometals useful for diagnosis (e.g., <sup>68</sup>Ga) and therapy (e.g., <sup>177</sup>Lu, <sup>90</sup>Y, <sup>213</sup>Bi).</div><div class="NLM_p last">This work has further confirmed previous findings from the preclinical evaluation of NMC-based <sup>99m</sup>Tc-radioligands on the efficacy of human GRP analogs to target GRPR-positive cancer with high sensitivity and specificity. Currently ongoing studies will establish potential benefits of their use against their frog-originating and less GRPR-selective counterparts. It is reasonable to assume that competent structural interventions on the GRP chain, involving for example smart selection of truncation site and/or strategic amino acid replacements, may yield radioligands of high diagnostic/therapeutic impact.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71017" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71017" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Materials and Instrumentation</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Chemicals</h4><div class="NLM_p">Unless otherwise stated all chemicals were reagent grade and were used without further purification. The Tenta Gel S Ram resin used as solid support during solid-phase peptide synthesis (SPPS) was purchased from Rapp Polymere GmbH (Tübingen, Germany), while the 9-fluorenylmethoxycarbonyl (Fmoc) amino acid precursors were supplied by Orpegen Pharma (Heidelberg, Germany). DOTA-tris(<sup><i>t</i></sup>Bu) ester was purchased from TCI Europe N.V. (Zwijndrecht, Belgium). The coupling reagents 1-hydroxybenzotriazole (HOBt) and benzotriazol-1-yloxy-tris(pyrrolidino)phosphonium hexafluorophosphate (PyBOP) were purchased from Iris Biotech GmbH (Marktredwitz, Germany). [Tyr<sup>4</sup>]BBN and GRP(14–27) were purchased from PSL GmbH (Heidelberg, Germany).</div><div class="NLM_p"><sup>111</sup>In was purchased as a solution of <sup>111</sup>InCl<sub>3</sub> in 0.05 M HCl (0.5 mL, 370–185 MBq) from Covidien (Petten, The Netherlands), and <sup>125</sup>I used in radioiodination was provided by MDS Nordion, SA (Fleurus, Belgium).</div><div class="NLM_p last">All manipulations with γ- and β-emitting radionuclides and their solutions were performed behind suitable shielding in dedicated laboratories in compliance with national and international radiation safety guidelines.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Analysis—Radiochemistry</h4><div class="NLM_p">Synthesis of analogs was carried out on an automated peptide synthesizer (PSSM 8, Shimadzu). Purification of the peptide conjugates was performed by RP-HPLC using an AKZO Nobel Kromasil Semi/Prep C18 column (250 mm × 20 mm) eluted with a linear gradient of solvent A (0.1% TFA in H<sub>2</sub>O) and solvent B (MeCN containing 0.1% TFA) from 10% B to 70% B in 50 min with a flow rate of 12 mL/min. The eluent was monitored by measuring the UV absorption at 215 nm.</div><div class="NLM_p">Mass spectra were obtained on a MALDI-TOF spectrometer (Kompact Kratos Axima Analytical, Shimadzu, Manchester, UK). Analytical HPLC characterization of the conjugates was performed by RP HPLC on an Agilent system equipped with a Nucleosil-100 (Macherey Nagel) C18 column (5 μm, 150 mm × 4 mm) and UV detection at 215 nm, applying a linear gradient of MeCN containing 0.1% TFA (10–90% in 30 min) and water containing 0.1% TFA with a flow rate of 1 mL/min (system 1). Analysis and radiochemical tests were additionally performed on a Waters Chromatograph (Waters, Vienna, Austria) with a 600 solvent delivery system coupled to both a 996 photodiode array UV detector (Waters, Vienna, Austria) and a Gabi γ-detector (Raytest RSM Analytische Instrumente GmbH, Germany); the Millennium Software (Waters, Vienna, Austria) was applied to control the HPLC system and process the data. Analyses were conducted on a Waters Xterra RP18 (5 μm, 4.6 mm × 150 mm) eluted with a linear gradient system of 15% B to 30% B in 30 min at a flow rate of 1 mL/min, where A = 0.1% TFA in H<sub>2</sub>O (v/v) and B = MeCN (system 2).</div><div class="NLM_p">Metabolic studies were conducted using a chromatograph (600 solvent delivery system, coupled to both a 2998 photodiode array UV detector; Waters, Vienna, Austria) and a Gabi γ-detector (Raytest RSM Analytische Instrumente GmbH, Germany). The Empower Software (Waters, Vienna, Austria) was used to control the HPLC system and process the data. A RP18 Symmetry Shield column was employed (5 μm, 3.9 mm × 20 mm, Waters, Vienna, Austria), and the column was eluted at a flow rate of 1 mL/min with the following gradient: 100% A to 90% A in 10 min and from 90% A to 60% for the next 60 min, where A = 0.1% aqueous TFA (v/v) and B = MeCN (system 3).</div><div class="NLM_p">For radioactivity measurements an automatic well-type γ-counter calibrated for <sup>111</sup>In and <sup>125</sup>I was used [NaI(Tl) 3′′-crystal, Canberra Packard Auto-Gamma 5000 series instrument].</div><div class="NLM_p last">As shown by analytical HPLC (systems 1 and  2), products <b>1</b>–<b>4</b> were obtained in ≥95% purity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis of [DOTA]GRP Peptide Conjugates</h3><div class="NLM_p last">Synthesis of the four [DOTA]GRP(13/14/17/18–27) peptide analogs was performed on an automated synthesizer on a Tenta Gel S Ram resin as solid support. The elongation was carried out by coupling of a 10-fold excess of Fmoc amino acid derivatives, in the presence of 1-hydroxybenzotriazole (HOBt), <i>N</i>,<i>N</i>′-diisopropylcarbodiimide (DIC) and diisopropylethylamine (DIPEA) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) and dichloromethane (DCM) 90:10 v/v as solvent. After each coupling step Fmoc deprotection was conducted with 30% piperidine in DMF. The assembled amino acid sequences were coupled with a 3-fold excess of DOTA-tris(<sup><i>t</i></sup>Bu ester), benzotriazol-1-yloxy-tris(pyrrolidino)phosphonium hexafluorophosphate (PyBOP), and DIPEA in DMF on the resin. Cleavage of the conjugates from the solid support was achieved by treating the fully protected peptide chains with a mixture of trifluoroacetic acid (TFA), 1,2-ethanedithiol (EDT), thioanisol (TA), and H<sub>2</sub>O in a ratio of 90:4:4:2 v/v/v/v at room temperature. After removal of the resin from the cleavage mixture by filtration, each crude peptide was collected by precipitation with ice-cooled diethyl ether. Finally, the crude [DOTA]GRP conjugates were purified by RP-HPLC on a Semi/Prep C18 column (250 mm × 20 mm). Analytical RP-HPLC data (systems 1 and  2) as well as MALDI-TOF MS results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Radiolabeling and Quality Control of [<sup>111</sup>In-DOTA]GRPs</h3><div class="NLM_p">Lyophilized analogs were dissolved in water to a final concentration of 2 mg/mL and stored at −20 °C in 50-μL aliquots. Radiolabeling with <sup>111</sup>In was conducted by adding 10 nmol of peptide analog per 37–74 MBq of <sup>111</sup>InCl<sub>3</sub> in 0.1 M sodium acetate buffer and 10 mM sodium ascorbate. Typical end pH was 4.6. Labeling was completed after incubation in a boiling water bath for ≤20 min.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> To prevent oxidation of Met residues to the corresponding sulfoxides, 0.1 M Met solution was added in the labeling reaction mixture to a final concentration of 20 mM.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p last">Quality control was conducted after addition of EDTA (in 0.1 M acetate buffer pH 4.6) to a final concentration of 1 mM in the labeling reaction mixture to capture free In<sup>3+</sup>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Analyses were performed on a RP18 column using system 2.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vitro Assays</h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Competition Binding of [DOTA]GRPs in PC-3 Cell Membranes</h4><div class="NLM_p last">For in vitro assays human androgen-independent prostate adenocarcinoma PC-3 cells were used as GRPR source.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> PC-3 cells (by LGC Promochem, Teddington, UK) were cultured as previously reported and PC-3 cell membranes used in competition binding experiments were cropped according to a published method.<a onclick="showRef(event, 'ref9 ref24'); return false;" href="javascript:void(0);" class="ref ref9 ref24">(9, 24)</a> The [<sup>125</sup>I-Tyr<sup>4</sup>]BBN radioligand was prepared as described previously and GRP(14–27) served as reference.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The radioligand (50 pM per assay tube) and increasing concentrations (10<sup>–5</sup>–10<sup>–13</sup> M) of test peptide in triplicates were incubated with membranes at 22 °C for 1 h in an incubator–orbital shaker (MPM Instr. SrI). Samples were measured for radioactivity in an automatic well-type γ-counter. IC<sub>50</sub> values were determined by nonlinear regression according to a one-site model applying the PRISM 2 program (Graph Pad Software, San Diego, CA).</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Internalization of [<sup>111</sup>In-DOTA]GRPs in PC-3 Cells</h4><div class="NLM_p last">For internalization, confluent PC-3 cells were seeded in six-well plates (∼1.0 × 10<sup>6</sup> cells per well) 24 h before conducting the experiment. Test [<sup>111</sup>In-DOTA]GRP analog (≈50 000 cpm corresponding to 250 fmol total peptide in 150 μL of 0.5% BSA/PBS) was added alone (total) or in the presence of 1 μM [Tyr<sup>4</sup>]BBN (nonspecific) and the experiment was performed following a published protocol.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Results were calculated as percent internalized activity per total added for each time point by applying the Microsoft Excel program and represent the average of at least two experiments performed in triplicate.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Metabolism of [<sup>111</sup>In-DOTA]GRPs in Mice</h3><div class="NLM_p last">[<sup>111</sup>In-DOTA]GRP was injected as a 100 μL bolus (11–22 MBq, 3 nmol total peptide) in the tail vein of male Swiss albino mice (30 ± 5 g, NCSR “Demokritos” Animal House Facility). Mice were anesthetized with ether and blood (0.5–1 mL) was collected from the heart at 5 min postinjection. Blood samples were immediately transferred in prechilled polypropylene tubes placed on ice containing EDTA and Met. Samples were prepared as previously described<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and analysis by HPLC was conducted by applying system 3; experiments were conducted at least twice. Co-injection with labeling reaction samples was performed to identify intact [<sup>111</sup>In-DOTA]GRPs by coelution (same <i>t</i><sub>R</sub>) through the HPLC column.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Biodistribution of [<sup>111</sup>In-DOTA]GRPs in SCID Mice Bearing Human PC-3 Xenografts</h3><div class="NLM_p">A ≈150 μL bolus containing a suspension of ≈1.5 × 10<sup>7</sup> freshly harvested human PC-3 cells in saline was subcutaneously injected in the flanks of female SCID mice (15 ± 3 g, 6 weeks of age on arrival day, NCSR “Demokritos” Animal House Facility). After 3 weeks the animals developed well-palpable tumors at the inoculation site (80–150 mg) and biodistribution was conducted. On the day of the experiment, test [<sup>111</sup>In-DOTA]GRP radioligand was injected in mice via the tail vein as a 100 μL bolus (37–74 kBq, 10 pmol total peptide; in saline/EtOH 9/1 v/v containing 1 mM Met), and the animals were sacrificed in groups of four at 4 and 24 h postinjection; for in vivo GRPR blockade a separate 4-h animal group was co-injected with excess [Tyr<sup>4</sup>]BBN (40 nmol). Biodistribution was conducted as previously described,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and data were calculated as percent injected dose per gram of tissue (% ID/g) with the aid of suitable standards of the injected dose using the Microsoft Excel program.</div><div class="NLM_p">Statistical analysis using the unpaired two-tailed Student’s <i>t</i> test was performed to compare values between the control and the in vivo GRPR blockade animal groups at 4 h postinjection; values <i>P</i> < 0.005 were considered statistically highly significant.</div><div class="NLM_p last">All animal experiments were carried out in compliance with European and national regulations and after approval of protocols by national authorities.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm4010237" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Berthold A. Nock</span> - <span class="hlFld-Affiliation affiliation">Molecular
Radiopharmacy, INRASTES, National Center
for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5b3534383004393e292f3334373f753a1b33342f363a323775383436"><span class="__cf_email__" data-cfemail="88e6e7ebe3d7eaedfafce0e7e4eca6e9c8e0e7fce5e9e1e4a6ebe7e5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Panteleimon J. Marsouvanidis</span> - <span class="hlFld-Affiliation affiliation">Molecular
Radiopharmacy, INRASTES, National Center
for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theodosia Maina</span> - <span class="hlFld-Affiliation affiliation">Molecular
Radiopharmacy, INRASTES, National Center
for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Werner Sallegger</span> - <span class="hlFld-Affiliation affiliation">piCHEM, A-8045 Graz, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric P. Krenning</span> - <span class="hlFld-Affiliation affiliation">Molecular
Radiopharmacy, INRASTES, National Center
for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Nuclear Medicine
and Radiology and §Department of Radiology, Erasmus MC, 3015 CE Rotterdam, The Netherlands</span>; 
    <span class="hlFld-Affiliation affiliation">piCHEM, A-8045 Graz, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marion  de Jong</span> - <span class="hlFld-Affiliation affiliation">Molecular
Radiopharmacy, INRASTES, National Center
for Scientific Research “Demokritos”, GR-153 10 Athens, Greece</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Nuclear Medicine
and Radiology and §Department of Radiology, Erasmus MC, 3015 CE Rotterdam, The Netherlands</span>; 
    <span class="hlFld-Affiliation affiliation">piCHEM, A-8045 Graz, Austria</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1015e2452-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48015" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48015" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors wish to thank Dr. Aikaterini Tatsi and Mrs. Xanthippi Kotsaka for their assistance in biodistribution experiments.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i27" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i27"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> Abbreviations Used</h2><tr><td class="NLM_term">GRP</td><td class="NLM_def"><p class="first last">gastrin releasing peptide (H-Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub>)</p></td></tr><tr><td class="NLM_term">GRPR</td><td class="NLM_def"><p class="first last">gastrin releasing peptide receptor</p></td></tr><tr><td class="NLM_term">BBN</td><td class="NLM_def"><p class="first last">bombesin (Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub>)</p></td></tr><tr><td class="NLM_term">DOTA</td><td class="NLM_def"><p class="first last">1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid</p></td></tr><tr><td class="NLM_term">PC-3 cells</td><td class="NLM_def"><p class="first last">androgen-insensitive human prostate adenocarcinoma cells</p></td></tr><tr><td class="NLM_term">RP-HPLC</td><td class="NLM_def"><p class="first last">reverse-phase high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">NMC</td><td class="NLM_def"><p class="first last">neuromedin C (H-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub>)</p></td></tr><tr><td class="NLM_term">NMB</td><td class="NLM_def"><p class="first last">neuromedin B (H-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH<sub>2</sub>)</p></td></tr><tr><td class="NLM_term">NMBR</td><td class="NLM_def"><p class="first last">neuromedin B receptor</p></td></tr><tr><td class="NLM_term">SPECT</td><td class="NLM_def"><p class="first last">single photon emission computed tomography</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>R</sub></td><td class="NLM_def"><p class="first last">retention or elution time</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immunodeficiency.</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Reubi, J. C.</span><span> </span><span class="NLM_article-title">Peptide receptors as molecular targets for cancer diagnosis and therapy</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1210%2Fer.2002-0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=12920149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=389-427&issue=4&author=J.+C.+Reubi&title=Peptide+receptors+as+molecular+targets+for+cancer+diagnosis+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide receptors as molecular targets for cancer diagnosis and therapy</span></div><div class="casAuthors">Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-427</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  During the past decade, proof of the principle that peptide receptors can be used successfully for in vivo targeting of human cancers has been provided.  A review.  The mol. basis for targeting rests on the in vitro observation that peptide receptors can be expressed in large quantities in certain tumors.  The clin. impact is at the diagnostic level: in vivo receptor scintigraphy uses radiolabeled peptides for the localization of tumors and their metastases.  It is also at the therapeutic level: peptide receptor radiotherapy of tumors emerges as a serious treatment option.  Peptides linked to cytotoxic agents are also considered for therapeutic applications.  The use of nonradiolabeled, noncytotoxic peptide analogs for long-term antiproliferative treatment of tumors appears promising for only a few tumor types, whereas the symptomatic treatment of neuroendocrine tumors by somatostatin analogs is clearly successful.  The present review summarizes and critically evaluates the in vitro data on peptide and peptide receptor expression in human cancers.  These data are considered to be the mol. basis for peptide receptor targeting of tumors.  The paradigmatic peptide somatostatin and its receptors are extensively reviewed in the light of in vivo targeting of neuroendocrine tumors.  The role of the more recently described targeting peptides vasoactive intestinal peptide, gastrin-releasing peptide, and cholecystokinin/gastrin is discussed.  Other emerging and promising peptides and their resp. receptors, including neurotensin, substance P, and neuropeptide Y, are introduced.  This information relates to established and potential clin. applications in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpImMX7eTxXDbVg90H21EOLACvtfcHk0lh52QL7PCyNKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlKjtbs%253D&md5=2203d38ced1a18b3998f9e284b7f2348</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fer.2002-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2002-0007%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DPeptide%2520receptors%2520as%2520molecular%2520targets%2520for%2520cancer%2520diagnosis%2520and%2520therapy%26jtitle%3DEndocr.%2520Rev.%26date%3D2003%26volume%3D24%26issue%3D4%26spage%3D389%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Markwalder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span> </span><span class="NLM_article-title">Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=1152-1159&issue=5&author=R.+Markwalderauthor=J.+C.+Reubi&title=Gastrin-releasing+peptide+receptors+in+the+human+prostate%3A+Relation+to+neoplastic+transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkwalder%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DGastrin-releasing%2520peptide%2520receptors%2520in%2520the%2520human%2520prostate%253A%2520Relation%2520to%2520neoplastic%2520transformation%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D5%26spage%3D1152%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gugger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span> </span><span class="NLM_article-title">Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2067</span><span class="NLM_x">–</span> <span class="NLM_lpage">2076</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1016%2FS0002-9440%2810%2965525-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=10595936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1Knsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1999&pages=2067-2076&issue=6&author=M.+Guggerauthor=J.+C.+Reubi&title=Gastrin-releasing+peptide+receptors+in+non-neoplastic+and+neoplastic+human+breast"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast</span></div><div class="casAuthors">Gugger, Mathias; Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2067-2076</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">The regulatory peptide gastrin-releasing peptide (GRP) may play a role in human cancer as a stimulatory growth factor.  To understand the potential role of GRP in human breast cancer, the authors have evaluated GRP receptor expression in human non-neoplastic and neoplastic breast tissues and in axillary lymph node metastases, using in vitro receptor autoradiog. on tissue sections with [125I]Tyr4-bombesin and with [125I]D-Tyr6, β Ala11, Phe13, Nle14-bombesin(6-14) as radioligands.  GRP receptors were detected, often in high d., in neoplastic epithelial mammary cells in 29 of 46 invasive ductal carcinomas, in 11 of 17 ductal carcinomas in situ, in 1 of 4 invasive lobular carcinomas, in 1 of 2 lobular carcinomas in situ, and in 1 mucinous and 1 tubular carcinoma.  A heterogeneous GRP receptor distribution was found in the neoplastic tissue samples in 32 of 52 cases with invasive carcinoma and 12 of 19 cases with carcinoma in situ.  The lymph node metastases from those primary carcinomas expressing GRP receptors were all pos., whereas surrounding lymphoreticular tissue was neg.  GRP receptors were also present in high d. but with heterogeneous distribution in ducts and lobules from all available breast tissue samples.  All of the receptors corresponded to the GRP receptor subtype of bombesin receptors, having high affinity for GRP and bombesin and lower affinity for neuromedin B.  All tissues expressing GRP receptors were identified similarly with both radioligands.  These data describe not only a high percentage of GRP receptor-pos. neoplastic breast tissues but also for the first time a ubiquitous GRP receptor expression in nonneoplastic human breast tissue.  Apart from suggesting a role of GRP in breast physiol., these data represent the mol. basis for potential clin. applications of GRP analogs such as GRP receptor scintigraphy, radiotherapy, or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7FaVfPA8ChLVg90H21EOLACvtfcHk0lh52QL7PCyNKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1Knsg%253D%253D&md5=c9033e2188ac6f5abee5ba4c97cc4531</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965525-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965525-3%26sid%3Dliteratum%253Aachs%26aulast%3DGugger%26aufirst%3DM.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DGastrin-releasing%2520peptide%2520receptors%2520in%2520non-neoplastic%2520and%2520neoplastic%2520human%2520breast%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D155%26issue%3D6%26spage%3D2067%26epage%3D2076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Guinee, D. G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishback, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koss, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbondanzo, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travis, W. D.</span><span> </span><span class="NLM_article-title">The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies</span> <span class="citation_source-journal">Am. J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=7524299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A280%3ADyaK2M%252FivFSqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1994&pages=406-414&issue=4&author=D.+G.+Guineeauthor=N.+F.+Fishbackauthor=M.+N.+Kossauthor=S.+L.+Abbondanzoauthor=W.+D.+Travis&title=The+spectrum+of+immunohistochemical+staining+of+small-cell+lung+carcinoma+in+specimens+from+transbronchial+and+open-lung+biopsies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies</span></div><div class="casAuthors">Guinee D G Jr; Fishback N F; Koss M N; Abbondanzo S L; Travis W D</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical pathology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">406-14</span>
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    </div><div class="casAbstract">Immunohistochemistry is increasingly used as an aid in the diagnosis of small-cell lung carcinoma (SCLC).  Previous studies have investigated immunohistochemical staining of SCLC with small numbers of antibodies, but few have examined large series with a broad panel of antibodies.  For this reason, the authors examined the distribution and intensity of staining of 20 open-lung biopsy (OLB) and 21 transbronchial biopsy (TBB) specimens of SCLC with a panel of epithelial, neuroendocrine, and hormonal markers.  Small-cell lung carcinoma stained most frequently with epithelial markers, followed by neuroendocrine and hormonal markers.  Similar percentages of OLB and TBB specimens stained for keratin (100% each) and epithelial membrane antigen (100% and 95%, respectively).  Unexpectedly, BER-EP4 stained 100% of OLB specimens.  Chromogranin A was the most frequent neuroendocrine marker in OLB and TBB specimens (60% and 47%, respectively) followed by neuron-specific enolase (60% and 33%), Leu-7 (40% and 24%), and synaptophysin (5% and 19%).  No neuroendocrine immunohistochemical reactivity was found in 24% of TBB specimens and 20% of OLB specimens.  Bombesin was the most sensitive hormonal marker (45% of OLB specimens).  These results show that keratin, epithelial membrane antigen, and BER-EP4 are reliable epithelial markers for SCLC in both TBB and OLB specimens.  In addition, negative staining for neuroendocrine markers, because it can occur in as many as 25% of cases, should not deter the diagnosis of SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3df4yPm4B1mZyxfu64m4ffW6udTcc2eZdM9TlDxH_Wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FivFSqtw%253D%253D&md5=6bb9fca317dea0ff96272ee75641fd5f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuinee%26aufirst%3DD.%2BG.%26aulast%3DFishback%26aufirst%3DN.%2BF.%26aulast%3DKoss%26aufirst%3DM.%2BN.%26aulast%3DAbbondanzo%26aufirst%3DS.%2BL.%26aulast%3DTravis%26aufirst%3DW.%2BD.%26atitle%3DThe%2520spectrum%2520of%2520immunohistochemical%2520staining%2520of%2520small-cell%2520lung%2520carcinoma%2520in%2520specimens%2520from%2520transbronchial%2520and%2520open-lung%2520biopsies%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D1994%26volume%3D102%26issue%3D4%26spage%3D406%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S.</span><span> </span><span class="NLM_article-title">Targeting prostate cancer with radiolabelled bombesins</span> <span class="citation_source-journal">Cancer Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=153-157&author=T.+Mainaauthor=B.+Nockauthor=S.+Mather&title=Targeting+prostate+cancer+with+radiolabelled+bombesins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DMather%26aufirst%3DS.%26atitle%3DTargeting%2520prostate%2520cancer%2520with%2520radiolabelled%2520bombesins%26jtitle%3DCancer%2520Imaging%26date%3D2006%26volume%3D6%26spage%3D153%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Sancho, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Florio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, R. T.</span><span> </span><span class="NLM_article-title">Bombesin receptor-mediated imaging and cytotoxicity: Review and current status</span> <span class="citation_source-journal">Curr. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=79-134&issue=1&author=V.+Sanchoauthor=A.+Di+Florioauthor=T.+W.+Moodyauthor=R.+T.+Jensen&title=Bombesin+receptor-mediated+imaging+and+cytotoxicity%3A+Review+and+current+status"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSancho%26aufirst%3DV.%26aulast%3DDi%2BFlorio%26aufirst%3DA.%26aulast%3DMoody%26aufirst%3DT.%2BW.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DBombesin%2520receptor-mediated%2520imaging%2520and%2520cytotoxicity%253A%2520Review%2520and%2520current%2520status%26jtitle%3DCurr.%2520Drug%2520Delivery%26date%3D2011%26volume%3D8%26issue%3D1%26spage%3D79%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Breeman, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofland, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwekkeboom, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1002%2F%28SICI%291097-0215%2819990517%2981%3A4%3C658%3A%3AAID-IJC24%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADyaK1MXjtF2lsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1999&pages=658-665&issue=4&author=W.+A.+Breemanauthor=L.+J.+Hoflandauthor=M.+de+Jongauthor=B.+F.+Bernardauthor=A.+Srinivasanauthor=D.+J.+Kwekkeboomauthor=T.+J.+Visserauthor=E.+P.+Krenning&title=Evaluation+of+radiolabelled+bombesin+analogues+for+receptor-targeted+scintigraphy+and+radiotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy</span></div><div class="casAuthors">Breeman, Wout A. P.; Hofland, Leo J.; De Jong, Marion; Bernard, Bert F.; Srinivasan, Ananth; Kwekkeboom, Dik J.; Visser, Theo J.; Krenning, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-665</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The 14-amino acid peptide bombesin (BN) has a high affinity for the gastrin-releasing peptide receptor which is expressed by a variety of tumors.  Thus, radiometal-labeled DTPA-BN derivs. are potentially useful radioligands for receptor-targeted scintigraphy and radiotherapy of BN receptor-expressing tumors.  A no. of such DTPA-BN analogs, [DTPA-D-Tyr6]BN(6-13)NHEt (Et=ethyl), [DTPA-Tyr5,D-Phe6]BN(5-13)NHEt, [DTPA-D-Phe6,Leu13ψPhe14]-BN(6-14), [DTPA-Tyr5,D-Phe6,Leu13ψPhe14]BN(5-14), [DTPA-Pro1,Tyr4]BN and [DTPA-Pro1,Tyr4,Nle14]BN, were synthesized and studied for their binding characteristics to the BN receptor on 7315b rat pituitary tumor cell membranes in competition with [125I-Tyr4]BN.  The effects of the BN analogs were detd. on basal and BN-stimulated prolactin secretion by 7315b cells to distinguish between their agonistic and antagonistic characteristics.  Internalization of selected 111In-labeled BN analogs was studied using the BN receptor-pos. 7315b pituitary tumor and the CA20948 and AR42J exocrine pancreas tumor cell lines.  The tissue distribution of these 111In-labeled BN analogs was investigated in 7315b tumor-bearing rats.  Two DTPA-conjugated analogs, the antagonist [DTPA-Tyr5,D-Phe6]BN(5-13)NHEt and the agonist [DTPA-Pro1,Tyr4]BN showed the highest affinity for the BN receptor on 7315b cell membranes.  Despite similar affinity for the BN receptor, the 111In-labeled agonist, but not the antagonist, was internalized by the BN receptor-pos. tumor cells.  Consonant with this observation, the agonist [111In-DTPA-Pro1,Tyr4]BN showed much higher specific uptake in BN receptor-pos. tissues and tumor than the antagonist [111In-DTPA-Tyr5,D-Phe6]BN(5-13)NHEt, with concordant target to background ratios.  We conclude that [111In-DTPA-Pro1,Tyr4]BN has promising characteristics for applications in nuclear medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtUBWBTOKH-LVg90H21EOLACvtfcHk0ljp9ti6nvWABw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtF2lsbY%253D&md5=c2763539d2972cbb478b64675ce9374e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819990517%2981%3A4%3C658%3A%3AAID-IJC24%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819990517%252981%253A4%253C658%253A%253AAID-IJC24%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3DHofland%26aufirst%3DL.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DKwekkeboom%26aufirst%3DD.%2BJ.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DEvaluation%2520of%2520radiolabelled%2520bombesin%2520analogues%2520for%2520receptor-targeted%2520scintigraphy%2520and%2520radiotherapy%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1999%26volume%3D81%26issue%3D4%26spage%3D658%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Breeman, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugaj, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwekkeboom, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Preclinical comparison of <sup>111</sup>In-labeled DTPA– or DOTA–bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1650</span><span class="NLM_x">–</span> <span class="NLM_lpage">1656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1650-1656&issue=12&author=W.+A.+Breemanauthor=M.+de+Jongauthor=J.+L.+Erionauthor=J.+E.+Bugajauthor=A.+Srinivasanauthor=B.+F.+Bernardauthor=D.+J.+Kwekkeboomauthor=T.+J.+Visserauthor=E.+P.+Krenning&title=Preclinical+comparison+of+111In-labeled+DTPA%E2%80%93+or+DOTA%E2%80%93bombesin+analogs+for+receptor-targeted+scintigraphy+and+radionuclide+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DBugaj%26aufirst%3DJ.%2BE.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3DKwekkeboom%26aufirst%3DD.%2BJ.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DPreclinical%2520comparison%2520of%2520111In-labeled%2520DTPA%25E2%2580%2593%2520or%2520DOTA%25E2%2580%2593bombesin%2520analogs%2520for%2520receptor-targeted%2520scintigraphy%2520and%2520radionuclide%2520therapy%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2002%26volume%3D43%26issue%3D12%26spage%3D1650%26epage%3D1656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Nock, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolopoulou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galanis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordopatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span> </span><span class="NLM_article-title">Potent bombesin-like peptides for GRP-receptor targeting of tumors with <sup>99m</sup>Tc: A preclinical study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049437y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=100-110&issue=1&author=B.+A.+Nockauthor=A.+Nikolopoulouauthor=A.+Galanisauthor=P.+Cordopatisauthor=B.+Waserauthor=J.+C.+Reubiauthor=T.+Maina&title=Potent+bombesin-like+peptides+for+GRP-receptor+targeting+of+tumors+with+99mTc%3A+A+preclinical+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm049437y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049437y%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DGalanis%26aufirst%3DA.%26aulast%3DCordopatis%26aufirst%3DP.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DPotent%2520bombesin-like%2520peptides%2520for%2520GRP-receptor%2520targeting%2520of%2520tumors%2520with%252099mTc%253A%2520A%2520preclinical%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D1%26spage%3D100%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ananias, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierckx, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Wiele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helfrich, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsinga, P. H.</span><span> </span><span class="NLM_article-title">Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">28</span><span class="NLM_x">) </span> <span class="NLM_fpage">3033</span><span class="NLM_x">–</span> <span class="NLM_lpage">3047</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.2174%2F138161208786404335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1ehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3033-3047&issue=28&author=H.+J.+Ananiasauthor=I.+J.+de+Jongauthor=R.+A.+Dierckxauthor=C.+van+de+Wieleauthor=W.+Helfrichauthor=P.+H.+Elsinga&title=Nuclear+imaging+of+prostate+cancer+with+gastrin-releasing-peptide-receptor+targeted+radiopharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals</span></div><div class="casAuthors">Ananias, H. J. K.; de Jong, I. J.; Dierckx, R. A.; van de Wiele, C.; Helfrich, W.; Elsinga, P. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3033-3047</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Prostate cancer is one of the most common causes of cancer in men.  Evaluating the different stages of prostate cancer with conventional imaging techniques still proves difficult.  Nuclear imaging might provide a technique that is able to evaluate prostate cancer, but clin. application has been limited due to lack of accuracy of current radiopharmaceuticals.  The development of radiopharmaceuticals that can be targeted to specific antigens, overexpressed in prostate cancer, but sparse in normal tissue, is crucial.  Peptides are of particular interest because of their favorable characteristics, leading to increased attention for nuclear imaging of the gastrin-releasing-peptide-receptor (GRPR) with radiolabeled bombesin-like peptides.  Several derivs. of bombesin and its truncated form have been prepd. for imaging with single photon emission computed tomog. (SPECT) or positron emission tomog. (PET), thereby delivering potent candidates for further clin. evaluation.  This article provides an overview of the development and preclin. evaluation of radiolabeled bombesin analogs for in vivo targeting of GRPR in prostate cancer.  The effect of the radionuclide, chelator, spacer and unnatural amino acids on affinity, metabolic stability and image quality are discussed, as well as agonistic or antagonistic properties.  Potent candidates are proposed based on these selection criteria: (I) high affinity for GRPR, with rapid and specific tumor uptake (II) high hydrophilicity resulting in the preferred renal-urinary mode of excretion and low hepatobiliary excretion, (III) high stability, but relatively rapid clearance from blood.  Also, a summary is made of clin. studies that report on the detection of prostate cancer with GRPR targeted radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC-UlwFOLzbrVg90H21EOLACvtfcHk0lgT3WmwgmY7Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1ehug%253D%253D&md5=bbd2930eedefa89686f6ceb9a55ebbbb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161208786404335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208786404335%26sid%3Dliteratum%253Aachs%26aulast%3DAnanias%26aufirst%3DH.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DI.%2BJ.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%26aulast%3Dvan%2Bde%2BWiele%26aufirst%3DC.%26aulast%3DHelfrich%26aufirst%3DW.%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26atitle%3DNuclear%2520imaging%2520of%2520prostate%2520cancer%2520with%2520gastrin-releasing-peptide-receptor%2520targeted%2520radiopharmaceuticals%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26issue%3D28%26spage%3D3033%26epage%3D3047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldherr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6707</span><span class="NLM_x">–</span> <span class="NLM_lpage">6715</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6707-6715&issue=18&author=H.+Zhangauthor=J.+Chenauthor=C.+Waldherrauthor=K.+Hinniauthor=B.+Waserauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Synthesis+and+evaluation+of+bombesin+derivatives+on+the+basis+of+pan-bombesin+peptides+labeled+with+indium-111%2C+lutetium-177%2C+and+yttrium-90+for+targeting+bombesin+receptor-expressing+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWaldherr%26aufirst%3DC.%26aulast%3DHinni%26aufirst%3DK.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520bombesin%2520derivatives%2520on%2520the%2520basis%2520of%2520pan-bombesin%2520peptides%2520labeled%2520with%2520indium-111%252C%2520lutetium-177%252C%2520and%2520yttrium-90%2520for%2520targeting%2520bombesin%2520receptor-expressing%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26issue%3D18%26spage%3D6707%26epage%3D6715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abiraj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorek, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Jones, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span> </span><span class="NLM_article-title">Evolution of bombesin conjugates for targeted PET imaging of tumors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">e44046</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e44046&issue=9&author=H.+Zhangauthor=K.+Abirajauthor=D.+L.+Thorekauthor=B.+Waserauthor=P.+M.+Smith-Jonesauthor=M.+Honerauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Evolution+of+bombesin+conjugates+for+targeted+PET+imaging+of+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DThorek%26aufirst%3DD.%2BL.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DSmith-Jones%26aufirst%3DP.%2BM.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DEvolution%2520of%2520bombesin%2520conjugates%2520for%2520targeted%2520PET%2520imaging%2520of%2520tumors%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D9%26spage%3De44046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Nanda, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottenus, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rold, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sieckman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczodroski, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. J.</span><span> </span><span class="NLM_article-title">Bombesin analogues for gastrin-releasing peptide receptor imaging</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1016%2Fj.nucmedbio.2011.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=22261143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFantro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=461-471&issue=4&author=P.+K.+Nandaauthor=U.+Pandeyauthor=B.+N.+Bottenusauthor=T.+L.+Roldauthor=G.+L.+Sieckmanauthor=A.+F.+Szczodroskiauthor=T.+J.+Hoffmanauthor=C.+J.+Smith&title=Bombesin+analogues+for+gastrin-releasing+peptide+receptor+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin analogues for gastrin-releasing peptide receptor imaging</span></div><div class="casAuthors">Nanda, Prasant K.; Pandey, Usha; Bottenus, Brienne N.; Rold, Tammy L.; Sieckman, Gary L.; Szczodroski, Ashley F.; Hoffman, Timothy J.; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">461-471</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The present study describes the design and development of a series of new bombesin (BBN) antagonist peptide ligands of the form [64Cu-(NO2A-X-D-Phe6-BBN(6-13)NHEt)], where Cu-64=a positron emitting radiometal; NO2A=1,4,7-triazacyclononane-1,4-diacetic acid; X=6-amino hexanoic acid, 8-amino octanoic acid or 9-Aminononanoic acid; and BBN(6-13)NHEt=Gln-Trp-Ala-Val-Gly-His-Leu-NHEt, an antagonist analog of bombesin peptide for specific targeting of the gastrin-releasing peptide receptor (GRPR).[NO2A-X-D-Phe6-BBN(6-13)NHEt] conjugates were manually conjugated with NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid), and the resulting conjugates were labeled with 64Cu to yield [64Cu-(NO2A-X-D-Phe6-BBN(6-13)NHEt)].  The metalated and nonmetallated conjugates were purified via reversed-phase high-performance liq. chromatog. and characterized by electrospray ionization-mass spectrometry.  Competitive displacement binding assays displayed nanomolar binding affinities toward human GRPR for all of the newly formed peptide analogs.  Biodistribution studies showed very high uptake and retention of tumor-assocd. radioactivity in PC-3 (a prostate tumor model known to express the GRPR) tumor-bearing rodent models.  The radiolabeled conjugates also exhibited rapid urinary excretion and very high tumor to background ratios.  Micro-positron emission tomog. (PET) mol. imaging investigations showed clear visualization of tumors in female PC-3 tumor-bearing mice 15 h postinjection.  The biodistribution and mol. imaging study suggests that these conjugates can be considered as potential PET tracer candidates for the diagnosis of GRPR-pos. tumors in human patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdDtB20eRmLrVg90H21EOLACvtfcHk0lgJGqN7H3jGYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFantro%253D&md5=c99e58b5cbbeb503d0d3526365b7897d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2011.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2011.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DNanda%26aufirst%3DP.%2BK.%26aulast%3DPandey%26aufirst%3DU.%26aulast%3DBottenus%26aufirst%3DB.%2BN.%26aulast%3DRold%26aufirst%3DT.%2BL.%26aulast%3DSieckman%26aufirst%3DG.%2BL.%26aulast%3DSzczodroski%26aufirst%3DA.%2BF.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DBombesin%2520analogues%2520for%2520gastrin-releasing%2520peptide%2520receptor%2520imaging%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2012%26volume%3D39%26issue%3D4%26spage%3D461%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Lantry, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelletti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddalena, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdan, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arunachalam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalfe, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattuada, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linder, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedle, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunn, A. D.</span><span> </span><span class="NLM_article-title"><sup>177</sup>Lu-AMBA: Synthesis and characterization of a selective <sup>177</sup>Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=1144-1152&issue=7&author=L.+E.+Lantryauthor=E.+Cappellettiauthor=M.+E.+Maddalenaauthor=J.+S.+Foxauthor=W.+Fengauthor=J.+Chenauthor=R.+Thomasauthor=S.+M.+Eatonauthor=N.+J.+Bogdanauthor=T.+Arunachalamauthor=J.+C.+Reubiauthor=N.+Rajuauthor=E.+C.+Metcalfeauthor=L.+Lattuadaauthor=K.+E.+Linderauthor=R.+E.+Swensonauthor=M.+F.+Tweedleauthor=A.+D.+Nunn&title=177Lu-AMBA%3A+Synthesis+and+characterization+of+a+selective+177Lu-labeled+GRP-R+agonist+for+systemic+radiotherapy+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLantry%26aufirst%3DL.%2BE.%26aulast%3DCappelletti%26aufirst%3DE.%26aulast%3DMaddalena%26aufirst%3DM.%2BE.%26aulast%3DFox%26aufirst%3DJ.%2BS.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DEaton%26aufirst%3DS.%2BM.%26aulast%3DBogdan%26aufirst%3DN.%2BJ.%26aulast%3DArunachalam%26aufirst%3DT.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DRaju%26aufirst%3DN.%26aulast%3DMetcalfe%26aufirst%3DE.%2BC.%26aulast%3DLattuada%26aufirst%3DL.%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DSwenson%26aufirst%3DR.%2BE.%26aulast%3DTweedle%26aufirst%3DM.%2BF.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26atitle%3D177Lu-AMBA%253A%2520Synthesis%2520and%2520characterization%2520of%2520a%2520selective%2520177Lu-labeled%2520GRP-R%2520agonist%2520for%2520systemic%2520radiotherapy%2520of%2520prostate%2520cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D47%26issue%3D7%26spage%3D1144%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wild, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frischknecht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruchertseifer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisclair, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Provencher-Bolliger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span> </span><span class="NLM_article-title">Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (<sup>213</sup>Bi–DOTA–PESIN and <sup>213</sup>Bi–AMBA versus <sup>177</sup>Lu–DOTA–PESIN)</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1009-1018&issue=3&author=D.+Wildauthor=M.+Frischknechtauthor=H.+Zhangauthor=A.+Morgensternauthor=F.+Bruchertseiferauthor=J.+Boisclairauthor=A.+Provencher-Bolligerauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Alpha-+versus+beta-particle+radiopeptide+therapy+in+a+human+prostate+cancer+model+%28213Bi%E2%80%93DOTA%E2%80%93PESIN+and+213Bi%E2%80%93AMBA+versus+177Lu%E2%80%93DOTA%E2%80%93PESIN%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DD.%26aulast%3DFrischknecht%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMorgenstern%26aufirst%3DA.%26aulast%3DBruchertseifer%26aufirst%3DF.%26aulast%3DBoisclair%26aufirst%3DJ.%26aulast%3DProvencher-Bolliger%26aufirst%3DA.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DAlpha-%2520versus%2520beta-particle%2520radiopeptide%2520therapy%2520in%2520a%2520human%2520prostate%2520cancer%2520model%2520%2528213Bi%25E2%2580%2593DOTA%25E2%2580%2593PESIN%2520and%2520213Bi%25E2%2580%2593AMBA%2520versus%2520177Lu%25E2%2580%2593DOTA%25E2%2580%2593PESIN%2529%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D3%26spage%3D1009%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Anastasi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erspamer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucci, M.</span><span> </span><span class="NLM_article-title">Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians <i>Bombina</i> and <i>Alytes</i></span> <span class="citation_source-journal">Experientia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1971&pages=166-167&issue=2&author=A.+Anastasiauthor=V.+Erspamerauthor=M.+Bucci&title=Isolation+and+structure+of+bombesin+and+alytesin%2C+2+analogous+active+peptides+from+the+skin+of+the+European+amphibians+Bombina+and+Alytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasi%26aufirst%3DA.%26aulast%3DErspamer%26aufirst%3DV.%26aulast%3DBucci%26aufirst%3DM.%26atitle%3DIsolation%2520and%2520structure%2520of%2520bombesin%2520and%2520alytesin%252C%25202%2520analogous%2520active%2520peptides%2520from%2520the%2520skin%2520of%2520the%2520European%2520amphibians%2520Bombina%2520and%2520Alytes%26jtitle%3DExperientia%26date%3D1971%26volume%3D27%26issue%3D2%26spage%3D166%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Jensen, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battey, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spindel, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benya, R. V.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: Nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1124%2Fpr.107.07108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=18055507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1GjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=1-42&issue=1&author=R.+T.+Jensenauthor=J.+F.+Batteyauthor=E.+R.+Spindelauthor=R.+V.+Benya&title=International+Union+of+Pharmacology.+LXVIII.+Mammalian+bombesin+receptors%3A+Nomenclature%2C+distribution%2C+pharmacology%2C+signaling%2C+and+functions+in+normal+and+disease+states"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">International union of pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states</span></div><div class="casAuthors">Jensen, R. T.; Battey, J. F.; Spindel, E. R.; Benya, R. V.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-42</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian bombesin receptor family comprises three G protein-coupled heptahelical receptors: the neuromedin B (NMB) receptor (BB1), the gastrin-releasing peptide (GRP) receptor (BB2), and the orphan receptor bombesin receptor subtype 3 (BRS-3) (BB3).  Each receptor is widely distributed, esp. in the gastrointestinal (GI) tract and central nervous system (CNS), and the receptors have a large range of effects in both normal physiol. and pathophysiol. conditions.  The mammalian bombesin peptides, GRP and NMB, demonstrate a broad spectrum of pharmacol./biol. responses.  GRP stimulates smooth muscle contraction and GI motility, release of numerous GI hormones/neurotransmitters, and secretion and/or hormone release from the pancreas, stomach, colon, and numerous endocrine organs and has potent effects on immune cells, potent growth effects on both normal tissues and tumors, potent CNS effects, including regulation of circadian rhythm, thermoregulation; anxiety/ fear responses, food intake, and numerous CNS effects on the GI tract as well as the spinal transmission of chronic pruritus.  NMB causes contraction of smooth muscle, has growth effects in various tissues, has CNS effects, including effects on feeding and thermoregulation, regulates TSH release, stimulates various CNS neurons, has behavioral effects, and has effects on spinal sensory transmission.  GRP, and to a lesser extent NMB, affects growth and/or differentiation of various human tumors, including colon, prostate, lung, and some gynecol. cancers.  Knockout studies show that BB3 has important effects in energy balance, glucose homeostasis, control of body wt., lung development and response to injury, tumor growth, and perhaps GI motility.  This review summarizes advances in our understanding of the biol./pharmacol. of these receptors, including their classification, structure, pharmacol., physiol., and role in pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxWTMzOm1oKrVg90H21EOLACvtfcHk0lji_DYctuG8ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1GjsLk%253D&md5=dfdaea93d8101fbc67906a40e6677cee</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fpr.107.07108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.107.07108%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DR.%2BT.%26aulast%3DBattey%26aufirst%3DJ.%2BF.%26aulast%3DSpindel%26aufirst%3DE.%2BR.%26aulast%3DBenya%26aufirst%3DR.%2BV.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520LXVIII.%2520Mammalian%2520bombesin%2520receptors%253A%2520Nomenclature%252C%2520distribution%252C%2520pharmacology%252C%2520signaling%252C%2520and%2520functions%2520in%2520normal%2520and%2520disease%2520states%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26issue%3D1%26spage%3D1%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gonzalez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, R. T.</span><span> </span><span class="NLM_article-title">Bombesin-related peptides and their receptors: Recent advances in their role in physiology and disease states</span> <span class="citation_source-journal">Curr. Opin. Endocrinol. Diabetes Obes.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1097%2FMED.0b013e3282f3709b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=18185064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitFKgsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=58-64&issue=1&author=N.+Gonzalezauthor=T.+W.+Moodyauthor=H.+Igarashiauthor=T.+Itoauthor=R.+T.+Jensen&title=Bombesin-related+peptides+and+their+receptors%3A+Recent+advances+in+their+role+in+physiology+and+disease+states"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states</span></div><div class="casAuthors">Gonzalez, Nieves; Moody, Terry W.; Igarashi, Hisato; Ito, Tetsuhide; Jensen, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Endocrinology, Diabetes and Obesity</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-64</span>CODEN:
                <span class="NLM_cas:coden">COEDFK</span>;
        ISSN:<span class="NLM_cas:issn">1752-296X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review Mammalian bombesin-related peptides, gastrin-releasing peptide and neuromedin B actions are mediated by two receptors (BB1-receptor, BB2-receptor), which are closely related to the orphan receptor BRS-3 (BB3-receptor).  The purpose of this review is to highlight advances in the understanding of these peptides in physiol./disease states.  Recent findings Pharmacol./receptor-knockout studies show involvement of these receptors in a no. of new processes/diseases.  Neuromedin B/BB1-receptor is an important physiol. regulator of pituitary-thyroid function; in mediating behavior, esp. fear/anxiety; in mediating satiety through different cascades than gastrin-releasing peptide/BB2 receptors and for its autocrine tumor-growth effects.  Gastrin-releasing peptide/BB2-receptor plays important roles in mediating signals for pruritus, lung development/injury, small intestinal mucosal defense, and central nervous system processes such as learning/memory.  The signaling mechanisms of its potent growth effects are being elucidated and their possible therapeutic targets identified.  BB3-receptor knockout mice provided insights for their obesity/glucose intolerance and demonstrated that this receptor may be important in the lung response to injury, tumor growth and gastrointestinal motility.  Each receptor is frequently overexpressed in human tumors and has potent growth effects.  This effect is being explored to develop new antitumor treatments, such as bombesin-receptor ligands conjugated to cytotoxic agents.  Summary This receptor family is involved in an increasing no. of central nervous system/peripheral processes physiol. and in disease states, and increased understanding of its role may lead to novel treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGVNLseVXx0rVg90H21EOLACvtfcHk0ligvnrMA0pfaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitFKgsrg%253D&md5=339d9e01f0564fa5b47c555b2806c8dd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1097%2FMED.0b013e3282f3709b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMED.0b013e3282f3709b%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DN.%26aulast%3DMoody%26aufirst%3DT.%2BW.%26aulast%3DIgarashi%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DBombesin-related%2520peptides%2520and%2520their%2520receptors%253A%2520Recent%2520advances%2520in%2520their%2520role%2520in%2520physiology%2520and%2520disease%2520states%26jtitle%3DCurr.%2520Opin.%2520Endocrinol.%2520Diabetes%2520Obes.%26date%3D2008%26volume%3D15%26issue%3D1%26spage%3D58%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Uehara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sancho, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantey, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuche-Berenguer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradhan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coy, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, R. T.</span><span> </span><span class="NLM_article-title">Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1685</span><span class="NLM_x">–</span> <span class="NLM_lpage">1699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1685-1699&issue=8&author=H.+Ueharaauthor=N.+Gonzalezauthor=V.+Sanchoauthor=S.+A.+Manteyauthor=B.+Nuche-Berenguerauthor=T.+Pradhanauthor=D.+H.+Coyauthor=R.+T.+Jensen&title=Pharmacology+and+selectivity+of+various+natural+and+synthetic+bombesin+related+peptide+agonists+for+human+and+rat+bombesin+receptors+differs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUehara%26aufirst%3DH.%26aulast%3DGonzalez%26aufirst%3DN.%26aulast%3DSancho%26aufirst%3DV.%26aulast%3DMantey%26aufirst%3DS.%2BA.%26aulast%3DNuche-Berenguer%26aufirst%3DB.%26aulast%3DPradhan%26aufirst%3DT.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DPharmacology%2520and%2520selectivity%2520of%2520various%2520natural%2520and%2520synthetic%2520bombesin%2520related%2520peptide%2520agonists%2520for%2520human%2520and%2520rat%2520bombesin%2520receptors%2520differs%26jtitle%3DPeptides%26date%3D2011%26volume%3D32%26issue%3D8%26spage%3D1685%26epage%3D1699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmuckli-Maurer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gugger, M.</span><span> </span><span class="NLM_article-title">Bombesin receptor subtypes in human cancers: Detection with the universal radioligand <sup>125</sup>I-[D-Tyr<sup>6</sup>, beta-Ala<sup>11</sup>, Phe<sup>13</sup>, Nle<sup>14</sup>]bombesin(6–14)</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1139</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=11948125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsF2lt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1139-1146&issue=4&author=J.+C.+Reubiauthor=S.+Wengerauthor=J.+Schmuckli-Maurerauthor=J.+C.+Schaerauthor=M.+Gugger&title=Bombesin+receptor+subtypes+in+human+cancers%3A+Detection+with+the+universal+radioligand+125I-%5BD-Tyr6%2C+beta-Ala11%2C+Phe13%2C+Nle14%5Dbombesin%286%E2%80%9314%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin receptor subtypes in human cancers: detection with the universal radioligand 125I-[D-Tyr6, β-Ala11, Phe13, Nle14] bombesin(6-14)</span></div><div class="casAuthors">Reubi, Jean Claude; Wenger, Sandra; Schmuckli-Maurer, Jacqueline; Schaer, Jean-Claude; Gugger, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1139-1146</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Bombesin and bombesin receptors have been shown to play a role in cancer.  Whereas the gastrin-releasing peptide (GRP) receptor is a bombesin receptor subtype frequently expressed by tumors, the other three subtypes, the neuromedin B (NMB), BB3, and BB4 receptors, have been poorly investigated in human tissues.  We investigated 161 human tumors for their bombesin receptor subtype expression using in vitro receptor autoradiog. with the universal bombesin radioligand 125I-[D-Tyr6, β-Ala11, Phe13, Nle14]bombesin(6-14) in displacement expts. with unlabeled GRP, bombesin, NMB, and [D-Tyr6, β-Ala11, Phe13, Nle14]bombesin(6-14).  The distinct rank order of potencies of these analogs for each receptor subtype allows us to identify the predominant subtype expressed by each tumor.  Twelve of 12 prostate cancers, 41 of 57 breast cancers, and 5 of 5 gastrinomas expressed predominantly GRP receptors; 11 of 24 intestinal, 1 of 26 bronchial, and 1 of 1 thymic carcinoids had preferentially NMB receptors; 9 of 26 bronchial carcinoids, 1 large cell neuroendocrine lung carcinoma, and 4 of 9 small cell lung carcinomas had preferentially BB3 receptors, whereas 3 of 9 small cell lung carcinomas had GRP receptors.  Renal cell carcinomas had GRP receptors in 6 of 16 cases and BB3 receptors in 4 of 16 cases.  Finally, 2 of 10 Ewing sarcomas had BB3 receptors.  In situ hybridization detected BB3 receptor mRNA in neuroendocrine tumors expressing the BB3 protein.  This is the first study detecting the proteins of BB3, NMB, and GRP receptors in a group of human tumors using differential binding techniques.  Particularly relevant is the BB3 expression in lung carcinoids and other neuroendocrine lung tumors, whereas gastrointestinal carcinoids preferably express NMB receptors.  These tumors may be targets for diagnostic and radiotherapeutic applications of subtype-selective bombesin analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRfYyxkp7qw7Vg90H21EOLACvtfcHk0ligvnrMA0pfaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsF2lt7w%253D&md5=a50d221d981065374b9facaae5744ee7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DWenger%26aufirst%3DS.%26aulast%3DSchmuckli-Maurer%26aufirst%3DJ.%26aulast%3DSchaer%26aufirst%3DJ.%2BC.%26aulast%3DGugger%26aufirst%3DM.%26atitle%3DBombesin%2520receptor%2520subtypes%2520in%2520human%2520cancers%253A%2520Detection%2520with%2520the%2520universal%2520radioligand%2520125I-%255BD-Tyr6%252C%2520beta-Ala11%252C%2520Phe13%252C%2520Nle14%255Dbombesin%25286%25E2%2580%259314%2529%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26issue%3D4%26spage%3D1139%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hohla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schally, A. V.</span><span> </span><span class="NLM_article-title">Targeting gastrin releasing peptide receptors: New options for the therapy and diagnosis of cancer</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1738</span><span class="NLM_x">–</span> <span class="NLM_lpage">1741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1738-1741&issue=9&author=F.+Hohlaauthor=A.+V.+Schally&title=Targeting+gastrin+releasing+peptide+receptors%3A+New+options+for+the+therapy+and+diagnosis+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHohla%26aufirst%3DF.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26atitle%3DTargeting%2520gastrin%2520releasing%2520peptide%2520receptors%253A%2520New%2520options%2520for%2520the%2520therapy%2520and%2520diagnosis%2520of%2520cancer%26jtitle%3DCell%2520Cycle%26date%3D2010%26volume%3D9%26issue%3D9%26spage%3D1738%26epage%3D1741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Weber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuckerman, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bostwick, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensch, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikic, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffin, T. A.</span><span> </span><span class="NLM_article-title">Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1985&pages=306-309&issue=1&author=S.+Weberauthor=J.+E.+Zuckermanauthor=D.+G.+Bostwickauthor=K.+G.+Benschauthor=B.+I.+Sikicauthor=T.+A.+Raffin&title=Gastrin+releasing+peptide+is+a+selective+mitogen+for+small+cell+lung+carcinoma+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DS.%26aulast%3DZuckerman%26aufirst%3DJ.%2BE.%26aulast%3DBostwick%26aufirst%3DD.%2BG.%26aulast%3DBensch%26aufirst%3DK.%2BG.%26aulast%3DSikic%26aufirst%3DB.%2BI.%26aulast%3DRaffin%26aufirst%3DT.%2BA.%26atitle%3DGastrin%2520releasing%2520peptide%2520is%2520a%2520selective%2520mitogen%2520for%2520small%2520cell%2520lung%2520carcinoma%2520in%2520vitro%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1985%26volume%3D75%26issue%3D1%26spage%3D306%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Matusiak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathaniel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matkowskyj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benya, R. V.</span><span> </span><span class="NLM_article-title">Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon</span> <span class="citation_source-journal">Am. J. Physiol. Gastrointest. Liver Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">G718</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2005&pages=G718-728&issue=4&author=D.+Matusiakauthor=S.+Gloverauthor=R.+Nathanielauthor=K.+Matkowskyjauthor=J.+Yangauthor=R.+V.+Benya&title=Neuromedin+B+and+its+receptor+are+mitogens+in+both+normal+and+malignant+epithelial+cells+lining+the+colon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatusiak%26aufirst%3DD.%26aulast%3DGlover%26aufirst%3DS.%26aulast%3DNathaniel%26aufirst%3DR.%26aulast%3DMatkowskyj%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DBenya%26aufirst%3DR.%2BV.%26atitle%3DNeuromedin%2520B%2520and%2520its%2520receptor%2520are%2520mitogens%2520in%2520both%2520normal%2520and%2520malignant%2520epithelial%2520cells%2520lining%2520the%2520colon%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2005%26volume%3D288%26issue%3D4%26spage%3DG718%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Nock, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cescato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18–27): Synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">8364</span><span class="NLM_x">–</span> <span class="NLM_lpage">8374</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300741f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8364-8374&issue=19&author=B.+A.+Nockauthor=R.+Cescatoauthor=E.+Ketaniauthor=B.+Waserauthor=J.+C.+Reubiauthor=T.+Maina&title=%5B99mTc%5DDemomedin+C%2C+a+radioligand+based+on+human+gastrin+releasing+peptide%2818%E2%80%9327%29%3A+Synthesis+and+preclinical+evaluation+in+gastrin+releasing+peptide+receptor-expressing+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm300741f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300741f%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DKetani%26aufirst%3DE.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3D%255B99mTc%255DDemomedin%2520C%252C%2520a%2520radioligand%2520based%2520on%2520human%2520gastrin%2520releasing%2520peptide%252818%25E2%2580%259327%2529%253A%2520Synthesis%2520and%2520preclinical%2520evaluation%2520in%2520gastrin%2520releasing%2520peptide%2520receptor-expressing%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D19%26spage%3D8364%26epage%3D8374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Marsouvanidis, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sallegger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B. A.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-Radiotracers based on human GRP(18–27): Synthesis and comparative evaluation</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1797</span><span class="NLM_x">–</span> <span class="NLM_lpage">1803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1797-1803&issue=10&author=P.+J.+Marsouvanidisauthor=T.+Mainaauthor=W.+Salleggerauthor=E.+P.+Krenningauthor=M.+de+Jongauthor=B.+A.+Nock&title=99mTc-Radiotracers+based+on+human+GRP%2818%E2%80%9327%29%3A+Synthesis+and+comparative+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarsouvanidis%26aufirst%3DP.%2BJ.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DSallegger%26aufirst%3DW.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DNock%26aufirst%3DB.%2BA.%26atitle%3D99mTc-Radiotracers%2520based%2520on%2520human%2520GRP%252818%25E2%2580%259327%2529%253A%2520Synthesis%2520and%2520comparative%2520evaluation%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26issue%3D10%26spage%3D1797%26epage%3D1803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Cutler, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennkens, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huclier-Markai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span> </span><span class="NLM_article-title">Radiometals for combined imaging and therapy</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">858</span><span class="NLM_x">–</span> <span class="NLM_lpage">883</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr3003104" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=858-883&issue=2&author=C.+S.+Cutlerauthor=H.+M.+Hennkensauthor=N.+Sisayauthor=S.+Huclier-Markaiauthor=S.+S.+Jurisson&title=Radiometals+for+combined+imaging+and+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcr3003104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr3003104%26sid%3Dliteratum%253Aachs%26aulast%3DCutler%26aufirst%3DC.%2BS.%26aulast%3DHennkens%26aufirst%3DH.%2BM.%26aulast%3DSisay%26aufirst%3DN.%26aulast%3DHuclier-Markai%26aufirst%3DS.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26atitle%3DRadiometals%2520for%2520combined%2520imaging%2520and%2520therapy%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26issue%3D2%26spage%3D858%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span> </span><span class="NLM_article-title">Radiometal-labeled agents (non-technetium) for diagnostic imaging</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2219</span><span class="NLM_x">–</span> <span class="NLM_lpage">2234</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr980451q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2219-2234&issue=9&author=C.+J.+Andersonauthor=M.+J.+Welch&title=Radiometal-labeled+agents+%28non-technetium%29+for+diagnostic+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcr980451q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr980451q%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26atitle%3DRadiometal-labeled%2520agents%2520%2528non-technetium%2529%2520for%2520diagnostic%2520imaging%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26issue%3D9%26spage%3D2219%26epage%3D2234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Nock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span> </span><span class="NLM_article-title">Tetraamine-coupled peptides and resulting <sup>99m</sup>Tc-radioligands: An effective route for receptor-targeted diagnostic imaging of human tumors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">2655</span><span class="NLM_x">–</span> <span class="NLM_lpage">2667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.2174%2F1568026611212230003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=2655-2667&issue=23&author=B.+Nockauthor=T.+Maina&title=Tetraamine-coupled+peptides+and+resulting+99mTc-radioligands%3A+An+effective+route+for+receptor-targeted+diagnostic+imaging+of+human+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Tetraamine-coupled peptides and resulting 99mTc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors</span></div><div class="casAuthors">Nock, Berthold A.; Maina, Theodosia</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2655-2667</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The successful application of OctreoScan ([111In-DTPA]octreotide) in the diagnosis of sst2-expressing neuroendocrine tumors (NETs), on one hand, and the manifestation of peptide receptor targets in a wide range of human cancers, on the other, have synergistically induced a booming emergence of numerous radiolabeled peptide (radiopeptide) probes for tumor diagnosis and therapy in man.  Definition of mol. targets and their relation to neoplastic disease has preceded peptide-based radiopharmaceutical design and development.  New criteria have been set to safeguard efficient localization of radionuclides on tumor-assocd. high affinity - low capacity peptide receptor systems.  New tech. and biol. terms, such as specific activity or receptor affinity and internalization, have invaded the Radiopharmacy domain and have irrevocably altered our concept of radiopharmaceutical design.  Nonetheless, 99mTc remains the gold std. of diagnostic nuclear medicine as a result of ideal nuclear characteristics, cost-effectiveness and wide availability in high purity and high specific activity by means of com. 99Mo/99mTc-generators.  The evolution of conventional 99mTc-perfusion agents into modern state-of-the-art mol. radiopharmaceuticals has been a challenge addressed by several researchers.  The present review summarizes recent advances in the development of 99mTc-labeled peptides for in vivo targeting of neoplastic disease, and, in particular, those functionalized with acyclic tetraamines.  Conclusions on their applicability in non-invasive diagnosis and staging of cancer patients are drawn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5hbozbNVAzLVg90H21EOLACvtfcHk0lgRDM7EHPxI9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlGqs70%253D&md5=f7464c81a9bfcc9b0d0b273431df9d72</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1568026611212230003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611212230003%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DTetraamine-coupled%2520peptides%2520and%2520resulting%252099mTc-radioligands%253A%2520An%2520effective%2520route%2520for%2520receptor-targeted%2520diagnostic%2520imaging%2520of%2520human%2520tumors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26issue%3D23%26spage%3D2655%26epage%3D2667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Breeman, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Optimising conditions for radiolabelling of DOTA-peptides with <sup>90</sup>Y, <sup>111</sup>In and <sup>177</sup>Lu at high specific activities</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1007%2Fs00259-003-1142-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=12677301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvF2lsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=917-920&issue=6&author=W.+A.+Breemanauthor=M.+De+Jongauthor=T.+J.+Visserauthor=J.+L.+Erionauthor=E.+P.+Krenning&title=Optimising+conditions+for+radiolabelling+of+DOTA-peptides+with+90Y%2C+111In+and+177Lu+at+high+specific+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing conditions for radiolabeling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities</span></div><div class="casAuthors">Breeman, Wouter A. P.; de Jong, Marion; Visser, Theo J.; Erion, Jack L.; Krenning, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">917-920</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">DOTA-conjugated peptides, such as [DOTA0,Tyr3]octreotide (DOTATOC) and [DOTA0,Tyr3]octreotate (DOTA-tate), can be labeled with radionuclides such as 90Y, 111In and 177Lu.  These radiolabeled somatostatin analogs are used for peptide receptor radionuclide therapy (PRRT).  Radioligands for PRRT require high specific activities.  However, although these radionuclides are produced without addn. of carrier, contaminants are introduced during prodn. and as decay products.  In this study, parameters influencing the kinetics of labeling of DOTA-peptides were investigated and conditions were optimized to obtain the highest achievable specific activity.  The effects of contaminants were systematically investigated, concn. dependently, in a test model mimicking conditions for labeling with minimal molar excess of DOTA-peptides over radionuclide.  Kinetics of labeling of DOTA-peptides were optimal at pH 4-4.5; pH <4 strongly slowed down the kinetics.  Above pH 5, reaction kinetics varied owing to the formation of radionuclide hydroxides.  Labeling with 90Y and 177Lu was completed after 20 min at 80°C, while labeling with 111In was completed after 30 min at 100°C.  The effects of contaminants were systematically categorized, e.g., Cd2+ is the target and decay product of 111In and it was found to be a strong competitor with 111In for incorporation in DOTA.  In contrast, Zr4+ and Hf4+, decay products of 90Y and 177Lu, resp., did not interfere with the incorporation of these radionuclides.  The following conclusions are drawn: (a) DOTA-peptides can be radiolabeled at high specific activity, (b) reaction kinetics differ for each radionuclide, and (c) reactions can be hampered by contaminants, such as target material and decay products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppyPxAqfM4yLVg90H21EOLACvtfcHk0lgRDM7EHPxI9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvF2lsb4%253D&md5=24bd1047a2ded6a7710b48608776551c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00259-003-1142-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-003-1142-0%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3DDe%2BJong%26aufirst%3DM.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DOptimising%2520conditions%2520for%2520radiolabelling%2520of%2520DOTA-peptides%2520with%252090Y%252C%2520111In%2520and%2520177Lu%2520at%2520high%2520specific%2520activities%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2003%26volume%3D30%26issue%3D6%26spage%3D917%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Breeman, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Wansem, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gameren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span> </span><span class="NLM_article-title">The addition of DTPA to [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate prior to administration reduces rat skeleton uptake of radioactivity</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1007%2Fs00259-002-1054-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=12552352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Cmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=312-315&issue=2&author=W.+A.+Breemanauthor=K.+van+der+Wansemauthor=B.+F.+Bernardauthor=A.+van+Gamerenauthor=J.+L.+Erionauthor=T.+J.+Visserauthor=E.+P.+Krenningauthor=M.+de+Jong&title=The+addition+of+DTPA+to+%5B177Lu-DOTA0%2CTyr3%5Doctreotate+prior+to+administration+reduces+rat+skeleton+uptake+of+radioactivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity</span></div><div class="casAuthors">Breeman, Wouter A. P.; van der Wansem, Katy; Bernard, Bert F.; van Gameren, Arthur; Erion, Jack L.; Visser, Theo J.; Krenning, Eric P.; de Jong, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">312-315</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Peptide receptor-targeted radionuclide therapy is nowadays also being performed with DOTA-conjugated peptides, such as [DOTA0,Tyr3]octreotate, labeled with radionuclides like 177Lu.  The incorporation of 177Lu is typically ≥99.5%; however, since a total patient dose can be as high as 800 mCi, the amt. of free 177Lu3+ (= non-DOTA-incorporated) can be substantial.  Free 177Lu3+ accumulates in bone with unwanted irradn. of bone marrow as a consequence.  177Lu-DTPA is reported to be stable in serum in vitro, and in vivo it has rapid renal excretion.  Transforming free Lu3+ to Lu-DTPA might reroute this fraction from accumulation in bone to renal clearance.  We therefore investigated: (a) the biodistribution in rats of 177LuCl3, [177Lu-DOTA0,Tyr3]octreotate and 177Lu-DTPA; (b) the possibilities of complexing the free 177Lu3+ in [177Lu-DOTA0,Tyr3]octreotate to 177Lu-DTPA prior to i.v. injection; and (c) the effects of free 177Lu3+ in [177Lu-DOTA0,Tyr3]octreotate, in the presence and absence of DTPA, on the biodistribution in rats.  177LuCl3 had high skeletal uptake (i.e. 5% ID per g femur, with localization mainly in the epiphyseal plates) and a 24-h total body retention of 80% injected dose (ID).  [177Lu-DOTA0,Tyr3]octreotate had high and specific uptake in somatostatin receptor-pos. tissues, and 24-h total body retention of 19% ID.  177Lu-DTPA had rapid renal clearance, and 24-h total body retention of 4% ID.  Free 177Lu3+ in [177Lu-DOTA0,Tyr3]octreotate could be complexed to 177Lu-DTPA.  Accumulation of 177Lu in femur, blood, liver and spleen showed a dose relation to the amt. of free 177Lu3+, while these accumulations could be normalized by the addn. of DTPA.  After labeling [DOTA0,Tyr3]octreotate with 177Lu the addn. of DTPA prior to i.v. administration of [177Lu-DOTA0,Tyr3]octreotate is strongly recommended.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkwsxwmVY94rVg90H21EOLACvtfcHk0lhD-ByGnN_CKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Cmtg%253D%253D&md5=a93a71f7ea735a0c2d8b1afbabadf501</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00259-002-1054-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-002-1054-4%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3Dvan%2Bder%2BWansem%26aufirst%3DK.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3Dvan%2BGameren%26aufirst%3DA.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DThe%2520addition%2520of%2520DTPA%2520to%2520%255B177Lu-DOTA0%252CTyr3%255Doctreotate%2520prior%2520to%2520administration%2520reduces%2520rat%2520skeleton%2520uptake%2520of%2520radioactivity%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2003%26volume%3D30%26issue%3D2%26spage%3D312%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">de Blois, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sze Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konijnenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Zanger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeman, W. A.</span><span> </span><span class="NLM_article-title">Effectiveness of quenchers to reduce radiolysis of <sup>111</sup>In- or <sup>177</sup>Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">2677</span><span class="NLM_x">–</span> <span class="NLM_lpage">2685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.2174%2F1568026611212230005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlGqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=2677-2685&issue=23&author=E.+de+Bloisauthor=H.+Sze+Chanauthor=M.+Konijnenbergauthor=R.+de+Zangerauthor=W.+A.+Breeman&title=Effectiveness+of+quenchers+to+reduce+radiolysis+of+111In-+or+177Lu-labelled+methionine-containing+regulatory+peptides.+Maintaining+radiochemical+purity+as+measured+by+HPLC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of quenchers to reduce radiolysis of 111In- or 177Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC</span></div><div class="casAuthors">de Blois, Erik; Chan, Ho Sze; Konijnenberg, Mark; de Zanger, Rory; Breeman, Wouter A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2677-2685</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">An overview how to measure and to quantify radiolysis by the addn. of quenchers and to maintain Radio-Chem. Purity (RCP) of vulnerable methionine-contg. regulatory peptides is presented.  High RCP was only achieved with a combination of quenchers.  However, quantification of RCP is not standardized, and therefore comparison of radiolabelling and RCP of regulatory peptides between different HPLC-systems and between labs. is cumbersome.  Therefore we suggest a set of standardized requirements to quantify RCP by HPLC for radiolabeled DTPA- or DOTA-peptides.  Moreover, a dosimetry model was developed to calc. the doses in the reaction vials during radiolabelling and storage of the radiopeptides, and to predict RCP in the presence and absence of quenchers.  RCP was measured by HPLC, and a relation between radiation dose and radiolysis of RCP was established.  The here described quenchers are tested individually as f(concn.) to investigate efficacy to reduce radiolysis of radiolabeled methionine-contg. regulatory peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmEcOBFFH9VLVg90H21EOLACvtfcHk0lj5fdoV3Fa-_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlGqs7s%253D&md5=08e2c76090c3911a1c58dee79cd87b0b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1568026611212230005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611212230005%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBlois%26aufirst%3DE.%26aulast%3DSze%2BChan%26aufirst%3DH.%26aulast%3DKonijnenberg%26aufirst%3DM.%26aulast%3Dde%2BZanger%26aufirst%3DR.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26atitle%3DEffectiveness%2520of%2520quenchers%2520to%2520reduce%2520radiolysis%2520of%2520111In-%2520or%2520177Lu-labelled%2520methionine-containing%2520regulatory%2520peptides.%2520Maintaining%2520radiochemical%2520purity%2520as%2520measured%2520by%2520HPLC%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26issue%3D23%26spage%3D2677%26epage%3D2685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Rolleman, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valkema, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span> </span><span class="NLM_article-title">Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1018</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1007%2Fs00259-009-1282-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=19915842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A280%3ADC%252BC3c3ls1yksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=1018-1031&issue=5&author=E.+J.+Rollemanauthor=M.+Melisauthor=R.+Valkemaauthor=O.+C.+Boermanauthor=E.+P.+Krenningauthor=M.+de+Jong&title=Kidney+protection+during+peptide+receptor+radionuclide+therapy+with+somatostatin+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues</span></div><div class="casAuthors">Rolleman Edgar J; Melis Marleen; Valkema Roelf; Boerman Otto C; Krenning Eric P; de Jong Marion</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1018-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This review focuses on the present status of kidney protection during peptide receptor radionuclide therapy (PRRT) using radiolabelled somatostatin analogues.  This treatment modality for somatostatin receptor-positive tumours is limited by renal reabsorption and retention of radiolabelled peptides resulting in dose-limiting high kidney radiation doses.  Radiation nephropathy has been described in several patients.  Studies on the mechanism and localization demonstrate that renal uptake of radiolabelled somatostatin analogues largely depends on the megalin/cubulin system in the proximal tubule cells.  Thus methods are needed that interfere with this reabsorption pathway to achieve kidney protection.  Such methods include coadministration of basic amino acids, the bovine gelatin-containing solution Gelofusine or albumin fragments.  Amino acids are already commonly used in the clinical setting during PRRT.  Other compounds that interfere with renal reabsorption capacity (maleic acid and colchicine) are not suitable for clinical use because of potential toxicity.  The safe limit for the renal radiation dose during PRRT is not exactly known.  Dosimetry studies applying the principle of the biological equivalent dose (correcting for the effect of dose fractionation) suggest that a dose of about 37 Gy is the threshold for development of kidney toxicity.  This threshold is lower when risk factors for development of renal damage exist: age over 60 years, hypertension, diabetes mellitus and previous chemotherapy.  A still experimental pathway for kidney protection is mitigation of radiation effects, possibly achievable by cotreatment with amifostine (Ethylol), a radiation protector, or with blockers of the renin-angiotensin-aldosterone system.  Future perspectives on improving kidney protection during PRRT include combinations of agents to reduce renal retention of radiolabelled peptides, eventually together with mitigating medicines.  Moreover, new somatostatin analogues with lower renal retention may be developed.  Furthermore, knowledge on kidney protection from radiolabelled somatostatin analogues may be expanded to other peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKpf3bQlnfvhgd2Wuil24tfW6udTcc2ebtlUaryDKRwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3ls1yksQ%253D%253D&md5=fac4a5cb290994a2d5addfad7fc5f11f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00259-009-1282-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-009-1282-y%26sid%3Dliteratum%253Aachs%26aulast%3DRolleman%26aufirst%3DE.%2BJ.%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DValkema%26aufirst%3DR.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DKidney%2520protection%2520during%2520peptide%2520receptor%2520radionuclide%2520therapy%2520with%2520somatostatin%2520analogues%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2010%26volume%3D37%26issue%3D5%26spage%3D1018%26epage%3D1031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Eerd-Vismale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolleman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O.</span><span> </span><span class="NLM_article-title">Indication for different mechanisms of kidney uptake of radiolabeled peptides</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=596-601&issue=4&author=M.+Gotthardtauthor=J.+van+Eerd-Vismaleauthor=W.+J.+Oyenauthor=M.+de+Jongauthor=H.+Zhangauthor=E.+Rollemanauthor=H.+R.+Maeckeauthor=M.+Beheauthor=O.+Boerman&title=Indication+for+different+mechanisms+of+kidney+uptake+of+radiolabeled+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3Dvan%2BEerd-Vismale%26aufirst%3DJ.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRolleman%26aufirst%3DE.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DBehe%26aufirst%3DM.%26aulast%3DBoerman%26aufirst%3DO.%26atitle%3DIndication%2520for%2520different%2520mechanisms%2520of%2520kidney%2520uptake%2520of%2520radiolabeled%2520peptides%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26issue%3D4%26spage%3D596%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Akizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mifune, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiso, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Effect of molecular charges on renal uptake of <sup>111</sup>In–DTPA-conjugated peptides</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1016%2FS0969-8051%2801%2900241-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=11578896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntV2htL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=761-768&issue=7&author=H.+Akizawaauthor=Y.+Aranoauthor=M.+Mifuneauthor=A.+Iwadoauthor=Y.+Saitoauthor=T.+Mukaiauthor=T.+Ueharaauthor=M.+Onoauthor=Y.+Fujiokaauthor=K.+Ogawaauthor=Y.+Kisoauthor=H.+Saji&title=Effect+of+molecular+charges+on+renal+uptake+of+111In%E2%80%93DTPA-conjugated+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides</span></div><div class="casAuthors">Akizawa, H.; Arano, Y.; Mifune, M.; Iwado, A.; Saito, Y.; Mukai, T.; Uehara, T.; Ono, M.; Fujioka, Y.; Ogawa, K.; Kiso, Y.; Saji, H.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">761-768</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The effect of mol. charges on renal accumulation of 111In-DTPA-labeled low mol. wt. (LMW) peptides was investigated using 111In-DTPA-octreotide derivs. as models to design radiolabeled peptides that are taken up less by renal cells.  The N-terminal d-phenylalanine (Phe) of 111In-DTPA-d-Phe1-octreotide was replaced with l-aspartic acid (Asp), l-lysine (Lys), l-methionine (Met) or l-Phe.  Cellulose acetate electrophoresis indicated that both 111In-DTPA-l-Phe1-octreotide and 111In-DTPA-l-Met1-octreotide showed similar net charges, whereas 111In-DTPA-l-αLys1-octreotide and 111In-DTPA-l-Asp1-octreotide had more pos. and neg. charges, resp., at pH values similar to those in blood and glomerular filtrate.  When injected into mice, significant differences were obsd. in the renal radioactivity levels. 111In-DTPA-l-αLys1-octreotide showed the highest radioactivity levels from 10 min to 6 h postinjection, whereas the lowest radioactivity levels were obsd. with 111In-DTPA-l-Asp1-octreotide at all the postinjection intervals.  These findings indicated that the replacement of only one amino acid in 111In-DTPA-d-Phe1-octreotide significantly altered net mol. charges of the resulting peptides and that the net charges of the 111In-DTPA-octreotide derivs. significantly affected their renal uptake.  Thus, an increase of neg. charges in peptide mols. may constitute a strategy for designing 111In-DTPA-conjugated LMW peptides with low renal radioactivity levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyC4T_TWv3trVg90H21EOLACvtfcHk0lg5BJRz4BQbrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntV2htL0%253D&md5=e489fa5a99aca979197d759502c6be0e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900241-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900241-4%26sid%3Dliteratum%253Aachs%26aulast%3DAkizawa%26aufirst%3DH.%26aulast%3DArano%26aufirst%3DY.%26aulast%3DMifune%26aufirst%3DM.%26aulast%3DIwado%26aufirst%3DA.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DMukai%26aufirst%3DT.%26aulast%3DUehara%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DFujioka%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DEffect%2520of%2520molecular%2520charges%2520on%2520renal%2520uptake%2520of%2520111In%25E2%2580%2593DTPA-conjugated%2520peptides%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26issue%3D7%26spage%3D761%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Vegt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzels, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereeuw, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O. C.</span><span> </span><span class="NLM_article-title">Renal toxicity of radiolabeled peptides and antibody fragments: Mechanisms, impact on radionuclide therapy, and strategies for prevention</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.2967%2Fjnumed.110.075101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=20554737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWmu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1049-1058&issue=7&author=E.+Vegtauthor=M.+de+Jongauthor=J.+F.+Wetzelsauthor=R.+Masereeuwauthor=M.+Melisauthor=W.+J.+Oyenauthor=M.+Gotthardtauthor=O.+C.+Boerman&title=Renal+toxicity+of+radiolabeled+peptides+and+antibody+fragments%3A+Mechanisms%2C+impact+on+radionuclide+therapy%2C+and+strategies+for+prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention</span></div><div class="casAuthors">Vegt, Erik; de Jong, Marion; Wetzels, Jack F. M.; Masereeuw, Rosalinde; Melis, Marleen; Oyen, Wim J. G.; Gotthardt, Martin; Boerman, Otto C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1049-1058</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">A review.  Peptide-receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogs such as octreotide is an effective therapy against neuroendocrine tumors.  Other radiolabeled peptides and antibody fragments are under investigation.  Most of these compds. are cleared through the kidneys and reabsorbed and partially retained in the proximal tubules, causing dose-limiting nephrotoxicity.  An overview of renal handling of radiolabeled peptides and resulting nephrotoxicity is presented, and strategies to reduce nephrotoxicity are discussed.  Modification of size, charge, or structure of radiolabeled peptides can alter glomerular filtration and tubular reabsorption.  Coinfusion of competitive inhibitors of reabsorption also interferes with the interaction of peptides with renal endocytic receptors; coinfusion of basic amino acids is currently used for kidney protection in clin. PRRT.  Furthermore, nephrotoxicity may be reduced by dose fractionation, use of radioprotectors, or use of mitigating agents.  Decreasing the risk of nephrotoxicity allows for administration of higher radiation doses, increasing the effectiveness of PRRT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohSe8SThaOrbVg90H21EOLACvtfcHk0ljAiOXjqDCRfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWmu73E&md5=c8f96ae39feed2adfe59f4badb31b084</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.110.075101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.110.075101%26sid%3Dliteratum%253Aachs%26aulast%3DVegt%26aufirst%3DE.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DWetzels%26aufirst%3DJ.%2BF.%26aulast%3DMasereeuw%26aufirst%3DR.%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26atitle%3DRenal%2520toxicity%2520of%2520radiolabeled%2520peptides%2520and%2520antibody%2520fragments%253A%2520Mechanisms%252C%2520impact%2520on%2520radionuclide%2520therapy%252C%2520and%2520strategies%2520for%2520prevention%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26issue%3D7%26spage%3D1049%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Laverman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joosten, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roosenburg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peitl, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aloj, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Guggenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosabowski, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O. C.</span><span> </span><span class="NLM_article-title">Comparative biodistribution of 12 <sup>111</sup>In-labelled gastrin/CCK2 receptor-targeting peptides</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1410</span><span class="NLM_x">–</span> <span class="NLM_lpage">1416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1007%2Fs00259-011-1806-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=21461732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2mtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=1410-1416&issue=8&author=P.+Lavermanauthor=L.+Joostenauthor=A.+Eekauthor=S.+Roosenburgauthor=P.+K.+Peitlauthor=T.+Mainaauthor=H.+Mackeauthor=L.+Alojauthor=E.+von+Guggenbergauthor=J.+K.+Sosabowskiauthor=M.+de+Jongauthor=J.+C.+Reubiauthor=W.+J.+Oyenauthor=O.+C.+Boerman&title=Comparative+biodistribution+of+12+111In-labelled+gastrin%2FCCK2+receptor-targeting+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides</span></div><div class="casAuthors">Laverman, Peter; Joosten, Lieke; Eek, Annemarie; Roosenburg, Susan; Peitl, Petra Kolenc; Maina, Theodosia; Maecke, Helmut; Aloj, Luigi; Guggenberg, Elisabeth; Sosabowski, Jane K.; Jong, Marion; Reubi, Jean-Claude; Oyen, Wim J. G.; Boerman, Otto C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1410-1416</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Cholecystokinin 2 (CCK-2) receptor overexpression has been demonstrated in various tumors such as medullary thyroid carcinomas and small-cell lung cancers.  Due to this high expression, CCK-2 receptors might be suitable targets for radionuclide imaging and/or radionuclide therapy.  Several CCK-2 receptor-binding radiopeptides have been developed and some have been tested in patients.  Here we aimed to compare the in vivo tumor targeting properties of 12 111In-labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated gastrin/CCK2 receptor-binding peptides.  Methods: Two CCK8-based peptides and ten gastrin-based peptide analogs were tested.  All peptides were conjugated with DOTA and labeled with 111In.  Biodistribution studies were performed in mice with s.c. CCK2/gastrin receptor-expressing tumors and with receptor-neg. tumors contralaterally.  Biodistribution was studied by counting dissected tissues at 1 and 4 h after injection.  Results: Both the CCK analogs displayed relatively low tumor uptake (approx. 2.5%ID/g) as compared to minigastrin analogs.  Two linear minigastrin peptides (MG0 and sargastrin) displayed moderate tumor uptake at both 1 and 4 h after injection, but also very high kidney uptake (both higher than 48%ID/g).  The linear MG11, lacking the penta-Glu sequence, showed lower tumor uptake and also low kidney uptake.  Varying the N-terminal Glu residues in the minigastrin analogs led to improved tumor targeting properties, with PP-F11 displaying the optimal biodistribution.  Besides the monomeric linear peptides, a cyclized peptide and a divalent peptide were tested.  Conclusion: Based on these studies, optimal peptides for peptide receptor radionuclide targeting of CCK2/gastrin receptor-expressing tumors were the linear minigastrin analog with six D-Glu residues (PP-F11), the divalent analog MGD5 and the cyclic peptide cyclo-MG1.  These peptides combined high tumor uptake with low kidney retention, and may therefore be good candidates for future clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAC_Zh5uIK3LVg90H21EOLACvtfcHk0liFMfVP46BS0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2mtL0%253D&md5=a9e82197b70009d5eab01adf9e0ba7c1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs00259-011-1806-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-011-1806-0%26sid%3Dliteratum%253Aachs%26aulast%3DLaverman%26aufirst%3DP.%26aulast%3DJoosten%26aufirst%3DL.%26aulast%3DEek%26aufirst%3DA.%26aulast%3DRoosenburg%26aufirst%3DS.%26aulast%3DPeitl%26aufirst%3DP.%2BK.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DMacke%26aufirst%3DH.%26aulast%3DAloj%26aufirst%3DL.%26aulast%3Dvon%2BGuggenberg%26aufirst%3DE.%26aulast%3DSosabowski%26aufirst%3DJ.%2BK.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26atitle%3DComparative%2520biodistribution%2520of%252012%2520111In-labelled%2520gastrin%252FCCK2%2520receptor-targeting%2520peptides%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2011%26volume%3D38%26issue%3D8%26spage%3D1410%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Linder, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalfe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arunachalam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnolini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantry, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunn, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, R. E.</span><span> </span><span class="NLM_article-title">In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1171</span><span class="NLM_x">–</span> <span class="NLM_lpage">1178</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9000189" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1171-1178&issue=6&author=K.+E.+Linderauthor=E.+Metcalfeauthor=T.+Arunachalamauthor=J.+Chenauthor=S.+M.+Eatonauthor=W.+Fengauthor=H.+Fanauthor=N.+Rajuauthor=A.+Cagnoliniauthor=L.+E.+Lantryauthor=A.+D.+Nunnauthor=R.+E.+Swenson&title=In+vitro+and+in+vivo+metabolism+of+Lu-AMBA%2C+a+GRP-receptor+binding+compound%2C+and+the+synthesis+and+characterization+of+its+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and in Vivo Metabolism of Lu-AMBA, a GRP-Receptor Binding Compound, and the Synthesis and Characterization of Its Metabolites</span></div><div class="casAuthors">Linder, Karen E.; Metcalfe, Edmund; Arunachalam, Thangavel; Chen, Jianqing; Eaton, Stephen M.; Feng, Weiwei; Fan, Hong; Raju, Natarajan; Cagnolini, Aldo; Lantry, Laura E.; Nunn, Adrian D.; Swenson, Rolf E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1171-1178</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metab. of 177Lu-AMBA (AMBA = DO3A-CH2CO-G-(4-aminobenzoyl)-QWAVGHLM-NH2), a radiotherapeutic compd. in clin. development that binds to GRP and NMB receptors, was studied in vitro (mouse, rat and human plasma, mouse kidney homogenate) and in vivo (by anal. of mouse and rat plasma and urine following IV injection of 177Lu-AMBA).  The primary metabolites were Lu-DO3A-CH2CO-G-Abz4-R, where R = -Q-OH (A), -QW-OH (B), and -QWAVGH-OH (C).  Minor amts. of (D) where R = -QWAVGHLM-OH and (E) -QWAVGHL-OH were also obsd.  Clearance of 177Lu-AMBA and of radioactivity from mouse and rat blood was rapid in vivo.  In mouse and rat urine, only metabolites Lu-A and Lu-B were found-no parent drug was excreted.  Unmetalated ligands and natLu and 177Lu complexes for Lu-AMBA metabolites A-E were synthesized, characterized by HPLC and MS, and used to perform in vitro competition and direct binding studies on GRP receptor-pos. PC-3 (human prostate) cancer cells.  Biodistribution studies with 177Lu-labeled metabolites A-E were performed in PC-3 tumor-bearing mice and the results compared with intact 177Lu-AMBA. IC50 values for unmetalated metabolite ligands A-E were >400 nM in PC-3 cells in competition binding studies against 177Lu-AMBA.  No direct binding to PC-3 cells was obsd. with 177Lu-labeled A-C, confirming IC50 results. 177Lu-labeled metabolites A-E showed no uptake in GRP-receptor pos. tumor or pancreas in PC-3 tumor bearing mice.  All metabolites were rapidly excreted via the renal route (∼78-87%) within 1 h.  These results demonstrate that the tumor uptake obsd. with 177Lu-AMBA is due to parent drug and not due to any of its identified metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvqAOuUWHaErVg90H21EOLACvtfcHk0liFMfVP46BS0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFGlsLY%253D&md5=da849967f62a36434ddaeae9a2f972eb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fbc9000189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9000189%26sid%3Dliteratum%253Aachs%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DMetcalfe%26aufirst%3DE.%26aulast%3DArunachalam%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DEaton%26aufirst%3DS.%2BM.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DRaju%26aufirst%3DN.%26aulast%3DCagnolini%26aufirst%3DA.%26aulast%3DLantry%26aufirst%3DL.%2BE.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26aulast%3DSwenson%26aufirst%3DR.%2BE.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520metabolism%2520of%2520Lu-AMBA%252C%2520a%2520GRP-receptor%2520binding%2520compound%252C%2520and%2520the%2520synthesis%2520and%2520characterization%2520of%2520its%2520metabolites%26jtitle%3DBioconjugate%2520Chem.%26date%3D2009%26volume%3D20%26issue%3D6%26spage%3D1171%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeman, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwekkeboom, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valkema, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Tumor imaging and therapy using radiolabeled somatostatin analogues</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar800188e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=873-880&issue=7&author=M.+de+Jongauthor=W.+A.+Breemanauthor=D.+J.+Kwekkeboomauthor=R.+Valkemaauthor=E.+P.+Krenning&title=Tumor+imaging+and+therapy+using+radiolabeled+somatostatin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Far800188e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far800188e%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3DKwekkeboom%26aufirst%3DD.%2BJ.%26aulast%3DValkema%26aufirst%3DR.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DTumor%2520imaging%2520and%2520therapy%2520using%2520radiolabeled%2520somatostatin%2520analogues%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2009%26volume%3D42%26issue%3D7%26spage%3D873%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Reile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armatis, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schally, A. V.</span><span> </span><span class="NLM_article-title">Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: Internalization of receptor bound <sup>125</sup>I-(Tyr<sup>4</sup>) bombesin by tumor cells</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=29-38&issue=1&author=H.+Reileauthor=P.+E.+Armatisauthor=A.+V.+Schally&title=Characterization+of+high-affinity+receptors+for+bombesin%2Fgastrin+releasing+peptide+on+the+human+prostate+cancer+cell+lines+PC-3+and+DU-145%3A+Internalization+of+receptor+bound+125I-%28Tyr4%29+bombesin+by+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReile%26aufirst%3DH.%26aulast%3DArmatis%26aufirst%3DP.%2BE.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26atitle%3DCharacterization%2520of%2520high-affinity%2520receptors%2520for%2520bombesin%252Fgastrin%2520releasing%2520peptide%2520on%2520the%2520human%2520prostate%2520cancer%2520cell%2520lines%2520PC-3%2520and%2520DU-145%253A%2520Internalization%2520of%2520receptor%2520bound%2520125I-%2528Tyr4%2529%2520bombesin%2520by%2520tumor%2520cells%26jtitle%3DProstate%26date%3D1994%26volume%3D25%26issue%3D1%26spage%3D29%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Tatsi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cescato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordopatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B. A.</span><span> </span><span class="NLM_article-title">[<sup>111</sup>In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers—First results of a preclinical study</span> <span class="citation_source-journal">EJNMMI Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1186%2F2191-219X-2-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyitbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=25&issue=1&author=A.+Tatsiauthor=T.+Mainaauthor=R.+Cescatoauthor=B.+Waserauthor=E.+P.+Krenningauthor=M.+de+Jongauthor=P.+Cordopatisauthor=J.+C.+Reubiauthor=B.+A.+Nock&title=%5B111In-DOTA%5DSomatostatin-14+analogs+as+potential+pansomatostatin-like+radiotracers%E2%80%94First+results+of+a+preclinical+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">[111In-DOTA]somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study</span></div><div class="casAuthors">Tatsi, Aikaterini; Maina, Theodosia; Cescato, Renzo; Waser, Beatrice; Krenning, Eric P.; de Jong, Marion; Cordopatis, Paul; Reubi, Jean Claude; Nock, Berthold A.</div><div class="citationInfo"><span class="NLM_cas:title">EJNMMI Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25/1-25/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">ERJEAI</span>;
        ISSN:<span class="NLM_cas:issn">2191-219X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Background: In this study, we report on the synthesis, radiolabeling, and biol. evaluation of two new somatostatin-14 (SS14) analogs, modified with the universal chelator DOTA.  We were interested to investigate if and to what extent such radiotracer prototypes may be useful for targeting sst1-5-expressing tumors in man but, most importantly, to outline potential drawbacks and benefits assocd. with their use.  Methods: AT1S and AT2S (DOTA-Ala1-Gly2-c[Cys3-Lys4-Asn5-Phe6-Phe7-Trp8/DTrp8-Lys9-Thr10-Phe11-Thr12-Ser13-Cys14-OH], resp.) were synthesized on the solid support and labeled with 111In.  The sst1-5 affinity profile of AT1S/AT2S was detd. by receptor autoradiog. using [Leu8,dTrp22,125I-Tyr25]SS28 as radioligand.  The ability of AT2S to stimulate sst2 or sst3 internalization was qual. analyzed by an immunofluorescence-based internalization assay using hsst2- or hsst3-expressing HEK293 cells.  Furthermore, the internalization of the radioligands [111In]AT1S and [111In]AT2S was studied at 37°C in AR4-2J cells endogenously expressing sst2.  The in vivo stability of [111In]AT1S and [111In]AT2S was tested by high-performance liq. chromatog. anal. of mouse blood collected 5 min after radioligand injection, and biodistribution was studied in normal mice.  Selectively for [111In]AT2S, biodistribution was further studied in SCID mice bearing AR4-2J, HEK293-hsst2A+, -hsst3+ or -hsst5+ tumors.  Results: The new SS14-derived analogs were obtained by solid phase peptide synthesis and were easily labeled with 111In.  Both SS14 conjugates, AT1S, and its DTrp8 counterpart, AT2S, showed a pansomatostatin affinity profile with the resp. hsst1-5 IC50 values in the lower nanomolar range.  In addn., AT2S behaved as an agonist for sst2 and sst3 since it stimulated receptor internalization.  The 111In radioligands effectively and specifically internalized into rsst2A-expressing AR4-2J cells with [111In]AT2S internalizing faster than [111In]AT1S.  Ex vivo mouse blood anal. revealed a rapid degrdn. of both radiopeptides in the bloodstream with the DTrp8 analog showing higher stability.  Biodistribution results in healthy mice were consistent with these findings with only [111In]AT2S showing specific uptake in the sst2-rich pancreas.  Biodistribution of [111In]AT2S in tumor-bearing mice revealed receptor-mediated uptake in the AR4-2J (1.82 ± 0.36 %ID/g-block 0.21 ± 0.17 %ID/g at 4 h post injection (pi)), the HEK293-hsst2A+ (1.49 ± 0.2 %ID/g-block 0.27 ± 0.20 %ID/g at 4 h pi), the HEK293-hsst3+ (1.24 ± 0.27 %ID/g-block 0.32 ± 0.06 %ID/g at 4 h pi), and the HEK293-hsst5+ tumors (0.41 ± 0.12 %ID/g-block 0.22 ± 0.006 %ID/g at 4 h pi).  Radioactivity washed out from blood and background tissues via the kidneys.  Conclusions: This study has revealed that the native SS14 structure can indeed serve as a motif for the development of promising pansomatostatin-like radiotracers.  Further peptide stabilization is required to increase in vivo stability and, consequently, to enhance in vivo delivery and tumor targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg7R9fdxYKDrVg90H21EOLACvtfcHk0lh_3eEm04qPKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyitbbI&md5=2ce622f111b105b37cf02e63bd9310c0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1186%2F2191-219X-2-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2191-219X-2-25%26sid%3Dliteratum%253Aachs%26aulast%3DTatsi%26aufirst%3DA.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DCordopatis%26aufirst%3DP.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DNock%26aufirst%3DB.%2BA.%26atitle%3D%255B111In-DOTA%255DSomatostatin-14%2520analogs%2520as%2520potential%2520pansomatostatin-like%2520radiotracers%25E2%2580%2594First%2520results%2520of%2520a%2520preclinical%2520study%26jtitle%3DEJNMMI%2520Res.%26date%3D2012%26volume%3D2%26issue%3D1%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yao  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Ma</span>, <span class="hlFld-ContribAuthor ">Zhe  Zhang</span>, <span class="hlFld-ContribAuthor ">Ziyan  Sun</span>, <span class="hlFld-ContribAuthor ">Mathias  Loft</span>, <span class="hlFld-ContribAuthor ">Bingbing  Ding</span>, <span class="hlFld-ContribAuthor ">Changhao  Liu</span>, <span class="hlFld-ContribAuthor ">Liying  Xu</span>, <span class="hlFld-ContribAuthor ">Meng  Yang</span>, <span class="hlFld-ContribAuthor ">Yuxin  Jiang</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Yuling  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhen  Cheng</span>, and <span class="hlFld-ContribAuthor ">Xuechuan  Hong</span>  . </span><span class="cited-content_cbyCitation_article-title">Preclinical Study on GRPR-Targeted 68Ga-Probes for PET Imaging of Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2016,</strong> <em>27 </em>
                                    (8)
                                     , 1857-1864. <a href="https://doi.org/10.1021/acs.bioconjchem.6b00279" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.6b00279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.6b00279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.6b00279%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DPreclinical%252BStudy%252Bon%252BGRPR-Targeted%252B68Ga-Probes%252Bfor%252BPET%252BImaging%252Bof%252BProstate%252BCancer%26aulast%3DSun%26aufirst%3DYao%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01062016%26date%3D05072016%26date%3D26072016%26date%3D17082016%26date%3D11072016%26volume%3D27%26issue%3D8%26spage%3D1857%26epage%3D1864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingjing  Zhang</span>, <span class="hlFld-ContribAuthor ">Aviral  Singh</span>, <span class="hlFld-ContribAuthor ">Harshad R.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Christiane  Schuchardt</span>, <span class="hlFld-ContribAuthor ">Dirk  Müller</span>, <span class="hlFld-ContribAuthor ">Hans-J.  Wester</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Frank  Rösch</span>, <span class="hlFld-ContribAuthor ">Nicholas P.  van der Meulen</span>, <span class="hlFld-ContribAuthor ">Cristina  Müller</span>, <span class="hlFld-ContribAuthor ">Helmut  Mäcke</span>, <span class="hlFld-ContribAuthor ">Richard P.  Baum</span>. </span><span class="cited-content_cbyCitation_article-title">From Bench to Bedside—The Bad Berka Experience With First-in-Human Studies. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Nuclear Medicine</span><span> <strong>2019,</strong> <em>49 </em>
                                    (5)
                                     , 422-437. <a href="https://doi.org/10.1053/j.semnuclmed.2019.06.002" title="DOI URL">https://doi.org/10.1053/j.semnuclmed.2019.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.semnuclmed.2019.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.semnuclmed.2019.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Nuclear%2520Medicine%26atitle%3DFrom%252BBench%252Bto%252BBedside%2525E2%252580%252594The%252BBad%252BBerka%252BExperience%252BWith%252BFirst-in-Human%252BStudies%26aulast%3DZhang%26aufirst%3DJingjing%26date%3D2019%26volume%3D49%26issue%3D5%26spage%3D422%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aikaterini  Kaloudi</span>, <span class="hlFld-ContribAuthor ">Emmanouil  Lymperis</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Kanellopoulos</span>, <span class="hlFld-ContribAuthor ">Beatrice  Waser</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>, <span class="hlFld-ContribAuthor ">Eric  Krenning</span>, <span class="hlFld-ContribAuthor ">Jean  Reubi</span>, <span class="hlFld-ContribAuthor ">Berthold  Nock</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>. </span><span class="cited-content_cbyCitation_article-title">Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     , 42. <a href="https://doi.org/10.3390/ph12010042" title="DOI URL">https://doi.org/10.3390/ph12010042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12010042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12010042%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DLocalization%252Bof%252B99mTc-GRP%252BAnalogs%252Bin%252BGRPR-Expressing%252BTumors%25253A%252BEffects%252Bof%252BPeptide%252BLength%252Band%252BNeprilysin%252BInhibition%252Bon%252BBiological%252BResponses%26aulast%3DKaloudi%26aufirst%3DAikaterini%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ingrid L.  Bakker</span>, <span class="hlFld-ContribAuthor ">Sandra T.  van Tiel</span>, <span class="hlFld-ContribAuthor ">Joost  Haeck</span>, <span class="hlFld-ContribAuthor ">Gabriela N.  Doeswijk</span>, <span class="hlFld-ContribAuthor ">Erik  de Blois</span>, <span class="hlFld-ContribAuthor ">Marcel  Segbers</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>, <span class="hlFld-ContribAuthor ">Simone U.  Dalm</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2018,</strong> <em>20 </em>
                                    (6)
                                     , 973-983. <a href="https://doi.org/10.1007/s11307-018-1185-z" title="DOI URL">https://doi.org/10.1007/s11307-018-1185-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-018-1185-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-018-1185-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DIn%252BVivo%252BStabilized%252BSB3%25252C%252Ban%252BAttractive%252BGRPR%252BAntagonist%25252C%252Bfor%252BPre-%252Band%252BIntra-Operative%252BImaging%252Bfor%252BProstate%252BCancer%26aulast%3DBakker%26aufirst%3DIngrid%2BL.%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D6%26spage%3D973%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>, <span class="hlFld-ContribAuthor ">Harshad  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Aviral  Singh</span>, <span class="hlFld-ContribAuthor ">Richard P.  Baum</span>. </span><span class="cited-content_cbyCitation_article-title">Theranostic Prospects of Gastrin-Releasing Peptide Receptor–Radioantagonists in Oncology. </span><span class="cited-content_cbyCitation_journal-name">PET Clinics</span><span> <strong>2017,</strong> <em>12 </em>
                                    (3)
                                     , 297-309. <a href="https://doi.org/10.1016/j.cpet.2017.02.007" title="DOI URL">https://doi.org/10.1016/j.cpet.2017.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cpet.2017.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cpet.2017.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DPET%2520Clinics%26atitle%3DTheranostic%252BProspects%252Bof%252BGastrin-Releasing%252BPeptide%252BReceptor%2525E2%252580%252593Radioantagonists%252Bin%252BOncology%26aulast%3DMaina%26aufirst%3DTheodosia%26date%3D2017%26volume%3D12%26issue%3D3%26spage%3D297%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>. </span><span class="cited-content_cbyCitation_article-title">From Bench to Bed. </span><span class="cited-content_cbyCitation_journal-name">PET Clinics</span><span> <strong>2017,</strong> <em>12 </em>
                                    (2)
                                     , 205-217. <a href="https://doi.org/10.1016/j.cpet.2016.12.002" title="DOI URL">https://doi.org/10.1016/j.cpet.2016.12.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cpet.2016.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cpet.2016.12.002%26sid%3Dliteratum%253Aachs%26jtitle%3DPET%2520Clinics%26atitle%3DFrom%252BBench%252Bto%252BBed%26aulast%3DMaina%26aufirst%3DTheodosia%26date%3D2017%26volume%3D12%26issue%3D2%26spage%3D205%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>, <span class="hlFld-ContribAuthor ">Aikaterini  Kaloudi</span>, <span class="hlFld-ContribAuthor ">Emmanouil  Lymperis</span>, <span class="hlFld-ContribAuthor ">Athina  Giarika</span>, <span class="hlFld-ContribAuthor ">Harshad R.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Ingo  Klette</span>, <span class="hlFld-ContribAuthor ">Aviral  Singh</span>, <span class="hlFld-ContribAuthor ">Eric P.  Krenning</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Richard P.  Baum</span>. </span><span class="cited-content_cbyCitation_article-title">Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2017,</strong> <em>58 </em>
                                    (1)
                                     , 75-80. <a href="https://doi.org/10.2967/jnumed.116.178889" title="DOI URL">https://doi.org/10.2967/jnumed.116.178889</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.116.178889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.116.178889%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DTheranostic%252BPerspectives%252Bin%252BProstate%252BCancer%252Bwith%252Bthe%252BGastrin-Releasing%252BPeptide%252BReceptor%252BAntagonist%252BNeoBOMB1%25253A%252BPreclinical%252Band%252BFirst%252BClinical%252BResults%26aulast%3DNock%26aufirst%3DBerthold%2BA.%26date%3D2017%26date%3D2016%26volume%3D58%26issue%3D1%26spage%3D75%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Hendrik  Bergsma</span>, <span class="hlFld-ContribAuthor ">Harshad R.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Dirk  Mueller</span>, <span class="hlFld-ContribAuthor ">David  Charalambidis</span>, <span class="hlFld-ContribAuthor ">Eric P.  Krenning</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>, <span class="hlFld-ContribAuthor ">Richard P.  Baum</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2016,</strong> <em>43 </em>
                                    (5)
                                     , 964-973. <a href="https://doi.org/10.1007/s00259-015-3232-1" title="DOI URL">https://doi.org/10.1007/s00259-015-3232-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-015-3232-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-015-3232-1%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DPreclinical%252Band%252Bfirst%252Bclinical%252Bexperience%252Bwith%252Bthe%252Bgastrin-releasing%252Bpeptide%252Breceptor-antagonist%252B%25255B68Ga%25255DSB3%252Band%252BPET%25252FCT%26aulast%3DMaina%26aufirst%3DTheodosia%26date%3D2016%26date%3D2015%26volume%3D43%26issue%3D5%26spage%3D964%26epage%3D973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priscilla B.  Pujatti</span>, <span class="hlFld-ContribAuthor ">Julie M.  Foster</span>, <span class="hlFld-ContribAuthor ">Ciara  Finucane</span>, <span class="hlFld-ContribAuthor ">Chantelle D.  Hudson</span>, <span class="hlFld-ContribAuthor ">Jerome C.  Burnet</span>, <span class="hlFld-ContribAuthor ">Kerly F.M.  Pasqualoto</span>, <span class="hlFld-ContribAuthor ">Jair  Mengatti</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Mather</span>, <span class="hlFld-ContribAuthor ">Elaine B.  de Araújo</span>, <span class="hlFld-ContribAuthor ">Jane K.  Sosabowski</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation and comparison of a new DOTA and DTPA - bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2015,</strong> <em>96 </em>, 91-101. <a href="https://doi.org/10.1016/j.apradiso.2014.11.006" title="DOI URL">https://doi.org/10.1016/j.apradiso.2014.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2014.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2014.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DEvaluation%252Band%252Bcomparison%252Bof%252Ba%252Bnew%252BDOTA%252Band%252BDTPA%252B-%252Bbombesin%252Bagonist%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bin%252Blow%252Band%252Bhigh%252BGRPR%252Bexpressing%252Bprostate%252Band%252Bbreast%252Btumor%252Bmodels%26aulast%3DPujatti%26aufirst%3DPriscilla%2BB.%26date%3D2015%26volume%3D96%26spage%3D91%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panteleimon J.  Marsouvanidis</span>, <span class="hlFld-ContribAuthor ">Marleen  Melis</span>, <span class="hlFld-ContribAuthor ">Erik  de Blois</span>, <span class="hlFld-ContribAuthor ">Wout A.P.  Breeman</span>, <span class="hlFld-ContribAuthor ">Eric P.  Krenning</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo
              Enzyme Inhibition Improves the Targeting of [
              177
              Lu]DOTA-GRP(13–27) in GRPR-Positive Tumors in Mice. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biotherapy and Radiopharmaceuticals</span><span> <strong>2014,</strong> <em>29 </em>
                                    (9)
                                     , 359-367. <a href="https://doi.org/10.1089/cbr.2014.1706" title="DOI URL">https://doi.org/10.1089/cbr.2014.1706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/cbr.2014.1706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fcbr.2014.1706%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biotherapy%2520and%2520Radiopharmaceuticals%26atitle%3DIn%252BVivo%252BEnzyme%252BInhibition%252BImproves%252Bthe%252BTargeting%252Bof%252B%25255B%252B177%252BLu%25255DDOTA-GRP%25252813%2525E2%252580%25259327%252529%252Bin%252BGRPR-Positive%252BTumors%252Bin%252BMice%26aulast%3DMarsouvanidis%26aufirst%3DPanteleimon%2BJ.%26date%3D2014%26volume%3D29%26issue%3D9%26spage%3D359%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/medium/jm-2013-010237_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4010237&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/medium/jm-2013-010237_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular structure of [<sup>111</sup>In]<b>1</b>; sequences corresponding to [<sup>111</sup>In]<b>2</b>, [<sup>111</sup>In]<b>3</b>, and [<sup>111</sup>In]<b>4</b> are listed below along with the native BBN sequence for comparison purposes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4010237&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/medium/jm-2013-010237_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Curves of [<sup>125</sup>I-Tyr<sup>4</sup>]BBN displacement from human GRPR sites in PC-3 cell membranes during 1 h incubation at 22 °C by increasing concentrations of test peptide: gray asterisks, GRP(14–27) (reference); red squares, <b>1</b>; open squares, <b>2</b>; red diamonds, <b>3</b>; and open diamonds, <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4010237&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/medium/jm-2013-010237_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Internalization of [<sup>111</sup>In-DOTA]GRP radioligands, expressed as percentage internalized of total added radioactivity in confluent monolayers of PC-3 cells after 1 h incubation at 37 °C: solid red bar, [<sup>111</sup>In]<b>1</b>; solid black bar, [<sup>111</sup>In]<b>2</b>; cross-hatched red bar, [<sup>111</sup>In]<b>3</b>; cross-hatched black bar, [<sup>111</sup>In]<b>4</b>. In the presence of 1 μM [Tyr<sup>4</sup>]BBN (nonspecific internalization) values dropped to <0.5% (left group of bars).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4010237&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/medium/jm-2013-010237_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative radiochromatograms of blood samples collected 5 min postinjection in mice for (A) [<sup>111</sup>In]<b>1</b> (<i>t</i><sub>R</sub> = 38.0 min), (B) [<sup>111</sup>In]<b>2</b> (<i>t</i><sub>R</sub> = 39.8 min), (C) [<sup>111</sup>In]<b>3</b> (<i>t</i><sub>R</sub> = 29.3 min), and (D) [<sup>111</sup>In]<b>4</b> (<i>t</i><sub>R</sub> = 32.7 min); co-injection with labeling reaction samples indicated the position of parent radiopeptides (green arrow); chromatographic system 3 was applied in analyses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-21/jm4010237/production/images/large/jm-2013-010237_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4010237&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Reubi, J. C.</span><span> </span><span class="NLM_article-title">Peptide receptors as molecular targets for cancer diagnosis and therapy</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1210%2Fer.2002-0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=12920149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=389-427&issue=4&author=J.+C.+Reubi&title=Peptide+receptors+as+molecular+targets+for+cancer+diagnosis+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide receptors as molecular targets for cancer diagnosis and therapy</span></div><div class="casAuthors">Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-427</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  During the past decade, proof of the principle that peptide receptors can be used successfully for in vivo targeting of human cancers has been provided.  A review.  The mol. basis for targeting rests on the in vitro observation that peptide receptors can be expressed in large quantities in certain tumors.  The clin. impact is at the diagnostic level: in vivo receptor scintigraphy uses radiolabeled peptides for the localization of tumors and their metastases.  It is also at the therapeutic level: peptide receptor radiotherapy of tumors emerges as a serious treatment option.  Peptides linked to cytotoxic agents are also considered for therapeutic applications.  The use of nonradiolabeled, noncytotoxic peptide analogs for long-term antiproliferative treatment of tumors appears promising for only a few tumor types, whereas the symptomatic treatment of neuroendocrine tumors by somatostatin analogs is clearly successful.  The present review summarizes and critically evaluates the in vitro data on peptide and peptide receptor expression in human cancers.  These data are considered to be the mol. basis for peptide receptor targeting of tumors.  The paradigmatic peptide somatostatin and its receptors are extensively reviewed in the light of in vivo targeting of neuroendocrine tumors.  The role of the more recently described targeting peptides vasoactive intestinal peptide, gastrin-releasing peptide, and cholecystokinin/gastrin is discussed.  Other emerging and promising peptides and their resp. receptors, including neurotensin, substance P, and neuropeptide Y, are introduced.  This information relates to established and potential clin. applications in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpImMX7eTxXDbVg90H21EOLACvtfcHk0liqRpwxrfiWJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlKjtbs%253D&md5=2203d38ced1a18b3998f9e284b7f2348</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1210%2Fer.2002-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2002-0007%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DPeptide%2520receptors%2520as%2520molecular%2520targets%2520for%2520cancer%2520diagnosis%2520and%2520therapy%26jtitle%3DEndocr.%2520Rev.%26date%3D2003%26volume%3D24%26issue%3D4%26spage%3D389%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Markwalder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span> </span><span class="NLM_article-title">Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=1152-1159&issue=5&author=R.+Markwalderauthor=J.+C.+Reubi&title=Gastrin-releasing+peptide+receptors+in+the+human+prostate%3A+Relation+to+neoplastic+transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkwalder%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DGastrin-releasing%2520peptide%2520receptors%2520in%2520the%2520human%2520prostate%253A%2520Relation%2520to%2520neoplastic%2520transformation%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D5%26spage%3D1152%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gugger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span> </span><span class="NLM_article-title">Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2067</span><span class="NLM_x">–</span> <span class="NLM_lpage">2076</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1016%2FS0002-9440%2810%2965525-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=10595936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1Knsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1999&pages=2067-2076&issue=6&author=M.+Guggerauthor=J.+C.+Reubi&title=Gastrin-releasing+peptide+receptors+in+non-neoplastic+and+neoplastic+human+breast"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast</span></div><div class="casAuthors">Gugger, Mathias; Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2067-2076</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">The regulatory peptide gastrin-releasing peptide (GRP) may play a role in human cancer as a stimulatory growth factor.  To understand the potential role of GRP in human breast cancer, the authors have evaluated GRP receptor expression in human non-neoplastic and neoplastic breast tissues and in axillary lymph node metastases, using in vitro receptor autoradiog. on tissue sections with [125I]Tyr4-bombesin and with [125I]D-Tyr6, β Ala11, Phe13, Nle14-bombesin(6-14) as radioligands.  GRP receptors were detected, often in high d., in neoplastic epithelial mammary cells in 29 of 46 invasive ductal carcinomas, in 11 of 17 ductal carcinomas in situ, in 1 of 4 invasive lobular carcinomas, in 1 of 2 lobular carcinomas in situ, and in 1 mucinous and 1 tubular carcinoma.  A heterogeneous GRP receptor distribution was found in the neoplastic tissue samples in 32 of 52 cases with invasive carcinoma and 12 of 19 cases with carcinoma in situ.  The lymph node metastases from those primary carcinomas expressing GRP receptors were all pos., whereas surrounding lymphoreticular tissue was neg.  GRP receptors were also present in high d. but with heterogeneous distribution in ducts and lobules from all available breast tissue samples.  All of the receptors corresponded to the GRP receptor subtype of bombesin receptors, having high affinity for GRP and bombesin and lower affinity for neuromedin B.  All tissues expressing GRP receptors were identified similarly with both radioligands.  These data describe not only a high percentage of GRP receptor-pos. neoplastic breast tissues but also for the first time a ubiquitous GRP receptor expression in nonneoplastic human breast tissue.  Apart from suggesting a role of GRP in breast physiol., these data represent the mol. basis for potential clin. applications of GRP analogs such as GRP receptor scintigraphy, radiotherapy, or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7FaVfPA8ChLVg90H21EOLACvtfcHk0liqRpwxrfiWJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1Knsg%253D%253D&md5=c9033e2188ac6f5abee5ba4c97cc4531</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965525-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965525-3%26sid%3Dliteratum%253Aachs%26aulast%3DGugger%26aufirst%3DM.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DGastrin-releasing%2520peptide%2520receptors%2520in%2520non-neoplastic%2520and%2520neoplastic%2520human%2520breast%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D155%26issue%3D6%26spage%3D2067%26epage%3D2076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Guinee, D. G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishback, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koss, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbondanzo, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travis, W. D.</span><span> </span><span class="NLM_article-title">The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies</span> <span class="citation_source-journal">Am. J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=7524299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A280%3ADyaK2M%252FivFSqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1994&pages=406-414&issue=4&author=D.+G.+Guineeauthor=N.+F.+Fishbackauthor=M.+N.+Kossauthor=S.+L.+Abbondanzoauthor=W.+D.+Travis&title=The+spectrum+of+immunohistochemical+staining+of+small-cell+lung+carcinoma+in+specimens+from+transbronchial+and+open-lung+biopsies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies</span></div><div class="casAuthors">Guinee D G Jr; Fishback N F; Koss M N; Abbondanzo S L; Travis W D</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical pathology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">406-14</span>
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    </div><div class="casAbstract">Immunohistochemistry is increasingly used as an aid in the diagnosis of small-cell lung carcinoma (SCLC).  Previous studies have investigated immunohistochemical staining of SCLC with small numbers of antibodies, but few have examined large series with a broad panel of antibodies.  For this reason, the authors examined the distribution and intensity of staining of 20 open-lung biopsy (OLB) and 21 transbronchial biopsy (TBB) specimens of SCLC with a panel of epithelial, neuroendocrine, and hormonal markers.  Small-cell lung carcinoma stained most frequently with epithelial markers, followed by neuroendocrine and hormonal markers.  Similar percentages of OLB and TBB specimens stained for keratin (100% each) and epithelial membrane antigen (100% and 95%, respectively).  Unexpectedly, BER-EP4 stained 100% of OLB specimens.  Chromogranin A was the most frequent neuroendocrine marker in OLB and TBB specimens (60% and 47%, respectively) followed by neuron-specific enolase (60% and 33%), Leu-7 (40% and 24%), and synaptophysin (5% and 19%).  No neuroendocrine immunohistochemical reactivity was found in 24% of TBB specimens and 20% of OLB specimens.  Bombesin was the most sensitive hormonal marker (45% of OLB specimens).  These results show that keratin, epithelial membrane antigen, and BER-EP4 are reliable epithelial markers for SCLC in both TBB and OLB specimens.  In addition, negative staining for neuroendocrine markers, because it can occur in as many as 25% of cases, should not deter the diagnosis of SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3df4yPm4B1mZyxfu64m4ffW6udTcc2eb1p4zY4W4DYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252FivFSqtw%253D%253D&md5=6bb9fca317dea0ff96272ee75641fd5f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuinee%26aufirst%3DD.%2BG.%26aulast%3DFishback%26aufirst%3DN.%2BF.%26aulast%3DKoss%26aufirst%3DM.%2BN.%26aulast%3DAbbondanzo%26aufirst%3DS.%2BL.%26aulast%3DTravis%26aufirst%3DW.%2BD.%26atitle%3DThe%2520spectrum%2520of%2520immunohistochemical%2520staining%2520of%2520small-cell%2520lung%2520carcinoma%2520in%2520specimens%2520from%2520transbronchial%2520and%2520open-lung%2520biopsies%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D1994%26volume%3D102%26issue%3D4%26spage%3D406%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S.</span><span> </span><span class="NLM_article-title">Targeting prostate cancer with radiolabelled bombesins</span> <span class="citation_source-journal">Cancer Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=153-157&author=T.+Mainaauthor=B.+Nockauthor=S.+Mather&title=Targeting+prostate+cancer+with+radiolabelled+bombesins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DMather%26aufirst%3DS.%26atitle%3DTargeting%2520prostate%2520cancer%2520with%2520radiolabelled%2520bombesins%26jtitle%3DCancer%2520Imaging%26date%3D2006%26volume%3D6%26spage%3D153%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Sancho, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Florio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, R. T.</span><span> </span><span class="NLM_article-title">Bombesin receptor-mediated imaging and cytotoxicity: Review and current status</span> <span class="citation_source-journal">Curr. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=79-134&issue=1&author=V.+Sanchoauthor=A.+Di+Florioauthor=T.+W.+Moodyauthor=R.+T.+Jensen&title=Bombesin+receptor-mediated+imaging+and+cytotoxicity%3A+Review+and+current+status"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSancho%26aufirst%3DV.%26aulast%3DDi%2BFlorio%26aufirst%3DA.%26aulast%3DMoody%26aufirst%3DT.%2BW.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DBombesin%2520receptor-mediated%2520imaging%2520and%2520cytotoxicity%253A%2520Review%2520and%2520current%2520status%26jtitle%3DCurr.%2520Drug%2520Delivery%26date%3D2011%26volume%3D8%26issue%3D1%26spage%3D79%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Breeman, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofland, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwekkeboom, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1002%2F%28SICI%291097-0215%2819990517%2981%3A4%3C658%3A%3AAID-IJC24%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADyaK1MXjtF2lsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1999&pages=658-665&issue=4&author=W.+A.+Breemanauthor=L.+J.+Hoflandauthor=M.+de+Jongauthor=B.+F.+Bernardauthor=A.+Srinivasanauthor=D.+J.+Kwekkeboomauthor=T.+J.+Visserauthor=E.+P.+Krenning&title=Evaluation+of+radiolabelled+bombesin+analogues+for+receptor-targeted+scintigraphy+and+radiotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy</span></div><div class="casAuthors">Breeman, Wout A. P.; Hofland, Leo J.; De Jong, Marion; Bernard, Bert F.; Srinivasan, Ananth; Kwekkeboom, Dik J.; Visser, Theo J.; Krenning, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-665</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The 14-amino acid peptide bombesin (BN) has a high affinity for the gastrin-releasing peptide receptor which is expressed by a variety of tumors.  Thus, radiometal-labeled DTPA-BN derivs. are potentially useful radioligands for receptor-targeted scintigraphy and radiotherapy of BN receptor-expressing tumors.  A no. of such DTPA-BN analogs, [DTPA-D-Tyr6]BN(6-13)NHEt (Et=ethyl), [DTPA-Tyr5,D-Phe6]BN(5-13)NHEt, [DTPA-D-Phe6,Leu13ψPhe14]-BN(6-14), [DTPA-Tyr5,D-Phe6,Leu13ψPhe14]BN(5-14), [DTPA-Pro1,Tyr4]BN and [DTPA-Pro1,Tyr4,Nle14]BN, were synthesized and studied for their binding characteristics to the BN receptor on 7315b rat pituitary tumor cell membranes in competition with [125I-Tyr4]BN.  The effects of the BN analogs were detd. on basal and BN-stimulated prolactin secretion by 7315b cells to distinguish between their agonistic and antagonistic characteristics.  Internalization of selected 111In-labeled BN analogs was studied using the BN receptor-pos. 7315b pituitary tumor and the CA20948 and AR42J exocrine pancreas tumor cell lines.  The tissue distribution of these 111In-labeled BN analogs was investigated in 7315b tumor-bearing rats.  Two DTPA-conjugated analogs, the antagonist [DTPA-Tyr5,D-Phe6]BN(5-13)NHEt and the agonist [DTPA-Pro1,Tyr4]BN showed the highest affinity for the BN receptor on 7315b cell membranes.  Despite similar affinity for the BN receptor, the 111In-labeled agonist, but not the antagonist, was internalized by the BN receptor-pos. tumor cells.  Consonant with this observation, the agonist [111In-DTPA-Pro1,Tyr4]BN showed much higher specific uptake in BN receptor-pos. tissues and tumor than the antagonist [111In-DTPA-Tyr5,D-Phe6]BN(5-13)NHEt, with concordant target to background ratios.  We conclude that [111In-DTPA-Pro1,Tyr4]BN has promising characteristics for applications in nuclear medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtUBWBTOKH-LVg90H21EOLACvtfcHk0lj8HpBMgnt1NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtF2lsbY%253D&md5=c2763539d2972cbb478b64675ce9374e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819990517%2981%3A4%3C658%3A%3AAID-IJC24%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819990517%252981%253A4%253C658%253A%253AAID-IJC24%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3DHofland%26aufirst%3DL.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DKwekkeboom%26aufirst%3DD.%2BJ.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DEvaluation%2520of%2520radiolabelled%2520bombesin%2520analogues%2520for%2520receptor-targeted%2520scintigraphy%2520and%2520radiotherapy%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1999%26volume%3D81%26issue%3D4%26spage%3D658%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Breeman, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugaj, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwekkeboom, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Preclinical comparison of <sup>111</sup>In-labeled DTPA– or DOTA–bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1650</span><span class="NLM_x">–</span> <span class="NLM_lpage">1656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1650-1656&issue=12&author=W.+A.+Breemanauthor=M.+de+Jongauthor=J.+L.+Erionauthor=J.+E.+Bugajauthor=A.+Srinivasanauthor=B.+F.+Bernardauthor=D.+J.+Kwekkeboomauthor=T.+J.+Visserauthor=E.+P.+Krenning&title=Preclinical+comparison+of+111In-labeled+DTPA%E2%80%93+or+DOTA%E2%80%93bombesin+analogs+for+receptor-targeted+scintigraphy+and+radionuclide+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DBugaj%26aufirst%3DJ.%2BE.%26aulast%3DSrinivasan%26aufirst%3DA.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3DKwekkeboom%26aufirst%3DD.%2BJ.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DPreclinical%2520comparison%2520of%2520111In-labeled%2520DTPA%25E2%2580%2593%2520or%2520DOTA%25E2%2580%2593bombesin%2520analogs%2520for%2520receptor-targeted%2520scintigraphy%2520and%2520radionuclide%2520therapy%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2002%26volume%3D43%26issue%3D12%26spage%3D1650%26epage%3D1656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Nock, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolopoulou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galanis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordopatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span> </span><span class="NLM_article-title">Potent bombesin-like peptides for GRP-receptor targeting of tumors with <sup>99m</sup>Tc: A preclinical study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049437y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=100-110&issue=1&author=B.+A.+Nockauthor=A.+Nikolopoulouauthor=A.+Galanisauthor=P.+Cordopatisauthor=B.+Waserauthor=J.+C.+Reubiauthor=T.+Maina&title=Potent+bombesin-like+peptides+for+GRP-receptor+targeting+of+tumors+with+99mTc%3A+A+preclinical+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm049437y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049437y%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DGalanis%26aufirst%3DA.%26aulast%3DCordopatis%26aufirst%3DP.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DPotent%2520bombesin-like%2520peptides%2520for%2520GRP-receptor%2520targeting%2520of%2520tumors%2520with%252099mTc%253A%2520A%2520preclinical%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D1%26spage%3D100%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ananias, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierckx, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Wiele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helfrich, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsinga, P. H.</span><span> </span><span class="NLM_article-title">Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">28</span><span class="NLM_x">) </span> <span class="NLM_fpage">3033</span><span class="NLM_x">–</span> <span class="NLM_lpage">3047</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.2174%2F138161208786404335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1ehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3033-3047&issue=28&author=H.+J.+Ananiasauthor=I.+J.+de+Jongauthor=R.+A.+Dierckxauthor=C.+van+de+Wieleauthor=W.+Helfrichauthor=P.+H.+Elsinga&title=Nuclear+imaging+of+prostate+cancer+with+gastrin-releasing-peptide-receptor+targeted+radiopharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals</span></div><div class="casAuthors">Ananias, H. J. K.; de Jong, I. J.; Dierckx, R. A.; van de Wiele, C.; Helfrich, W.; Elsinga, P. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3033-3047</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Prostate cancer is one of the most common causes of cancer in men.  Evaluating the different stages of prostate cancer with conventional imaging techniques still proves difficult.  Nuclear imaging might provide a technique that is able to evaluate prostate cancer, but clin. application has been limited due to lack of accuracy of current radiopharmaceuticals.  The development of radiopharmaceuticals that can be targeted to specific antigens, overexpressed in prostate cancer, but sparse in normal tissue, is crucial.  Peptides are of particular interest because of their favorable characteristics, leading to increased attention for nuclear imaging of the gastrin-releasing-peptide-receptor (GRPR) with radiolabeled bombesin-like peptides.  Several derivs. of bombesin and its truncated form have been prepd. for imaging with single photon emission computed tomog. (SPECT) or positron emission tomog. (PET), thereby delivering potent candidates for further clin. evaluation.  This article provides an overview of the development and preclin. evaluation of radiolabeled bombesin analogs for in vivo targeting of GRPR in prostate cancer.  The effect of the radionuclide, chelator, spacer and unnatural amino acids on affinity, metabolic stability and image quality are discussed, as well as agonistic or antagonistic properties.  Potent candidates are proposed based on these selection criteria: (I) high affinity for GRPR, with rapid and specific tumor uptake (II) high hydrophilicity resulting in the preferred renal-urinary mode of excretion and low hepatobiliary excretion, (III) high stability, but relatively rapid clearance from blood.  Also, a summary is made of clin. studies that report on the detection of prostate cancer with GRPR targeted radiopharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC-UlwFOLzbrVg90H21EOLACvtfcHk0ljaJTuGqeh-dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1ehug%253D%253D&md5=bbd2930eedefa89686f6ceb9a55ebbbb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138161208786404335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208786404335%26sid%3Dliteratum%253Aachs%26aulast%3DAnanias%26aufirst%3DH.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DI.%2BJ.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%26aulast%3Dvan%2Bde%2BWiele%26aufirst%3DC.%26aulast%3DHelfrich%26aufirst%3DW.%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26atitle%3DNuclear%2520imaging%2520of%2520prostate%2520cancer%2520with%2520gastrin-releasing-peptide-receptor%2520targeted%2520radiopharmaceuticals%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26issue%3D28%26spage%3D3033%26epage%3D3047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldherr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6707</span><span class="NLM_x">–</span> <span class="NLM_lpage">6715</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6707-6715&issue=18&author=H.+Zhangauthor=J.+Chenauthor=C.+Waldherrauthor=K.+Hinniauthor=B.+Waserauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Synthesis+and+evaluation+of+bombesin+derivatives+on+the+basis+of+pan-bombesin+peptides+labeled+with+indium-111%2C+lutetium-177%2C+and+yttrium-90+for+targeting+bombesin+receptor-expressing+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWaldherr%26aufirst%3DC.%26aulast%3DHinni%26aufirst%3DK.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520bombesin%2520derivatives%2520on%2520the%2520basis%2520of%2520pan-bombesin%2520peptides%2520labeled%2520with%2520indium-111%252C%2520lutetium-177%252C%2520and%2520yttrium-90%2520for%2520targeting%2520bombesin%2520receptor-expressing%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26issue%3D18%26spage%3D6707%26epage%3D6715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abiraj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorek, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Jones, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span> </span><span class="NLM_article-title">Evolution of bombesin conjugates for targeted PET imaging of tumors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">e44046</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e44046&issue=9&author=H.+Zhangauthor=K.+Abirajauthor=D.+L.+Thorekauthor=B.+Waserauthor=P.+M.+Smith-Jonesauthor=M.+Honerauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Evolution+of+bombesin+conjugates+for+targeted+PET+imaging+of+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DThorek%26aufirst%3DD.%2BL.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DSmith-Jones%26aufirst%3DP.%2BM.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DEvolution%2520of%2520bombesin%2520conjugates%2520for%2520targeted%2520PET%2520imaging%2520of%2520tumors%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D9%26spage%3De44046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Nanda, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottenus, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rold, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sieckman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczodroski, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. J.</span><span> </span><span class="NLM_article-title">Bombesin analogues for gastrin-releasing peptide receptor imaging</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1016%2Fj.nucmedbio.2011.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=22261143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFantro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=461-471&issue=4&author=P.+K.+Nandaauthor=U.+Pandeyauthor=B.+N.+Bottenusauthor=T.+L.+Roldauthor=G.+L.+Sieckmanauthor=A.+F.+Szczodroskiauthor=T.+J.+Hoffmanauthor=C.+J.+Smith&title=Bombesin+analogues+for+gastrin-releasing+peptide+receptor+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin analogues for gastrin-releasing peptide receptor imaging</span></div><div class="casAuthors">Nanda, Prasant K.; Pandey, Usha; Bottenus, Brienne N.; Rold, Tammy L.; Sieckman, Gary L.; Szczodroski, Ashley F.; Hoffman, Timothy J.; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">461-471</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The present study describes the design and development of a series of new bombesin (BBN) antagonist peptide ligands of the form [64Cu-(NO2A-X-D-Phe6-BBN(6-13)NHEt)], where Cu-64=a positron emitting radiometal; NO2A=1,4,7-triazacyclononane-1,4-diacetic acid; X=6-amino hexanoic acid, 8-amino octanoic acid or 9-Aminononanoic acid; and BBN(6-13)NHEt=Gln-Trp-Ala-Val-Gly-His-Leu-NHEt, an antagonist analog of bombesin peptide for specific targeting of the gastrin-releasing peptide receptor (GRPR).[NO2A-X-D-Phe6-BBN(6-13)NHEt] conjugates were manually conjugated with NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid), and the resulting conjugates were labeled with 64Cu to yield [64Cu-(NO2A-X-D-Phe6-BBN(6-13)NHEt)].  The metalated and nonmetallated conjugates were purified via reversed-phase high-performance liq. chromatog. and characterized by electrospray ionization-mass spectrometry.  Competitive displacement binding assays displayed nanomolar binding affinities toward human GRPR for all of the newly formed peptide analogs.  Biodistribution studies showed very high uptake and retention of tumor-assocd. radioactivity in PC-3 (a prostate tumor model known to express the GRPR) tumor-bearing rodent models.  The radiolabeled conjugates also exhibited rapid urinary excretion and very high tumor to background ratios.  Micro-positron emission tomog. (PET) mol. imaging investigations showed clear visualization of tumors in female PC-3 tumor-bearing mice 15 h postinjection.  The biodistribution and mol. imaging study suggests that these conjugates can be considered as potential PET tracer candidates for the diagnosis of GRPR-pos. tumors in human patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdDtB20eRmLrVg90H21EOLACvtfcHk0ljaJTuGqeh-dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFantro%253D&md5=c99e58b5cbbeb503d0d3526365b7897d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2011.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2011.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DNanda%26aufirst%3DP.%2BK.%26aulast%3DPandey%26aufirst%3DU.%26aulast%3DBottenus%26aufirst%3DB.%2BN.%26aulast%3DRold%26aufirst%3DT.%2BL.%26aulast%3DSieckman%26aufirst%3DG.%2BL.%26aulast%3DSzczodroski%26aufirst%3DA.%2BF.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DBombesin%2520analogues%2520for%2520gastrin-releasing%2520peptide%2520receptor%2520imaging%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2012%26volume%3D39%26issue%3D4%26spage%3D461%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Lantry, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelletti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddalena, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdan, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arunachalam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalfe, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattuada, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linder, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedle, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunn, A. D.</span><span> </span><span class="NLM_article-title"><sup>177</sup>Lu-AMBA: Synthesis and characterization of a selective <sup>177</sup>Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=1144-1152&issue=7&author=L.+E.+Lantryauthor=E.+Cappellettiauthor=M.+E.+Maddalenaauthor=J.+S.+Foxauthor=W.+Fengauthor=J.+Chenauthor=R.+Thomasauthor=S.+M.+Eatonauthor=N.+J.+Bogdanauthor=T.+Arunachalamauthor=J.+C.+Reubiauthor=N.+Rajuauthor=E.+C.+Metcalfeauthor=L.+Lattuadaauthor=K.+E.+Linderauthor=R.+E.+Swensonauthor=M.+F.+Tweedleauthor=A.+D.+Nunn&title=177Lu-AMBA%3A+Synthesis+and+characterization+of+a+selective+177Lu-labeled+GRP-R+agonist+for+systemic+radiotherapy+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLantry%26aufirst%3DL.%2BE.%26aulast%3DCappelletti%26aufirst%3DE.%26aulast%3DMaddalena%26aufirst%3DM.%2BE.%26aulast%3DFox%26aufirst%3DJ.%2BS.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DEaton%26aufirst%3DS.%2BM.%26aulast%3DBogdan%26aufirst%3DN.%2BJ.%26aulast%3DArunachalam%26aufirst%3DT.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DRaju%26aufirst%3DN.%26aulast%3DMetcalfe%26aufirst%3DE.%2BC.%26aulast%3DLattuada%26aufirst%3DL.%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DSwenson%26aufirst%3DR.%2BE.%26aulast%3DTweedle%26aufirst%3DM.%2BF.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26atitle%3D177Lu-AMBA%253A%2520Synthesis%2520and%2520characterization%2520of%2520a%2520selective%2520177Lu-labeled%2520GRP-R%2520agonist%2520for%2520systemic%2520radiotherapy%2520of%2520prostate%2520cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D47%26issue%3D7%26spage%3D1144%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wild, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frischknecht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruchertseifer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisclair, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Provencher-Bolliger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span> </span><span class="NLM_article-title">Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (<sup>213</sup>Bi–DOTA–PESIN and <sup>213</sup>Bi–AMBA versus <sup>177</sup>Lu–DOTA–PESIN)</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1009-1018&issue=3&author=D.+Wildauthor=M.+Frischknechtauthor=H.+Zhangauthor=A.+Morgensternauthor=F.+Bruchertseiferauthor=J.+Boisclairauthor=A.+Provencher-Bolligerauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Alpha-+versus+beta-particle+radiopeptide+therapy+in+a+human+prostate+cancer+model+%28213Bi%E2%80%93DOTA%E2%80%93PESIN+and+213Bi%E2%80%93AMBA+versus+177Lu%E2%80%93DOTA%E2%80%93PESIN%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DD.%26aulast%3DFrischknecht%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMorgenstern%26aufirst%3DA.%26aulast%3DBruchertseifer%26aufirst%3DF.%26aulast%3DBoisclair%26aufirst%3DJ.%26aulast%3DProvencher-Bolliger%26aufirst%3DA.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DAlpha-%2520versus%2520beta-particle%2520radiopeptide%2520therapy%2520in%2520a%2520human%2520prostate%2520cancer%2520model%2520%2528213Bi%25E2%2580%2593DOTA%25E2%2580%2593PESIN%2520and%2520213Bi%25E2%2580%2593AMBA%2520versus%2520177Lu%25E2%2580%2593DOTA%25E2%2580%2593PESIN%2529%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D3%26spage%3D1009%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Anastasi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erspamer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucci, M.</span><span> </span><span class="NLM_article-title">Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians <i>Bombina</i> and <i>Alytes</i></span> <span class="citation_source-journal">Experientia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1971&pages=166-167&issue=2&author=A.+Anastasiauthor=V.+Erspamerauthor=M.+Bucci&title=Isolation+and+structure+of+bombesin+and+alytesin%2C+2+analogous+active+peptides+from+the+skin+of+the+European+amphibians+Bombina+and+Alytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasi%26aufirst%3DA.%26aulast%3DErspamer%26aufirst%3DV.%26aulast%3DBucci%26aufirst%3DM.%26atitle%3DIsolation%2520and%2520structure%2520of%2520bombesin%2520and%2520alytesin%252C%25202%2520analogous%2520active%2520peptides%2520from%2520the%2520skin%2520of%2520the%2520European%2520amphibians%2520Bombina%2520and%2520Alytes%26jtitle%3DExperientia%26date%3D1971%26volume%3D27%26issue%3D2%26spage%3D166%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Jensen, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battey, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spindel, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benya, R. V.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: Nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1124%2Fpr.107.07108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=18055507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1GjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=1-42&issue=1&author=R.+T.+Jensenauthor=J.+F.+Batteyauthor=E.+R.+Spindelauthor=R.+V.+Benya&title=International+Union+of+Pharmacology.+LXVIII.+Mammalian+bombesin+receptors%3A+Nomenclature%2C+distribution%2C+pharmacology%2C+signaling%2C+and+functions+in+normal+and+disease+states"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">International union of pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states</span></div><div class="casAuthors">Jensen, R. T.; Battey, J. F.; Spindel, E. R.; Benya, R. V.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-42</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian bombesin receptor family comprises three G protein-coupled heptahelical receptors: the neuromedin B (NMB) receptor (BB1), the gastrin-releasing peptide (GRP) receptor (BB2), and the orphan receptor bombesin receptor subtype 3 (BRS-3) (BB3).  Each receptor is widely distributed, esp. in the gastrointestinal (GI) tract and central nervous system (CNS), and the receptors have a large range of effects in both normal physiol. and pathophysiol. conditions.  The mammalian bombesin peptides, GRP and NMB, demonstrate a broad spectrum of pharmacol./biol. responses.  GRP stimulates smooth muscle contraction and GI motility, release of numerous GI hormones/neurotransmitters, and secretion and/or hormone release from the pancreas, stomach, colon, and numerous endocrine organs and has potent effects on immune cells, potent growth effects on both normal tissues and tumors, potent CNS effects, including regulation of circadian rhythm, thermoregulation; anxiety/ fear responses, food intake, and numerous CNS effects on the GI tract as well as the spinal transmission of chronic pruritus.  NMB causes contraction of smooth muscle, has growth effects in various tissues, has CNS effects, including effects on feeding and thermoregulation, regulates TSH release, stimulates various CNS neurons, has behavioral effects, and has effects on spinal sensory transmission.  GRP, and to a lesser extent NMB, affects growth and/or differentiation of various human tumors, including colon, prostate, lung, and some gynecol. cancers.  Knockout studies show that BB3 has important effects in energy balance, glucose homeostasis, control of body wt., lung development and response to injury, tumor growth, and perhaps GI motility.  This review summarizes advances in our understanding of the biol./pharmacol. of these receptors, including their classification, structure, pharmacol., physiol., and role in pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxWTMzOm1oKrVg90H21EOLACvtfcHk0lgixyv7ZtKr6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1GjsLk%253D&md5=dfdaea93d8101fbc67906a40e6677cee</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fpr.107.07108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.107.07108%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DR.%2BT.%26aulast%3DBattey%26aufirst%3DJ.%2BF.%26aulast%3DSpindel%26aufirst%3DE.%2BR.%26aulast%3DBenya%26aufirst%3DR.%2BV.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520LXVIII.%2520Mammalian%2520bombesin%2520receptors%253A%2520Nomenclature%252C%2520distribution%252C%2520pharmacology%252C%2520signaling%252C%2520and%2520functions%2520in%2520normal%2520and%2520disease%2520states%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26issue%3D1%26spage%3D1%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gonzalez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, R. T.</span><span> </span><span class="NLM_article-title">Bombesin-related peptides and their receptors: Recent advances in their role in physiology and disease states</span> <span class="citation_source-journal">Curr. Opin. Endocrinol. Diabetes Obes.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1097%2FMED.0b013e3282f3709b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=18185064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitFKgsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=58-64&issue=1&author=N.+Gonzalezauthor=T.+W.+Moodyauthor=H.+Igarashiauthor=T.+Itoauthor=R.+T.+Jensen&title=Bombesin-related+peptides+and+their+receptors%3A+Recent+advances+in+their+role+in+physiology+and+disease+states"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states</span></div><div class="casAuthors">Gonzalez, Nieves; Moody, Terry W.; Igarashi, Hisato; Ito, Tetsuhide; Jensen, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Endocrinology, Diabetes and Obesity</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-64</span>CODEN:
                <span class="NLM_cas:coden">COEDFK</span>;
        ISSN:<span class="NLM_cas:issn">1752-296X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review Mammalian bombesin-related peptides, gastrin-releasing peptide and neuromedin B actions are mediated by two receptors (BB1-receptor, BB2-receptor), which are closely related to the orphan receptor BRS-3 (BB3-receptor).  The purpose of this review is to highlight advances in the understanding of these peptides in physiol./disease states.  Recent findings Pharmacol./receptor-knockout studies show involvement of these receptors in a no. of new processes/diseases.  Neuromedin B/BB1-receptor is an important physiol. regulator of pituitary-thyroid function; in mediating behavior, esp. fear/anxiety; in mediating satiety through different cascades than gastrin-releasing peptide/BB2 receptors and for its autocrine tumor-growth effects.  Gastrin-releasing peptide/BB2-receptor plays important roles in mediating signals for pruritus, lung development/injury, small intestinal mucosal defense, and central nervous system processes such as learning/memory.  The signaling mechanisms of its potent growth effects are being elucidated and their possible therapeutic targets identified.  BB3-receptor knockout mice provided insights for their obesity/glucose intolerance and demonstrated that this receptor may be important in the lung response to injury, tumor growth and gastrointestinal motility.  Each receptor is frequently overexpressed in human tumors and has potent growth effects.  This effect is being explored to develop new antitumor treatments, such as bombesin-receptor ligands conjugated to cytotoxic agents.  Summary This receptor family is involved in an increasing no. of central nervous system/peripheral processes physiol. and in disease states, and increased understanding of its role may lead to novel treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGVNLseVXx0rVg90H21EOLACvtfcHk0liQ1bh9F1VrzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitFKgsrg%253D&md5=339d9e01f0564fa5b47c555b2806c8dd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1097%2FMED.0b013e3282f3709b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMED.0b013e3282f3709b%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DN.%26aulast%3DMoody%26aufirst%3DT.%2BW.%26aulast%3DIgarashi%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DBombesin-related%2520peptides%2520and%2520their%2520receptors%253A%2520Recent%2520advances%2520in%2520their%2520role%2520in%2520physiology%2520and%2520disease%2520states%26jtitle%3DCurr.%2520Opin.%2520Endocrinol.%2520Diabetes%2520Obes.%26date%3D2008%26volume%3D15%26issue%3D1%26spage%3D58%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Uehara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sancho, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantey, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuche-Berenguer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradhan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coy, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, R. T.</span><span> </span><span class="NLM_article-title">Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1685</span><span class="NLM_x">–</span> <span class="NLM_lpage">1699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1685-1699&issue=8&author=H.+Ueharaauthor=N.+Gonzalezauthor=V.+Sanchoauthor=S.+A.+Manteyauthor=B.+Nuche-Berenguerauthor=T.+Pradhanauthor=D.+H.+Coyauthor=R.+T.+Jensen&title=Pharmacology+and+selectivity+of+various+natural+and+synthetic+bombesin+related+peptide+agonists+for+human+and+rat+bombesin+receptors+differs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUehara%26aufirst%3DH.%26aulast%3DGonzalez%26aufirst%3DN.%26aulast%3DSancho%26aufirst%3DV.%26aulast%3DMantey%26aufirst%3DS.%2BA.%26aulast%3DNuche-Berenguer%26aufirst%3DB.%26aulast%3DPradhan%26aufirst%3DT.%26aulast%3DCoy%26aufirst%3DD.%2BH.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DPharmacology%2520and%2520selectivity%2520of%2520various%2520natural%2520and%2520synthetic%2520bombesin%2520related%2520peptide%2520agonists%2520for%2520human%2520and%2520rat%2520bombesin%2520receptors%2520differs%26jtitle%3DPeptides%26date%3D2011%26volume%3D32%26issue%3D8%26spage%3D1685%26epage%3D1699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmuckli-Maurer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gugger, M.</span><span> </span><span class="NLM_article-title">Bombesin receptor subtypes in human cancers: Detection with the universal radioligand <sup>125</sup>I-[D-Tyr<sup>6</sup>, beta-Ala<sup>11</sup>, Phe<sup>13</sup>, Nle<sup>14</sup>]bombesin(6–14)</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1139</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=11948125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsF2lt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1139-1146&issue=4&author=J.+C.+Reubiauthor=S.+Wengerauthor=J.+Schmuckli-Maurerauthor=J.+C.+Schaerauthor=M.+Gugger&title=Bombesin+receptor+subtypes+in+human+cancers%3A+Detection+with+the+universal+radioligand+125I-%5BD-Tyr6%2C+beta-Ala11%2C+Phe13%2C+Nle14%5Dbombesin%286%E2%80%9314%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bombesin receptor subtypes in human cancers: detection with the universal radioligand 125I-[D-Tyr6, β-Ala11, Phe13, Nle14] bombesin(6-14)</span></div><div class="casAuthors">Reubi, Jean Claude; Wenger, Sandra; Schmuckli-Maurer, Jacqueline; Schaer, Jean-Claude; Gugger, Mathias</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1139-1146</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Bombesin and bombesin receptors have been shown to play a role in cancer.  Whereas the gastrin-releasing peptide (GRP) receptor is a bombesin receptor subtype frequently expressed by tumors, the other three subtypes, the neuromedin B (NMB), BB3, and BB4 receptors, have been poorly investigated in human tissues.  We investigated 161 human tumors for their bombesin receptor subtype expression using in vitro receptor autoradiog. with the universal bombesin radioligand 125I-[D-Tyr6, β-Ala11, Phe13, Nle14]bombesin(6-14) in displacement expts. with unlabeled GRP, bombesin, NMB, and [D-Tyr6, β-Ala11, Phe13, Nle14]bombesin(6-14).  The distinct rank order of potencies of these analogs for each receptor subtype allows us to identify the predominant subtype expressed by each tumor.  Twelve of 12 prostate cancers, 41 of 57 breast cancers, and 5 of 5 gastrinomas expressed predominantly GRP receptors; 11 of 24 intestinal, 1 of 26 bronchial, and 1 of 1 thymic carcinoids had preferentially NMB receptors; 9 of 26 bronchial carcinoids, 1 large cell neuroendocrine lung carcinoma, and 4 of 9 small cell lung carcinomas had preferentially BB3 receptors, whereas 3 of 9 small cell lung carcinomas had GRP receptors.  Renal cell carcinomas had GRP receptors in 6 of 16 cases and BB3 receptors in 4 of 16 cases.  Finally, 2 of 10 Ewing sarcomas had BB3 receptors.  In situ hybridization detected BB3 receptor mRNA in neuroendocrine tumors expressing the BB3 protein.  This is the first study detecting the proteins of BB3, NMB, and GRP receptors in a group of human tumors using differential binding techniques.  Particularly relevant is the BB3 expression in lung carcinoids and other neuroendocrine lung tumors, whereas gastrointestinal carcinoids preferably express NMB receptors.  These tumors may be targets for diagnostic and radiotherapeutic applications of subtype-selective bombesin analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRfYyxkp7qw7Vg90H21EOLACvtfcHk0liQ1bh9F1VrzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsF2lt7w%253D&md5=a50d221d981065374b9facaae5744ee7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DWenger%26aufirst%3DS.%26aulast%3DSchmuckli-Maurer%26aufirst%3DJ.%26aulast%3DSchaer%26aufirst%3DJ.%2BC.%26aulast%3DGugger%26aufirst%3DM.%26atitle%3DBombesin%2520receptor%2520subtypes%2520in%2520human%2520cancers%253A%2520Detection%2520with%2520the%2520universal%2520radioligand%2520125I-%255BD-Tyr6%252C%2520beta-Ala11%252C%2520Phe13%252C%2520Nle14%255Dbombesin%25286%25E2%2580%259314%2529%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26issue%3D4%26spage%3D1139%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hohla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schally, A. V.</span><span> </span><span class="NLM_article-title">Targeting gastrin releasing peptide receptors: New options for the therapy and diagnosis of cancer</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1738</span><span class="NLM_x">–</span> <span class="NLM_lpage">1741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1738-1741&issue=9&author=F.+Hohlaauthor=A.+V.+Schally&title=Targeting+gastrin+releasing+peptide+receptors%3A+New+options+for+the+therapy+and+diagnosis+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHohla%26aufirst%3DF.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26atitle%3DTargeting%2520gastrin%2520releasing%2520peptide%2520receptors%253A%2520New%2520options%2520for%2520the%2520therapy%2520and%2520diagnosis%2520of%2520cancer%26jtitle%3DCell%2520Cycle%26date%3D2010%26volume%3D9%26issue%3D9%26spage%3D1738%26epage%3D1741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Weber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuckerman, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bostwick, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensch, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikic, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffin, T. A.</span><span> </span><span class="NLM_article-title">Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1985&pages=306-309&issue=1&author=S.+Weberauthor=J.+E.+Zuckermanauthor=D.+G.+Bostwickauthor=K.+G.+Benschauthor=B.+I.+Sikicauthor=T.+A.+Raffin&title=Gastrin+releasing+peptide+is+a+selective+mitogen+for+small+cell+lung+carcinoma+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DS.%26aulast%3DZuckerman%26aufirst%3DJ.%2BE.%26aulast%3DBostwick%26aufirst%3DD.%2BG.%26aulast%3DBensch%26aufirst%3DK.%2BG.%26aulast%3DSikic%26aufirst%3DB.%2BI.%26aulast%3DRaffin%26aufirst%3DT.%2BA.%26atitle%3DGastrin%2520releasing%2520peptide%2520is%2520a%2520selective%2520mitogen%2520for%2520small%2520cell%2520lung%2520carcinoma%2520in%2520vitro%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1985%26volume%3D75%26issue%3D1%26spage%3D306%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Matusiak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathaniel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matkowskyj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benya, R. V.</span><span> </span><span class="NLM_article-title">Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon</span> <span class="citation_source-journal">Am. J. Physiol. Gastrointest. Liver Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">G718</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2005&pages=G718-728&issue=4&author=D.+Matusiakauthor=S.+Gloverauthor=R.+Nathanielauthor=K.+Matkowskyjauthor=J.+Yangauthor=R.+V.+Benya&title=Neuromedin+B+and+its+receptor+are+mitogens+in+both+normal+and+malignant+epithelial+cells+lining+the+colon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatusiak%26aufirst%3DD.%26aulast%3DGlover%26aufirst%3DS.%26aulast%3DNathaniel%26aufirst%3DR.%26aulast%3DMatkowskyj%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DBenya%26aufirst%3DR.%2BV.%26atitle%3DNeuromedin%2520B%2520and%2520its%2520receptor%2520are%2520mitogens%2520in%2520both%2520normal%2520and%2520malignant%2520epithelial%2520cells%2520lining%2520the%2520colon%26jtitle%3DAm.%2520J.%2520Physiol.%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2005%26volume%3D288%26issue%3D4%26spage%3DG718%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Nock, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cescato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18–27): Synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">8364</span><span class="NLM_x">–</span> <span class="NLM_lpage">8374</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300741f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8364-8374&issue=19&author=B.+A.+Nockauthor=R.+Cescatoauthor=E.+Ketaniauthor=B.+Waserauthor=J.+C.+Reubiauthor=T.+Maina&title=%5B99mTc%5DDemomedin+C%2C+a+radioligand+based+on+human+gastrin+releasing+peptide%2818%E2%80%9327%29%3A+Synthesis+and+preclinical+evaluation+in+gastrin+releasing+peptide+receptor-expressing+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm300741f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300741f%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DKetani%26aufirst%3DE.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3D%255B99mTc%255DDemomedin%2520C%252C%2520a%2520radioligand%2520based%2520on%2520human%2520gastrin%2520releasing%2520peptide%252818%25E2%2580%259327%2529%253A%2520Synthesis%2520and%2520preclinical%2520evaluation%2520in%2520gastrin%2520releasing%2520peptide%2520receptor-expressing%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D19%26spage%3D8364%26epage%3D8374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Marsouvanidis, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sallegger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B. A.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-Radiotracers based on human GRP(18–27): Synthesis and comparative evaluation</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1797</span><span class="NLM_x">–</span> <span class="NLM_lpage">1803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1797-1803&issue=10&author=P.+J.+Marsouvanidisauthor=T.+Mainaauthor=W.+Salleggerauthor=E.+P.+Krenningauthor=M.+de+Jongauthor=B.+A.+Nock&title=99mTc-Radiotracers+based+on+human+GRP%2818%E2%80%9327%29%3A+Synthesis+and+comparative+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarsouvanidis%26aufirst%3DP.%2BJ.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DSallegger%26aufirst%3DW.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DNock%26aufirst%3DB.%2BA.%26atitle%3D99mTc-Radiotracers%2520based%2520on%2520human%2520GRP%252818%25E2%2580%259327%2529%253A%2520Synthesis%2520and%2520comparative%2520evaluation%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26issue%3D10%26spage%3D1797%26epage%3D1803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Cutler, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennkens, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huclier-Markai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurisson, S. S.</span><span> </span><span class="NLM_article-title">Radiometals for combined imaging and therapy</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">858</span><span class="NLM_x">–</span> <span class="NLM_lpage">883</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr3003104" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=858-883&issue=2&author=C.+S.+Cutlerauthor=H.+M.+Hennkensauthor=N.+Sisayauthor=S.+Huclier-Markaiauthor=S.+S.+Jurisson&title=Radiometals+for+combined+imaging+and+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcr3003104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr3003104%26sid%3Dliteratum%253Aachs%26aulast%3DCutler%26aufirst%3DC.%2BS.%26aulast%3DHennkens%26aufirst%3DH.%2BM.%26aulast%3DSisay%26aufirst%3DN.%26aulast%3DHuclier-Markai%26aufirst%3DS.%26aulast%3DJurisson%26aufirst%3DS.%2BS.%26atitle%3DRadiometals%2520for%2520combined%2520imaging%2520and%2520therapy%26jtitle%3DChem.%2520Rev.%26date%3D2013%26volume%3D113%26issue%3D2%26spage%3D858%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Anderson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span> </span><span class="NLM_article-title">Radiometal-labeled agents (non-technetium) for diagnostic imaging</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2219</span><span class="NLM_x">–</span> <span class="NLM_lpage">2234</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr980451q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2219-2234&issue=9&author=C.+J.+Andersonauthor=M.+J.+Welch&title=Radiometal-labeled+agents+%28non-technetium%29+for+diagnostic+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcr980451q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr980451q%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DC.%2BJ.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26atitle%3DRadiometal-labeled%2520agents%2520%2528non-technetium%2529%2520for%2520diagnostic%2520imaging%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26issue%3D9%26spage%3D2219%26epage%3D2234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Nock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span> </span><span class="NLM_article-title">Tetraamine-coupled peptides and resulting <sup>99m</sup>Tc-radioligands: An effective route for receptor-targeted diagnostic imaging of human tumors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">2655</span><span class="NLM_x">–</span> <span class="NLM_lpage">2667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.2174%2F1568026611212230003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=2655-2667&issue=23&author=B.+Nockauthor=T.+Maina&title=Tetraamine-coupled+peptides+and+resulting+99mTc-radioligands%3A+An+effective+route+for+receptor-targeted+diagnostic+imaging+of+human+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Tetraamine-coupled peptides and resulting 99mTc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors</span></div><div class="casAuthors">Nock, Berthold A.; Maina, Theodosia</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2655-2667</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The successful application of OctreoScan ([111In-DTPA]octreotide) in the diagnosis of sst2-expressing neuroendocrine tumors (NETs), on one hand, and the manifestation of peptide receptor targets in a wide range of human cancers, on the other, have synergistically induced a booming emergence of numerous radiolabeled peptide (radiopeptide) probes for tumor diagnosis and therapy in man.  Definition of mol. targets and their relation to neoplastic disease has preceded peptide-based radiopharmaceutical design and development.  New criteria have been set to safeguard efficient localization of radionuclides on tumor-assocd. high affinity - low capacity peptide receptor systems.  New tech. and biol. terms, such as specific activity or receptor affinity and internalization, have invaded the Radiopharmacy domain and have irrevocably altered our concept of radiopharmaceutical design.  Nonetheless, 99mTc remains the gold std. of diagnostic nuclear medicine as a result of ideal nuclear characteristics, cost-effectiveness and wide availability in high purity and high specific activity by means of com. 99Mo/99mTc-generators.  The evolution of conventional 99mTc-perfusion agents into modern state-of-the-art mol. radiopharmaceuticals has been a challenge addressed by several researchers.  The present review summarizes recent advances in the development of 99mTc-labeled peptides for in vivo targeting of neoplastic disease, and, in particular, those functionalized with acyclic tetraamines.  Conclusions on their applicability in non-invasive diagnosis and staging of cancer patients are drawn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5hbozbNVAzLVg90H21EOLACvtfcHk0lj933Ar_mkTdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlGqs70%253D&md5=f7464c81a9bfcc9b0d0b273431df9d72</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1568026611212230003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611212230003%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DTetraamine-coupled%2520peptides%2520and%2520resulting%252099mTc-radioligands%253A%2520An%2520effective%2520route%2520for%2520receptor-targeted%2520diagnostic%2520imaging%2520of%2520human%2520tumors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26issue%3D23%26spage%3D2655%26epage%3D2667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Breeman, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Optimising conditions for radiolabelling of DOTA-peptides with <sup>90</sup>Y, <sup>111</sup>In and <sup>177</sup>Lu at high specific activities</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1007%2Fs00259-003-1142-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=12677301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvF2lsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=917-920&issue=6&author=W.+A.+Breemanauthor=M.+De+Jongauthor=T.+J.+Visserauthor=J.+L.+Erionauthor=E.+P.+Krenning&title=Optimising+conditions+for+radiolabelling+of+DOTA-peptides+with+90Y%2C+111In+and+177Lu+at+high+specific+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing conditions for radiolabeling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities</span></div><div class="casAuthors">Breeman, Wouter A. P.; de Jong, Marion; Visser, Theo J.; Erion, Jack L.; Krenning, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">917-920</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">DOTA-conjugated peptides, such as [DOTA0,Tyr3]octreotide (DOTATOC) and [DOTA0,Tyr3]octreotate (DOTA-tate), can be labeled with radionuclides such as 90Y, 111In and 177Lu.  These radiolabeled somatostatin analogs are used for peptide receptor radionuclide therapy (PRRT).  Radioligands for PRRT require high specific activities.  However, although these radionuclides are produced without addn. of carrier, contaminants are introduced during prodn. and as decay products.  In this study, parameters influencing the kinetics of labeling of DOTA-peptides were investigated and conditions were optimized to obtain the highest achievable specific activity.  The effects of contaminants were systematically investigated, concn. dependently, in a test model mimicking conditions for labeling with minimal molar excess of DOTA-peptides over radionuclide.  Kinetics of labeling of DOTA-peptides were optimal at pH 4-4.5; pH <4 strongly slowed down the kinetics.  Above pH 5, reaction kinetics varied owing to the formation of radionuclide hydroxides.  Labeling with 90Y and 177Lu was completed after 20 min at 80°C, while labeling with 111In was completed after 30 min at 100°C.  The effects of contaminants were systematically categorized, e.g., Cd2+ is the target and decay product of 111In and it was found to be a strong competitor with 111In for incorporation in DOTA.  In contrast, Zr4+ and Hf4+, decay products of 90Y and 177Lu, resp., did not interfere with the incorporation of these radionuclides.  The following conclusions are drawn: (a) DOTA-peptides can be radiolabeled at high specific activity, (b) reaction kinetics differ for each radionuclide, and (c) reactions can be hampered by contaminants, such as target material and decay products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppyPxAqfM4yLVg90H21EOLACvtfcHk0lj933Ar_mkTdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvF2lsb4%253D&md5=24bd1047a2ded6a7710b48608776551c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00259-003-1142-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-003-1142-0%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3DDe%2BJong%26aufirst%3DM.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DOptimising%2520conditions%2520for%2520radiolabelling%2520of%2520DOTA-peptides%2520with%252090Y%252C%2520111In%2520and%2520177Lu%2520at%2520high%2520specific%2520activities%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2003%26volume%3D30%26issue%3D6%26spage%3D917%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Breeman, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Wansem, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gameren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span> </span><span class="NLM_article-title">The addition of DTPA to [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate prior to administration reduces rat skeleton uptake of radioactivity</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1007%2Fs00259-002-1054-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=12552352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Cmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=312-315&issue=2&author=W.+A.+Breemanauthor=K.+van+der+Wansemauthor=B.+F.+Bernardauthor=A.+van+Gamerenauthor=J.+L.+Erionauthor=T.+J.+Visserauthor=E.+P.+Krenningauthor=M.+de+Jong&title=The+addition+of+DTPA+to+%5B177Lu-DOTA0%2CTyr3%5Doctreotate+prior+to+administration+reduces+rat+skeleton+uptake+of+radioactivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity</span></div><div class="casAuthors">Breeman, Wouter A. P.; van der Wansem, Katy; Bernard, Bert F.; van Gameren, Arthur; Erion, Jack L.; Visser, Theo J.; Krenning, Eric P.; de Jong, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">312-315</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Peptide receptor-targeted radionuclide therapy is nowadays also being performed with DOTA-conjugated peptides, such as [DOTA0,Tyr3]octreotate, labeled with radionuclides like 177Lu.  The incorporation of 177Lu is typically ≥99.5%; however, since a total patient dose can be as high as 800 mCi, the amt. of free 177Lu3+ (= non-DOTA-incorporated) can be substantial.  Free 177Lu3+ accumulates in bone with unwanted irradn. of bone marrow as a consequence.  177Lu-DTPA is reported to be stable in serum in vitro, and in vivo it has rapid renal excretion.  Transforming free Lu3+ to Lu-DTPA might reroute this fraction from accumulation in bone to renal clearance.  We therefore investigated: (a) the biodistribution in rats of 177LuCl3, [177Lu-DOTA0,Tyr3]octreotate and 177Lu-DTPA; (b) the possibilities of complexing the free 177Lu3+ in [177Lu-DOTA0,Tyr3]octreotate to 177Lu-DTPA prior to i.v. injection; and (c) the effects of free 177Lu3+ in [177Lu-DOTA0,Tyr3]octreotate, in the presence and absence of DTPA, on the biodistribution in rats.  177LuCl3 had high skeletal uptake (i.e. 5% ID per g femur, with localization mainly in the epiphyseal plates) and a 24-h total body retention of 80% injected dose (ID).  [177Lu-DOTA0,Tyr3]octreotate had high and specific uptake in somatostatin receptor-pos. tissues, and 24-h total body retention of 19% ID.  177Lu-DTPA had rapid renal clearance, and 24-h total body retention of 4% ID.  Free 177Lu3+ in [177Lu-DOTA0,Tyr3]octreotate could be complexed to 177Lu-DTPA.  Accumulation of 177Lu in femur, blood, liver and spleen showed a dose relation to the amt. of free 177Lu3+, while these accumulations could be normalized by the addn. of DTPA.  After labeling [DOTA0,Tyr3]octreotate with 177Lu the addn. of DTPA prior to i.v. administration of [177Lu-DOTA0,Tyr3]octreotate is strongly recommended.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkwsxwmVY94rVg90H21EOLACvtfcHk0lj933Ar_mkTdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Cmtg%253D%253D&md5=a93a71f7ea735a0c2d8b1afbabadf501</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00259-002-1054-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-002-1054-4%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3Dvan%2Bder%2BWansem%26aufirst%3DK.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3Dvan%2BGameren%26aufirst%3DA.%26aulast%3DErion%26aufirst%3DJ.%2BL.%26aulast%3DVisser%26aufirst%3DT.%2BJ.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DThe%2520addition%2520of%2520DTPA%2520to%2520%255B177Lu-DOTA0%252CTyr3%255Doctreotate%2520prior%2520to%2520administration%2520reduces%2520rat%2520skeleton%2520uptake%2520of%2520radioactivity%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2003%26volume%3D30%26issue%3D2%26spage%3D312%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">de Blois, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sze Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konijnenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Zanger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeman, W. A.</span><span> </span><span class="NLM_article-title">Effectiveness of quenchers to reduce radiolysis of <sup>111</sup>In- or <sup>177</sup>Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">2677</span><span class="NLM_x">–</span> <span class="NLM_lpage">2685</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.2174%2F1568026611212230005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlGqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=2677-2685&issue=23&author=E.+de+Bloisauthor=H.+Sze+Chanauthor=M.+Konijnenbergauthor=R.+de+Zangerauthor=W.+A.+Breeman&title=Effectiveness+of+quenchers+to+reduce+radiolysis+of+111In-+or+177Lu-labelled+methionine-containing+regulatory+peptides.+Maintaining+radiochemical+purity+as+measured+by+HPLC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of quenchers to reduce radiolysis of 111In- or 177Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC</span></div><div class="casAuthors">de Blois, Erik; Chan, Ho Sze; Konijnenberg, Mark; de Zanger, Rory; Breeman, Wouter A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2677-2685</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">An overview how to measure and to quantify radiolysis by the addn. of quenchers and to maintain Radio-Chem. Purity (RCP) of vulnerable methionine-contg. regulatory peptides is presented.  High RCP was only achieved with a combination of quenchers.  However, quantification of RCP is not standardized, and therefore comparison of radiolabelling and RCP of regulatory peptides between different HPLC-systems and between labs. is cumbersome.  Therefore we suggest a set of standardized requirements to quantify RCP by HPLC for radiolabeled DTPA- or DOTA-peptides.  Moreover, a dosimetry model was developed to calc. the doses in the reaction vials during radiolabelling and storage of the radiopeptides, and to predict RCP in the presence and absence of quenchers.  RCP was measured by HPLC, and a relation between radiation dose and radiolysis of RCP was established.  The here described quenchers are tested individually as f(concn.) to investigate efficacy to reduce radiolysis of radiolabeled methionine-contg. regulatory peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmEcOBFFH9VLVg90H21EOLACvtfcHk0lj933Ar_mkTdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlGqs7s%253D&md5=08e2c76090c3911a1c58dee79cd87b0b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1568026611212230005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611212230005%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBlois%26aufirst%3DE.%26aulast%3DSze%2BChan%26aufirst%3DH.%26aulast%3DKonijnenberg%26aufirst%3DM.%26aulast%3Dde%2BZanger%26aufirst%3DR.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26atitle%3DEffectiveness%2520of%2520quenchers%2520to%2520reduce%2520radiolysis%2520of%2520111In-%2520or%2520177Lu-labelled%2520methionine-containing%2520regulatory%2520peptides.%2520Maintaining%2520radiochemical%2520purity%2520as%2520measured%2520by%2520HPLC%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26issue%3D23%26spage%3D2677%26epage%3D2685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Rolleman, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valkema, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span> </span><span class="NLM_article-title">Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1018</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1007%2Fs00259-009-1282-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=19915842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A280%3ADC%252BC3c3ls1yksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=1018-1031&issue=5&author=E.+J.+Rollemanauthor=M.+Melisauthor=R.+Valkemaauthor=O.+C.+Boermanauthor=E.+P.+Krenningauthor=M.+de+Jong&title=Kidney+protection+during+peptide+receptor+radionuclide+therapy+with+somatostatin+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues</span></div><div class="casAuthors">Rolleman Edgar J; Melis Marleen; Valkema Roelf; Boerman Otto C; Krenning Eric P; de Jong Marion</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1018-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This review focuses on the present status of kidney protection during peptide receptor radionuclide therapy (PRRT) using radiolabelled somatostatin analogues.  This treatment modality for somatostatin receptor-positive tumours is limited by renal reabsorption and retention of radiolabelled peptides resulting in dose-limiting high kidney radiation doses.  Radiation nephropathy has been described in several patients.  Studies on the mechanism and localization demonstrate that renal uptake of radiolabelled somatostatin analogues largely depends on the megalin/cubulin system in the proximal tubule cells.  Thus methods are needed that interfere with this reabsorption pathway to achieve kidney protection.  Such methods include coadministration of basic amino acids, the bovine gelatin-containing solution Gelofusine or albumin fragments.  Amino acids are already commonly used in the clinical setting during PRRT.  Other compounds that interfere with renal reabsorption capacity (maleic acid and colchicine) are not suitable for clinical use because of potential toxicity.  The safe limit for the renal radiation dose during PRRT is not exactly known.  Dosimetry studies applying the principle of the biological equivalent dose (correcting for the effect of dose fractionation) suggest that a dose of about 37 Gy is the threshold for development of kidney toxicity.  This threshold is lower when risk factors for development of renal damage exist: age over 60 years, hypertension, diabetes mellitus and previous chemotherapy.  A still experimental pathway for kidney protection is mitigation of radiation effects, possibly achievable by cotreatment with amifostine (Ethylol), a radiation protector, or with blockers of the renin-angiotensin-aldosterone system.  Future perspectives on improving kidney protection during PRRT include combinations of agents to reduce renal retention of radiolabelled peptides, eventually together with mitigating medicines.  Moreover, new somatostatin analogues with lower renal retention may be developed.  Furthermore, knowledge on kidney protection from radiolabelled somatostatin analogues may be expanded to other peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKpf3bQlnfvhgd2Wuil24tfW6udTcc2eZMC4Rft8L9jLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3ls1yksQ%253D%253D&md5=fac4a5cb290994a2d5addfad7fc5f11f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00259-009-1282-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-009-1282-y%26sid%3Dliteratum%253Aachs%26aulast%3DRolleman%26aufirst%3DE.%2BJ.%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DValkema%26aufirst%3DR.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DKidney%2520protection%2520during%2520peptide%2520receptor%2520radionuclide%2520therapy%2520with%2520somatostatin%2520analogues%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2010%26volume%3D37%26issue%3D5%26spage%3D1018%26epage%3D1031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Eerd-Vismale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolleman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O.</span><span> </span><span class="NLM_article-title">Indication for different mechanisms of kidney uptake of radiolabeled peptides</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=596-601&issue=4&author=M.+Gotthardtauthor=J.+van+Eerd-Vismaleauthor=W.+J.+Oyenauthor=M.+de+Jongauthor=H.+Zhangauthor=E.+Rollemanauthor=H.+R.+Maeckeauthor=M.+Beheauthor=O.+Boerman&title=Indication+for+different+mechanisms+of+kidney+uptake+of+radiolabeled+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3Dvan%2BEerd-Vismale%26aufirst%3DJ.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRolleman%26aufirst%3DE.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DBehe%26aufirst%3DM.%26aulast%3DBoerman%26aufirst%3DO.%26atitle%3DIndication%2520for%2520different%2520mechanisms%2520of%2520kidney%2520uptake%2520of%2520radiolabeled%2520peptides%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26issue%3D4%26spage%3D596%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Akizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mifune, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiso, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Effect of molecular charges on renal uptake of <sup>111</sup>In–DTPA-conjugated peptides</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1016%2FS0969-8051%2801%2900241-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=11578896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntV2htL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=761-768&issue=7&author=H.+Akizawaauthor=Y.+Aranoauthor=M.+Mifuneauthor=A.+Iwadoauthor=Y.+Saitoauthor=T.+Mukaiauthor=T.+Ueharaauthor=M.+Onoauthor=Y.+Fujiokaauthor=K.+Ogawaauthor=Y.+Kisoauthor=H.+Saji&title=Effect+of+molecular+charges+on+renal+uptake+of+111In%E2%80%93DTPA-conjugated+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides</span></div><div class="casAuthors">Akizawa, H.; Arano, Y.; Mifune, M.; Iwado, A.; Saito, Y.; Mukai, T.; Uehara, T.; Ono, M.; Fujioka, Y.; Ogawa, K.; Kiso, Y.; Saji, H.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">761-768</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The effect of mol. charges on renal accumulation of 111In-DTPA-labeled low mol. wt. (LMW) peptides was investigated using 111In-DTPA-octreotide derivs. as models to design radiolabeled peptides that are taken up less by renal cells.  The N-terminal d-phenylalanine (Phe) of 111In-DTPA-d-Phe1-octreotide was replaced with l-aspartic acid (Asp), l-lysine (Lys), l-methionine (Met) or l-Phe.  Cellulose acetate electrophoresis indicated that both 111In-DTPA-l-Phe1-octreotide and 111In-DTPA-l-Met1-octreotide showed similar net charges, whereas 111In-DTPA-l-αLys1-octreotide and 111In-DTPA-l-Asp1-octreotide had more pos. and neg. charges, resp., at pH values similar to those in blood and glomerular filtrate.  When injected into mice, significant differences were obsd. in the renal radioactivity levels. 111In-DTPA-l-αLys1-octreotide showed the highest radioactivity levels from 10 min to 6 h postinjection, whereas the lowest radioactivity levels were obsd. with 111In-DTPA-l-Asp1-octreotide at all the postinjection intervals.  These findings indicated that the replacement of only one amino acid in 111In-DTPA-d-Phe1-octreotide significantly altered net mol. charges of the resulting peptides and that the net charges of the 111In-DTPA-octreotide derivs. significantly affected their renal uptake.  Thus, an increase of neg. charges in peptide mols. may constitute a strategy for designing 111In-DTPA-conjugated LMW peptides with low renal radioactivity levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyC4T_TWv3trVg90H21EOLACvtfcHk0liKED_oPejYHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntV2htL0%253D&md5=e489fa5a99aca979197d759502c6be0e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900241-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900241-4%26sid%3Dliteratum%253Aachs%26aulast%3DAkizawa%26aufirst%3DH.%26aulast%3DArano%26aufirst%3DY.%26aulast%3DMifune%26aufirst%3DM.%26aulast%3DIwado%26aufirst%3DA.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DMukai%26aufirst%3DT.%26aulast%3DUehara%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DFujioka%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DKiso%26aufirst%3DY.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DEffect%2520of%2520molecular%2520charges%2520on%2520renal%2520uptake%2520of%2520111In%25E2%2580%2593DTPA-conjugated%2520peptides%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26issue%3D7%26spage%3D761%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Vegt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzels, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereeuw, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O. C.</span><span> </span><span class="NLM_article-title">Renal toxicity of radiolabeled peptides and antibody fragments: Mechanisms, impact on radionuclide therapy, and strategies for prevention</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.2967%2Fjnumed.110.075101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=20554737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWmu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1049-1058&issue=7&author=E.+Vegtauthor=M.+de+Jongauthor=J.+F.+Wetzelsauthor=R.+Masereeuwauthor=M.+Melisauthor=W.+J.+Oyenauthor=M.+Gotthardtauthor=O.+C.+Boerman&title=Renal+toxicity+of+radiolabeled+peptides+and+antibody+fragments%3A+Mechanisms%2C+impact+on+radionuclide+therapy%2C+and+strategies+for+prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention</span></div><div class="casAuthors">Vegt, Erik; de Jong, Marion; Wetzels, Jack F. M.; Masereeuw, Rosalinde; Melis, Marleen; Oyen, Wim J. G.; Gotthardt, Martin; Boerman, Otto C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1049-1058</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">A review.  Peptide-receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogs such as octreotide is an effective therapy against neuroendocrine tumors.  Other radiolabeled peptides and antibody fragments are under investigation.  Most of these compds. are cleared through the kidneys and reabsorbed and partially retained in the proximal tubules, causing dose-limiting nephrotoxicity.  An overview of renal handling of radiolabeled peptides and resulting nephrotoxicity is presented, and strategies to reduce nephrotoxicity are discussed.  Modification of size, charge, or structure of radiolabeled peptides can alter glomerular filtration and tubular reabsorption.  Coinfusion of competitive inhibitors of reabsorption also interferes with the interaction of peptides with renal endocytic receptors; coinfusion of basic amino acids is currently used for kidney protection in clin. PRRT.  Furthermore, nephrotoxicity may be reduced by dose fractionation, use of radioprotectors, or use of mitigating agents.  Decreasing the risk of nephrotoxicity allows for administration of higher radiation doses, increasing the effectiveness of PRRT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohSe8SThaOrbVg90H21EOLACvtfcHk0lhlt0RU1VtiTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWmu73E&md5=c8f96ae39feed2adfe59f4badb31b084</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.110.075101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.110.075101%26sid%3Dliteratum%253Aachs%26aulast%3DVegt%26aufirst%3DE.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DWetzels%26aufirst%3DJ.%2BF.%26aulast%3DMasereeuw%26aufirst%3DR.%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26atitle%3DRenal%2520toxicity%2520of%2520radiolabeled%2520peptides%2520and%2520antibody%2520fragments%253A%2520Mechanisms%252C%2520impact%2520on%2520radionuclide%2520therapy%252C%2520and%2520strategies%2520for%2520prevention%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26issue%3D7%26spage%3D1049%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Laverman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joosten, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roosenburg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peitl, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aloj, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Guggenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosabowski, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O. C.</span><span> </span><span class="NLM_article-title">Comparative biodistribution of 12 <sup>111</sup>In-labelled gastrin/CCK2 receptor-targeting peptides</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1410</span><span class="NLM_x">–</span> <span class="NLM_lpage">1416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1007%2Fs00259-011-1806-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm4010237&amp;key=21461732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2mtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=1410-1416&issue=8&author=P.+Lavermanauthor=L.+Joostenauthor=A.+Eekauthor=S.+Roosenburgauthor=P.+K.+Peitlauthor=T.+Mainaauthor=H.+Mackeauthor=L.+Alojauthor=E.+von+Guggenbergauthor=J.+K.+Sosabowskiauthor=M.+de+Jongauthor=J.+C.+Reubiauthor=W.+J.+Oyenauthor=O.+C.+Boerman&title=Comparative+biodistribution+of+12+111In-labelled+gastrin%2FCCK2+receptor-targeting+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides</span></div><div class="casAuthors">Laverman, Peter; Joosten, Lieke; Eek, Annemarie; Roosenburg, Susan; Peitl, Petra Kolenc; Maina, Theodosia; Maecke, Helmut; Aloj, Luigi; Guggenberg, Elisabeth; Sosabowski, Jane K.; Jong, Marion; Reubi, Jean-Claude; Oyen, Wim J. G.; Boerman, Otto C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1410-1416</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Cholecystokinin 2 (CCK-2) receptor overexpression has been demonstrated in various tumors such as medullary thyroid carcinomas and small-cell lung cancers.  Due to this high expression, CCK-2 receptors might be suitable targets for radionuclide imaging and/or radionuclide therapy.  Several CCK-2 receptor-binding radiopeptides have been developed and some have been tested in patients.  Here we aimed to compare the in vivo tumor targeting properties of 12 111In-labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated gastrin/CCK2 receptor-binding peptides.  Methods: Two CCK8-based peptides and ten gastrin-based peptide analogs were tested.  All peptides were conjugated with DOTA and labeled with 111In.  Biodistribution studies were performed in mice with s.c. CCK2/gastrin receptor-expressing tumors and with receptor-neg. tumors contralaterally.  Biodistribution was studied by counting dissected tissues at 1 and 4 h after injection.  Results: Both the CCK analogs displayed relatively low tumor uptake (approx. 2.5%ID/g) as compared to minigastrin analogs.  Two linear minigastrin peptides (MG0 and sargastrin) displayed moderate tumor uptake at both 1 and 4 h after injection, but also very high kidney uptake (both higher than 48%ID/g).  The linear MG11, lacking the penta-Glu sequence, showed lower tumor uptake and also low kidney uptake.  Varying the N-terminal Glu residues in the minigastrin analogs led to improved tumor targeting properties, with PP-F11 displaying the optimal biodistribution.  Besides the monomeric linear peptides, a cyclized peptide and a divalent peptide were tested.  Conclusion: Based on these studies, optimal peptides for peptide receptor radionuclide targeting of CCK2/gastrin receptor-expressing tumors were the linear minigastrin analog with six D-Glu residues (PP-F11), the divalent analog MGD5 and the cyclic peptide cyclo-MG1.  These peptides combined high tumor uptake with low kidney retention, and may therefore be good candidates for future clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAC_Zh5uIK3LVg90H21EOLACvtfcHk0lhlt0RU1VtiTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2mtL0%253D&md5=a9e82197b70009d5eab01adf9e0ba7c1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs00259-011-1806-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-011-1806-0%26sid%3Dliteratum%253Aachs%26aulast%3DLaverman%26aufirst%3DP.%26aulast%3DJoosten%26aufirst%3DL.%26aulast%3DEek%26aufirst%3DA.%26aulast%3DRoosenburg%26aufirst%3DS.%26aulast%3DPeitl%26aufirst%3DP.%2BK.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DMacke%26aufirst%3DH.%26aulast%3DAloj%26aufirst%3DL.%26aulast%3Dvon%2BGuggenberg%26aufirst%3DE.%26aulast%3DSosabowski%26aufirst%3DJ.%2BK.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26atitle%3DComparative%2520biodistribution%2520of%252012%2520111In-labelled%2520gastrin%252FCCK2%2520receptor-targeting%2520peptides%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2011%26volume%3D38%26issue%3D8%26spage%3D1410%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Linder, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalfe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arunachalam, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnolini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantry, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunn, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, R. E.</span><span> </span><span class="NLM_article-title">In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1171</span><span class="NLM_x">–</span> <span class="NLM_lpage">1178</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc9000189" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1171-1178&issue=6&author=K.+E.+Linderauthor=E.+Metcalfeauthor=T.+Arunachalamauthor=J.+Chenauthor=S.+M.+Eatonauthor=W.+Fengauthor=H.+Fanauthor=N.+Rajuauthor=A.+Cagnoliniauthor=L.+E.+Lantryauthor=A.+D.+Nunnauthor=R.+E.+Swenson&title=In+vitro+and+in+vivo+metabolism+of+Lu-AMBA%2C+a+GRP-receptor+binding+compound%2C+and+the+synthesis+and+characterization+of+its+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and in Vivo Metabolism of Lu-AMBA, a GRP-Receptor Binding Compound, and the Synthesis and Characterization of Its Metabolites</span></div><div class="casAuthors">Linder, Karen E.; Metcalfe, Edmund; Arunachalam, Thangavel; Chen, Jianqing; Eaton, Stephen M.; Feng, Weiwei; Fan, Hong; Raju, Natarajan; Cagnolini, Aldo; Lantry, Laura E.; Nunn, Adrian D.; Swenson, Rolf E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1171-1178</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metab. of 177Lu-AMBA (AMBA = DO3A-CH2CO-G-(4-aminobenzoyl)-QWAVGHLM-NH2), a radiotherapeutic compd. in clin. development that binds to GRP and NMB receptors, was studied in vitro (mouse, rat and human plasma, mouse kidney homogenate) and in vivo (by anal. of mouse and rat plasma and urine following IV injection of 177Lu-AMBA).  The primary metabolites were Lu-DO3A-CH2CO-G-Abz4-R, where R = -Q-OH (A), -QW-OH (B), and -QWAVGH-OH (C).  Minor amts. of (D) where R = -QWAVGHLM-OH and (E) -QWAVGHL-OH were also obsd.  Clearance of 177Lu-AMBA and of radioactivity from mouse and rat blood was rapid in vivo.  In mouse and rat urine, only metabolites Lu-A and Lu-B were found-no parent drug was excreted.  Unmetalated ligands and natLu and 177Lu complexes for Lu-AMBA metabolites A-E were synthesized, characterized by HPLC and MS, and used to perform in vitro competition and direct binding studies on GRP receptor-pos. PC-3 (human prostate) cancer cells.  Biodistribution studies with 177Lu-labeled metabolites A-E were performed in PC-3 tumor-bearing mice and the results compared with intact 177Lu-AMBA. IC50 values for unmetalated metabolite ligands A-E were >400 nM in PC-3 cells in competition binding studies against 177Lu-AMBA.  No direct binding to PC-3 cells was obsd. with 177Lu-labeled A-C, confirming IC50 results. 177Lu-labeled metabolites A-E showed no uptake in GRP-receptor pos. tumor or pancreas in PC-3 tumor bearing mice.  All metabolites were rapidly excreted via the renal route (∼78-87%) within 1 h.  These results demonstrate that the tumor uptake obsd. with 177Lu-AMBA is due to parent drug and not due to any of its identified metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvqAOuUWHaErVg90H21EOLACvtfcHk0lgDA91ZfT_-1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFGlsLY%253D&md5=da849967f62a36434ddaeae9a2f972eb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fbc9000189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9000189%26sid%3Dliteratum%253Aachs%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DMetcalfe%26aufirst%3DE.%26aulast%3DArunachalam%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DEaton%26aufirst%3DS.%2BM.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DRaju%26aufirst%3DN.%26aulast%3DCagnolini%26aufirst%3DA.%26aulast%3DLantry%26aufirst%3DL.%2BE.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26aulast%3DSwenson%26aufirst%3DR.%2BE.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520metabolism%2520of%2520Lu-AMBA%252C%2520a%2520GRP-receptor%2520binding%2520compound%252C%2520and%2520the%2520synthesis%2520and%2520characterization%2520of%2520its%2520metabolites%26jtitle%3DBioconjugate%2520Chem.%26date%3D2009%26volume%3D20%26issue%3D6%26spage%3D1171%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeman, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwekkeboom, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valkema, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span> </span><span class="NLM_article-title">Tumor imaging and therapy using radiolabeled somatostatin analogues</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar800188e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=873-880&issue=7&author=M.+de+Jongauthor=W.+A.+Breemanauthor=D.+J.+Kwekkeboomauthor=R.+Valkemaauthor=E.+P.+Krenning&title=Tumor+imaging+and+therapy+using+radiolabeled+somatostatin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Far800188e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far800188e%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%26aulast%3DKwekkeboom%26aufirst%3DD.%2BJ.%26aulast%3DValkema%26aufirst%3DR.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26atitle%3DTumor%2520imaging%2520and%2520therapy%2520using%2520radiolabeled%2520somatostatin%2520analogues%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2009%26volume%3D42%26issue%3D7%26spage%3D873%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Reile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armatis, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schally, A. V.</span><span> </span><span class="NLM_article-title">Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: Internalization of receptor bound <sup>125</sup>I-(Tyr<sup>4</sup>) bombesin by tumor cells</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=29-38&issue=1&author=H.+Reileauthor=P.+E.+Armatisauthor=A.+V.+Schally&title=Characterization+of+high-affinity+receptors+for+bombesin%2Fgastrin+releasing+peptide+on+the+human+prostate+cancer+cell+lines+PC-3+and+DU-145%3A+Internalization+of+receptor+bound+125I-%28Tyr4%29+bombesin+by+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReile%26aufirst%3DH.%26aulast%3DArmatis%26aufirst%3DP.%2BE.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26atitle%3DCharacterization%2520of%2520high-affinity%2520receptors%2520for%2520bombesin%252Fgastrin%2520releasing%2520peptide%2520on%2520the%2520human%2520prostate%2520cancer%2520cell%2520lines%2520PC-3%2520and%2520DU-145%253A%2520Internalization%2520of%2520receptor%2520bound%2520125I-%2528Tyr4%2529%2520bombesin%2520by%2520tumor%2520cells%26jtitle%3DProstate%26date%3D1994%26volume%3D25%26issue%3D1%26spage%3D29%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Tatsi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cescato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordopatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B. A.</span><span> </span><span class="NLM_article-title">[<sup>111</sup>In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers—First results of a preclinical study</span> <span class="citation_source-journal">EJNMMI Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm4010237&amp;key=10.1186%2F2191-219X-2-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm4010237&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyitbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=25&issue=1&author=A.+Tatsiauthor=T.+Mainaauthor=R.+Cescatoauthor=B.+Waserauthor=E.+P.+Krenningauthor=M.+de+Jongauthor=P.+Cordopatisauthor=J.+C.+Reubiauthor=B.+A.+Nock&title=%5B111In-DOTA%5DSomatostatin-14+analogs+as+potential+pansomatostatin-like+radiotracers%E2%80%94First+results+of+a+preclinical+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">[111In-DOTA]somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study</span></div><div class="casAuthors">Tatsi, Aikaterini; Maina, Theodosia; Cescato, Renzo; Waser, Beatrice; Krenning, Eric P.; de Jong, Marion; Cordopatis, Paul; Reubi, Jean Claude; Nock, Berthold A.</div><div class="citationInfo"><span class="NLM_cas:title">EJNMMI Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25/1-25/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">ERJEAI</span>;
        ISSN:<span class="NLM_cas:issn">2191-219X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Background: In this study, we report on the synthesis, radiolabeling, and biol. evaluation of two new somatostatin-14 (SS14) analogs, modified with the universal chelator DOTA.  We were interested to investigate if and to what extent such radiotracer prototypes may be useful for targeting sst1-5-expressing tumors in man but, most importantly, to outline potential drawbacks and benefits assocd. with their use.  Methods: AT1S and AT2S (DOTA-Ala1-Gly2-c[Cys3-Lys4-Asn5-Phe6-Phe7-Trp8/DTrp8-Lys9-Thr10-Phe11-Thr12-Ser13-Cys14-OH], resp.) were synthesized on the solid support and labeled with 111In.  The sst1-5 affinity profile of AT1S/AT2S was detd. by receptor autoradiog. using [Leu8,dTrp22,125I-Tyr25]SS28 as radioligand.  The ability of AT2S to stimulate sst2 or sst3 internalization was qual. analyzed by an immunofluorescence-based internalization assay using hsst2- or hsst3-expressing HEK293 cells.  Furthermore, the internalization of the radioligands [111In]AT1S and [111In]AT2S was studied at 37°C in AR4-2J cells endogenously expressing sst2.  The in vivo stability of [111In]AT1S and [111In]AT2S was tested by high-performance liq. chromatog. anal. of mouse blood collected 5 min after radioligand injection, and biodistribution was studied in normal mice.  Selectively for [111In]AT2S, biodistribution was further studied in SCID mice bearing AR4-2J, HEK293-hsst2A+, -hsst3+ or -hsst5+ tumors.  Results: The new SS14-derived analogs were obtained by solid phase peptide synthesis and were easily labeled with 111In.  Both SS14 conjugates, AT1S, and its DTrp8 counterpart, AT2S, showed a pansomatostatin affinity profile with the resp. hsst1-5 IC50 values in the lower nanomolar range.  In addn., AT2S behaved as an agonist for sst2 and sst3 since it stimulated receptor internalization.  The 111In radioligands effectively and specifically internalized into rsst2A-expressing AR4-2J cells with [111In]AT2S internalizing faster than [111In]AT1S.  Ex vivo mouse blood anal. revealed a rapid degrdn. of both radiopeptides in the bloodstream with the DTrp8 analog showing higher stability.  Biodistribution results in healthy mice were consistent with these findings with only [111In]AT2S showing specific uptake in the sst2-rich pancreas.  Biodistribution of [111In]AT2S in tumor-bearing mice revealed receptor-mediated uptake in the AR4-2J (1.82 ± 0.36 %ID/g-block 0.21 ± 0.17 %ID/g at 4 h post injection (pi)), the HEK293-hsst2A+ (1.49 ± 0.2 %ID/g-block 0.27 ± 0.20 %ID/g at 4 h pi), the HEK293-hsst3+ (1.24 ± 0.27 %ID/g-block 0.32 ± 0.06 %ID/g at 4 h pi), and the HEK293-hsst5+ tumors (0.41 ± 0.12 %ID/g-block 0.22 ± 0.006 %ID/g at 4 h pi).  Radioactivity washed out from blood and background tissues via the kidneys.  Conclusions: This study has revealed that the native SS14 structure can indeed serve as a motif for the development of promising pansomatostatin-like radiotracers.  Further peptide stabilization is required to increase in vivo stability and, consequently, to enhance in vivo delivery and tumor targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg7R9fdxYKDrVg90H21EOLACvtfcHk0lhLm5QFtJvgjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyitbbI&md5=2ce622f111b105b37cf02e63bd9310c0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1186%2F2191-219X-2-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2191-219X-2-25%26sid%3Dliteratum%253Aachs%26aulast%3DTatsi%26aufirst%3DA.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DCordopatis%26aufirst%3DP.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DNock%26aufirst%3DB.%2BA.%26atitle%3D%255B111In-DOTA%255DSomatostatin-14%2520analogs%2520as%2520potential%2520pansomatostatin-like%2520radiotracers%25E2%2580%2594First%2520results%2520of%2520a%2520preclinical%2520study%26jtitle%3DEJNMMI%2520Res.%26date%3D2012%26volume%3D2%26issue%3D1%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4010237&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm4010237%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-21%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4010237" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799331f4f743c58","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
